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Abstract 
Background/Objectives: Surgical site infection (SSI) is the third most common type of 
healthcare-associated infection accounting for approximately 38% of all infections in the 
surgical patient population. In 2005, the Canadian "Safer Healthcare Now" campaign 
identified 4 strategies to reduce SSI risk based on available evidence: 1) antibiotic 
prophylaxis, 2) maintenance of glycemic control in the coronary artery bypass graft 
surgery population, 3) maintenance of intraoperative normothermia in the colorectal 
surgery patient population, and 4) appropriate preoperative hair removal. Published 
research is limited on the use of these four strategies in the prevention of SSis in vascular 
surgery patients. The purpose of this study was to determine risk factors for SSI in 
vascular surgery and to identify nursing interventions to decrease this risk. A secondary 
purpose was to determine the SSI rate for vascular surgery patients. 
Methods: A sample of 116 was drawn from all vascular surgery patients who underwent 
Class 1 (clean) vascular surgeries of interest (bypass and abdominal aortic aneurysm 
[AAA] repair) during 2005. Every second patient from a list with one of these surgeries 
formed the sample. Paper and electronic charts were retrospectively reviewed, including 
post discharge records from outpatients clinics, ER, and the Vascular Laboratory. 
Information on risk factors for SSI, practices related to the management of risk factors, 
and incidence of SSI was gathered. Standard CDC definitions were used. An attending 
physician saw 95.7% of patients within 6 weeks oftheir surgery. 
Results: The SSI rate was 17.2%. Significant SSI risk factors were incorrect timing of 
antibiotic prophylaxis (p = 0.0068), increased glucose or HbA 1 c level perioperatively in 
non-diabetic patients (p = 0.0468), and abrasion in the incisional area preoperatively with 
no antibiotic prophylaxis (p = 0.0047). Risk factors with a trend but not significant were: 
not receiving antibiotic prophylaxis with no artificial graft inserted, elevated HbAlc 
level, hypothermia despite receiving a warming intervention in the post-anaesthesia 
recovery room (PARR), hypothermia on transfer between units, abrasion in the incisional 
area preoperatively, emergency procedure, renal/liver disease, increased number of 
cigarettes smoked, blood loss of 1200-4499 mL, and anemia with blood loss 300-1199 
11 
mL. Practice findings included antibiotic prophylaxis was not given to all patients at the 
correct time or at all, the frequency of glucose and temperature assessments was 
inconsistent, interventions for hyperglycemia and hypothermia were inconsistently 
provided and evaluated for effectiveness, aspects of assessment and care were not 
documented, and policy and protocols for temperature assessment were inconsistently 
followed. 
Implications: The findings highlight elements of care which might reduce SSI in vascular 
surgery patients. Improvements are needed in glucose and temperature assessment and 
control, and antibiotic prophylaxis. Additional research is required with a larger sample 
size, and on strategies to improve adherence to protocols and policies in existence. 
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Chapter 1: Introduction 
Patient safety initiatives are important in preventing some of the adverse events 
that have been identified in Canadian Hospitals (Ross Baker et al. , 2004). In order to 
promote patient safety it is critical to examine these adverse events and the risk factors 
associated with them. The most frequent type of adverse event reported in the 2004 
Canadian Adverse Event study was surgical complications, including surgical site 
infection (SSI) (Safer Healthcare Now [SHN], 2009). SSis are associated with high 
morbidity and mortality. There are a number of factors that increase the risk of SSI 
development (Spear, 2008). Much of the work that has been conducted on these risk 
factors has been done in general and coronary artery bypass graft (CABG) surgery. Less 
work has been done in vascular surgery and the specific risk factors associated with this 
type of surgery as well as the nursing interventions that may reduce these risk factors. 
This exploratory, descriptive study was designed to address these gaps in knowledge and 
contribute to increasing patient safety. 
Background to the Problem 
Surgical site infection (SSI) is the third most common type of healthcare-
associated infection (HAl), and accounts for approximately 38% of all infections in the 
surgical patient population (Neumayer et al., 2007). Of the surgical procedures performed 
in the USA each year, 3% of patients go on to develop an SSI (Odom-Forren, 2006). 
Patients unfortunate enough to develop an SSI are twice as likely to die and 60% more 
likely to require an Intensive Care Unit (ICU) admission than those who do not have this 
post-operative complication (Griffin, 2005; Kirkland, Briggs, Trivette, Wilkinson, & 
1 
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Sexton, 1999; Woods, 2005). Patients who develop an SSI remain in hospital twice as 
long and have rates of readmission 6 times higher than those without infection (Griffin, 
2005; Kluytmans & Voss, 2002; Kirkland et al. , 1999). The monetary and time resources 
required to care for patients who develop an SSI places further stress on an already 
stressed nursing workforce. There are no recently published Canadian studies that report 
the financial cost associated with SSI. However, in 1998, Zoutman, McDonald, and 
Vethanayagan reported that each SSI cost close to $4000 per wound infection. While this 
amount appeared high 11 years ago, it is likely that the cost is even higher now. For 
patients with an SSI, there is increased exposure to antibiotic resistant organisms (AROs) 
while in hospital, monetary loss due to time away from gainful employment, and 
decreased quality of life related to illness, pain, stress, decreased mobility and time away 
from family and loved ones. With vascular surgery in particular, a patient also has a 
greater chance of requiring an amputation ifthey develop an SSI (Calligaro et al., 1994). 
In response to the preventable economic and personal burden of SSI, in 2004 the 
USA initiated the "1 00,000 Lives Campaign". Canada followed this plan in April 2005, 
and initiated the "Safer Healthcare Now" (SHN) campaign through the Canadian Patient 
Safety Institute (CPSI). The objectives of these 2 campaigns were to reduce medical 
errors that were causing suffering and death to patients in acute care institutions. 
Partnering hospitals in the Canadian SHN campaign received how-to kits, literature 
resources, access to resource staff, and on-going education to address six specific areas: 
1) reduction in deaths from myocardial infarctions, 2) prevention of ventilator associated 
pneumonia, 3) prevention of SSI, 4) activation of rapid response teams, 5) prevention of 
medication errors, and 6) prevention of vascular access device infections. 
3 
These SIX interventions were targeted with the primary goal of improving 
processes for healthcare delivery by focusing on patients and their safety while in the care 
of health providers in acute care institutions. The program has since been expanded to 
include prevention of AROs, patient falls, and venous thromboembolism. Eastern Health, 
in the province of Newfoundland and Labrador, which includes the acute care city 
hospital used for this study, undertook three projects with the SHN campaign to reduce 
deaths from myocardial infarctions, prevent ventilator associated pneumonia, and prevent 
and reduce the rate of SSis. 
The SHN campaign has identified four strategies to reduce SSI risk based on 
available evidence, which are: I) antibiotic prophylaxis, 2) maintenance of glycemic 
control in the Coronary Artery Bypass Graft (CABG) surgery population, 3) maintenance 
of intraoperative normothem1ia in the colorectal surgery patient population, and 4) 
appropriate preoperative hair removal. Published standards are currently available that 
outline appropriate methods of preoperative antibiotic prophylaxis and hair removal 
(Bratzler et al., 2005; Mangram, Horan, Pearson, Silver, & Jarvis, 1999; Operating Room 
Nurses Association of Canada [ORNAC], 2007). Glycemic control has been primarily 
studied in CABG surgery and critically ill ICU patients, while intraoperative temperature 
control has mainly been studied in colorectal surgery patients. 
Study Rationale 
The SHN campaign recommends antibiotic prophylaxis and appropriate hair 
removal, both of which are accepted practices, to decrease the risk of SSI in most 
surgeries. However, there is little known information regarding the relevance of 
--- ---- ------------ --------------------~-
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hyperglycemia and hypothermia as risk factors in other surgeries. One such group where 
limited information exists about risk factors is the vascular surgery patient population. 
Patients with peripheral arterial disease (PAD) requiring vascular surgery have a 
similar pathophysiological process of atherosclerosis as those patients with coronary 
artery disease (CAD) who require CABG surgery. Both groups also have increased rates 
of diabetes and hyperglycemia causing glycosylation of the lining of arteries, which leads 
to arterial complications. Because of the similarity in pathophysiological processes 
between these 2 groups, and the recommendation of SHN to maintain normoglycemia in 
CABG surgery patients due to the increased risk of SSis with hyperglycemia, it seemed 
reasonable to investigate if hyperglycemia is a risk factor for SSI in vascular surgery 
patients as well. Because the SHN campaign identified maintenance of normothermia as 
an intervention to reduce SSI risk, it also seemed reasonable to explore the effect of 
hypothermia on SSI in the vascular surgery patient population. 
Besides the 4 risk factors listed above, several other factors have been identified to 
increase SSI risk in vascular and other surgeries. Despite not being the focus of this study, 
these additional risk factors were included in data collection and analysis to assess and 
control for their effects. Some examples of these risk factors include, but are not limited 
to: gender, age, location of incision, body mass index (BMI), smoking, and blood 
transfusions (Abboud, Wey, & Baltar, 2004; Aragon, Ring, & Covelli, 2003; Borger et 
al. , 1998; Kurz, Sessler, & Lenhardt, 1996; Malone, Genuit, Tracy, Gannon & 
Napolitano, 2002; Neumayer et al. , 2007; Trick et al. , 2000a; Wilson & Sexton, 2003; 
Wong, 2004; Yeung, Cope, Whittome, & Lintott, 2008). Additional SSI risk factors 
identified in other surgeries will be discussed in Chapter 2. 
5 
If SSI risk factors are identified in vascular surgery patients, then interventions 
can be taken to reduce these risks. However, there is little information available, either in 
the published literature or at Eastern Health, about perioperative nursing assessments and 
interventions related to addressing patients' SSI risk. Many SSI risk factors, including the 
4 identified by the SHN campaign, are amenable to intervention by nurses. Nurses are 
involved at every stage of the perioperative process and can play a vital role in the 
reduction of SSis. Preoperatively, nurses can influence patients through education about 
strategies to reduce risk factors such as anemia, smoking and increased BMI. 
Intraoperatively, nurses can ensure timely antibiotic prophylaxis is given and provide 
appropriate hair removal for each surgery. Intraoperatively as well, nurses can advocate 
for patients who do not have a voice while under anaesthetic through accurate monitoring 
and documentation of glucose and temperature control and employment of appropriate 
interventions to ensure that patients are kept normoglycemic and normothermic. 
Postoperatively, in the Post Anesthesia Recovery Room (PARR) and on the postoperative 
unit, nurses can provide timely and accurate assessment and maintenance of 
normoglycemia and normothermia as well as assessment of wound healing. This study 
therefore collected data on selected nursing assessments and interventions. Such 
information could help identify how nurses are caring for patients and if change is 
required; this information would be helpful to Eastern Health before resources are put 
into place to change practice. 
While risk factors for SSI in vascular surgery in addition to perioperative 
assessments and interventions provided by nurses were the focus of this study, there was 
also interest in determining the incidence of SSI in vascular surgery patients as a 
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secondary objective. Although targeted surveillance is carried out on select patient 
populations within Canada, the results are not reported into a central registry as exists in 
the USA with the National Healthcare Safety Network (NHSN), formerly called the 
National Nosocomial Infections Surveillance reporting system (NNIS) (Edwards et al., 
2008). In St. John's city hospitals within Eastern Health, postoperative SSI surveillance 
had been conducted on select patient populations including CABG, breast, C-section, 
neurosurgery, colorectal, and gynecologic oncology surgery, while SSI surveillance in 
vascular surgery has not been a focus. The results of our study could therefore contribute 
to Canadian statistics on vascular surgery SSI rates. 
Study Purpose and Research Questions 
The main purpose of this study was to learn more about vascular surgery patient 
risk factors for SSI and how nurses intervene to reduce SSI risk in these patients. Based 
on the recommendations for targeted interventions in other patient populations in the 
SHN campaign and risk factors for SSI identified in the research literature, the primary 
research questions were: 
1) Was preoperative antibiotic prophylaxis appropriate? 
2) Was perioperative normoglycemia maintained? 
3) Was perioperative normothermia maintained? 
4) Was preoperative hair removal appropriate? 
5) What was the association between these factors and SSI? 
6) What nursing interventions related to these four factors were used by nurses? 
----- --------------------------------------
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Secondary research questions were: 
7) What was the incidence of SSI? 
8) What were other important risk factors for SSI? 
Study Framework 
The chain of infection model guides Infection Prevention and Control (IP&C) 
practice and was therefore chosen as the model to guide this research study. The basic 
tenet is that the chain is made up of links in a sequence of events that must happen for an 
infection to occur. If any of the links in the chain of infection are broken, then an 
infection cannot occur (Goering et al., 2008). Figure 1 shows a graphic representation of 
the chain of infection model. 
Figure 1: Chain of Infection 
(Used with permission from Dr. D. Moralejo, 2009) 
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An SSI cannot occur without an infectious agent at the site of the incision. The 
reservoir in the chain of infection model is the area where the infectious agent or 
microorganism resides. The source of the infectious agent may be endogenous, meaning 
from the patient, or exogenous, meaning from the environment (Chalmers & Straub, 
2006). Typically, in SSI, there is no portal of exit because the reservoir in many cases is 
the patient's own skin. Preoperatively, ineffective skin cleansing may leave 
microorganisms on the skin, increasing the microbial load, which is the number of 
microorganisms in the area. This is especially relevant for vascular surgery when the 
incision site is the groin, which has a high microbial load to begin with due to the nature 
of its location and the moist environment that exists there. Intraoperatively, factors 
influencing the presence of an infectious agent include incorrect use of antibiotics that do 
no( target the appropriate microorganism or antibiotics that are not given in sufficient 
time or amount to allow tissue antibiotic levels to be at their peak at the time of the 
incision. Attention to these factors with appropriate interventions may potentially 
decrease the microbial load of infectious organisms at the incision site and possibly break 
the ·chain of infection. 
Transmission of an infectious agent in the chain of infection model occurs when 
the infectious agent is passed on to the patient. Typically in SSI, this occurs when the 
surgical incision is made, opening a portal of entry through the skin to the inside of the 
body. Another portal of entry may occur during hair removal when skin may be abraded 
or have microscopic nicks that allow entry of microorganisms from the reservoir (skin) 
into the wound. Health care workers may also be involved in transmission of an 
infectious agent from an exogenous source to the patient. Some factors affecting 
9 
transmission intraoperatively include the improper use of surgical attire like gowns, 
gloves, caps, shoe covers, and masks or broken sterile technique (Wong, 2004). 
The susceptible host is the final link in the chain of infection model. In surgical 
patients, it is the patient undergoing surgery who may be exposed to the infectious agent 
that has been transmitted. Factors that increase host susceptibility, which have been 
tem1ed risk factors, are the focus of Chapter 2 and will be discussed in detail there. 
In this study, the chain of infection model provided a framework of links in a 
chain to consider in terms of risk factors to assess and areas for possible intervention to 
decrease the risk of SSI. 
Study Methodology 
This descriptive study used a retrospective chart review of paper and electronic 
inpatient and outpatient charts to collect information on each patient's glycemic and 
temperature status, other risk factors for SSI, practices related to the management of risk 
factors with emphasis on glucose and temperature, and incidence of SSI. Further details 
ofthe study's methodology are found in Chapter 3. 
Summary 
In summary, this exploratory, descriptive study will address gaps in the literature 
about risk factors for SSI in vascular surgery patients. It will also contribute to nursing 
literature about interventions to reduce SSI in vascular surgery patients that are amenable 
to nursing intervention. Finally, it will provide information on the incidence of SSI in 
vascular surgery within Eastern Health. 
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Chapter 2: Literature Review 
This chapter provides an overview of the literature relevant to this study. It begins 
with a summary of methods used for the literature review, a definition of surgical site 
infection (SSI) and a summary of strategies to use to identify SSis, which were the 
outcome measure in this study. It next discusses the chain of infection model and the 
pathogenesis of SSI including the inflammatory response leading to signs and symptoms 
experienced by the patient. The literature will then be reviewed about antibiotic 
prophylaxis, glycemic and temperature control, and preoperative hair removal as these 
were the main foci of the "Safer Healthcare Now" (SHN) campaign and have been 
identified as risk factors in other surgical groups. Other risk factors for SSI that were 
assessed for effects, and to control for confounding, will be discussed as they pertain to 
surgery patients, with a more specific discussion of vascular surgery studies where studies 
are available. The chapter will conclude with a brief outline of SSI rates in vascular 
surgery, and a discussion of interventions nurses can provide to reduce SSI risk and rates. 
Literature Review Methods 
Sources for the review of the literature were online databases, websites, the 
Google search engine, textbooks on nursing, microbiology, pathophysiology, and 
infection control, and the references/bibliographies of journal articles and book chapters. 
Specific websites reviewed were the Centers for Disease Control (CDC), the Public 
Health Agency of Canada (PHAC), the Canadian Diabetes Association (CDA), the 
Community and Hospital Infection Control Association (CHICA-Canada), the 
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Association for Professionals in Infection Control and Epidemiology (APIC), the 
International Federation of Infection Control (IFIC), the Operating Room Nurses 
Association of Canada (ORNAC), the National Association of PeriAnaesthesia Nurses of 
Canada (NAPANc), the Canadian Anesthesiologists Society, and the American Society of 
Anesthesiologists (ASA). 
For this review an online search of PubMed, CINAHL, the Cochrane 
Collaboration, and the internet using Google was conducted for the years 1990 - 2009. 
Some key words used in this search were "risk factor", "antibiotic prophylaxis", 
"glycemic", "glucose", "diabetes", "temperature", "hypothermia", "normothermia", "hair 
removal", "surgery", "infection", "SSI", "surveillance", "nursing", "intervention", 
"assessment", and "protocol". Searches were limited to English language publications and 
research involving humans only. Abstracts were reviewed and applicable articles were 
obtained. Pertinent full text articles were obtained though e-journals, paper journals and 
the interlibrary loan system. 
Definition of Surgical Site Jrifection and Risk Factor 
An ssr is an infection that occurs in the incision or surrounding tissue of a patient 
who has undergone a surgical procedure. The SSI does not exist before the incision is 
made; instead the microorganisms are transmitted into the incision during the surgical 
procedure once the skin has been incised. The Centres for Disease Control (CDC) has 
published criteria for diagnosing an SSI that are found in Appendix I and were used for 
the diagnosis of SSI in this study (Mangram, Horan, Pearson, Silver, & Jarvis, 1999). 
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As described in Chapter 1, a number of factors will influence whether or not an 
infection develops, even in the presence of infectious agents. A risk factor is any variable 
that has a significant, independent association with the development of an SSI (Horan, 
Andrus, & Dudeck, 2008). However, before determining the relationship between risk 
factors and SSI, which was the primary purpose of this study, it is important to have an 
accurate account of the number of SSis that developed. Routine monitoring of SSis is 
referred to as surveillance. 
SSI Surveillance 
While this study was not a surveillance study, use of surveillance methods was 
appropriate to identify SSis. Therefore, a review of the literature on surveillance methods 
was done to identify strategies that would balance the ability to find cases (sensitivity) 
with feasibility. The findings of this review will be presented briefly here. Several options 
exist for conducting SSI surveillance; each method has benefits and limitations (Mangram 
et al. , 1999; Zoutman et al., 2003). 
One of the most cost efficient methods is to mail out a questionnaire to patients; 
however, these may have a return rate as low as 2% (Gravel-Tropper, Oxley, Memish, & 
Garber, 1995), with most return rates being between 15.2 - 57.5% (Fanning, Johnston, 
MacDonald, LeFort-Jost, & Dockerty, 1995; Mitchell, Swift, & Gilbert, 1999; Poulsen & 
Meyer, 1996). Higher return rates were found in one study where the questionnaire return 
rate was 71.2% at week 4 after discharge, decreasing to 60.1% at week 6 after discharge 
(Whitby et al., 2002). Questionnaires may also have a low sensitivity measurement, 
which is the proportion of actual cases that are detected. A sensitivity of 0.09 - 0.28 has 
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been reported, meaning that the questionnaire is only able to detect 9 - 28% of cases of 
SSI that actually developed (Holtz & Wenzel, 1992; Sands, Vineyard, & Platt, 1996; 
Whitby et al., 2002). This low sensitivity measurement may be due to the fact that they 
are not completed and returned or that they rely on patient self-report. 
In a systematic literature review, Petherick, Dalton, Moore, and Cullum (2006) 
repmted on a study that assessed patient self-diagnosis of SSI through telephone survey 
or questionnaire (Seaman & Lammers, 1991). This study reported that only 52.4% (n = 
11) of 21 patients accurately identified an SSI. Inflammation was incorrectly identified as 
an SSI in 47.6% of the cases. However, other studies have shown a high correlation 
between patient self-report and actual SSI presence (Mitchell et al., 1999; Valentine, 
Steele, & Zaloga, 1998). 
Studies of telephone surveys by Infection Control Practitioners have reported that 
72.3 -95.4% of patients were able to be reached for surveillance but they also have the 
potential to be very labour intensive as well if calls are not taken by the patients and 
repeat calls are necessary (Fanning et al. , 1995; Martinez et al., 1997). Surgeons' reports 
are another logical way to identify an infection, as surgeon diagnosis is one of the criteria 
in the CDC guidelines to use for identification of SSI (Mangram et al., 1999). However, 
the sensitivity of this method may be diminished if the surgeon does not have the 
oppmtunity to assess the patient post-discharge, or does not return a questionnaire (Sands 
et al., 1996). 
Accessibility of charts makes their review very feasible. Charts have different 
components that could be used for surveillance with variable sensitivity accorded to each 
part. For example, laboratory result based surveillance has a sensitivity of 0.77 - 0.91 , 
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while reviewing antimicrobial usage has a sensitivity of 0.70, and screening hospital 
kardexes has a sensitivity of 0.75 - 0.94. Surveillance sensitivity measurements for other 
methods such as fever record reviews is much lower at 0.09- 0.56 (Pottinger, Herwaldt, 
& Perl, 1997; Roy & Perl, 1997; Smyth & Emmerson, 2000). Total chart reviews, which 
review all sources including laboratory data, notes, and visits to the facility such as to the 
ER and OPD, are the most commonly used method for SSI surveillance, as they balance 
feasibility with an acceptable sensitivity of 0.74 - 0.94 (Haley et al. , 1980). The total 
chart review was the chosen surveillance method for this study because of the feasibility 
and sensitivity of this method. 
The sensitivity of any of these methods for detecting the true SSI rate is affected 
by the period of surveillance. According to the CDC guidelines, surveillance for SSI 
should not be limited to the hospital period only. For surgical patients without an artificial 
implant inserted during surgery, surveillance should be done up to 30 days after surgery 
including after the patient is discharged. For patients who have an artificial implant 
during surgery, their surveillance should be done for a full year (Mangrarn et al., 1999). 
Post-discharge surveillance is essential to identifying an accurate SSI rate, as it 
has been estimated that 46 to 84% of infections occur after discharge (Burns & Dippe, 
1982; Delgado-Rodriguez, Gomez-Ortega, Sillero-Arenas & Llorca, 2001 ; Jonkers, 
Elenbaas, Terporten, Nieman, & Stobberingh, 2003; Mitchell et al. , 1999; Moro et al. , 
2005; Sands et al. , 1996). The most common post-discharge surveillance method of total 
chart reviews, previously described, count only those patients who report back to the 
facility with an SSI up to 30 days or 1 year after surgery depending on the presence of an 
implant. This type of post-discharge surveillance will not identify patients who developed 
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an SSI but saw their family physician or went to another facility, or did not seek 
treatment, likely resulting in under-reporting of the true SSI rate. 
For post-discharge surveillance to be complete, each patient should be assessed to 
determine whether an SSI did or did not develop, verifying that those counted as not 
having an SSI in fact did not have one. This post-discharge surveillance can take place 
through Infection Prevention and Control (IP&C) practitioners phoning patients, surgeons 
returning forms on all patients, with or without an SSI, or a chart review of clinic visits if 
all patients return to the same clinic. Yetman, Moralejo, and Coffin (200 1) conducted a 
study with patients in St. John's, the site of this study, where they compared SSI rates as 
calculated by 3 methods: phone calls by the IP&C practitioner on all patients, return of 
SSI notification forms by community health nurses, and total chart reviews as previously 
described. Routine surveillance done on patients having undergone a C-section would 
have missed two thirds of infections that developed postoperatively if they had limited 
their surveillance to standard methods of total chart reviews only. 
The final factor in SSI surveillance is the use of standardized criteria, such as 
those from the CDC, to diagnose infection. The use of standardized criteria ensures that 
results are comparable within an IP&C program, regardless of when the data were 
collected or who collected it, and between different studies that report SSI surveillance 
(Smyth & Emmerson, 2000). 
Overview of the Literature on Risk Factors 
A review of the literature yielded only 6 studies that specifically investigated risk 
factors for SSI in vascular surgery patients. One of these 6 studies was a systematic 
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literature review of 22 studies that focused primarily on antibiotic prophylaxis as a risk 
factor for SSI and did not report on other risk factors assessed in this study. There is more 
information available about SSI risk factors in other patient populations than vascular 
surgery. Because of the lack of literature related to vascular surgery patients, the focus of 
this review is on studies of other surgical patient groups, such as those with coronary 
artery disease (CAD) undergoing Coronary Artery Bypass Graft (CABG) surgery. There 
is a lot of emphasis on literature regarding patients with CAD because of similarities in 
the pathophysiological processes that occur in patients with CAD and peripheral arterial 
disease (PAD). 
Peripheral Arterial Disease, Coronary Artery Disease and Diabetes 
The pathophysiological process of atherosclerosis is common to CAD (the 
indication for CABG surgery) and PAD (the indication for vascular surgery). This 
process causes the development of hard plaques on the arteries of patients with CAD and 
PAD. These hard plaques thicken and subsequently narrow the opening in the affected 
arteries, thereby reducing blood flow and oxygen supply to the organs and tissues they 
supply. In CAD, the coronary arteries supplying the heart are affected and in PAD, the 
peripheral arteries supplying the extremities are affected (McCance & Huether, 2006). 
The most common symptom experienced by patients with PAD is intermittent 
claudication. This is a severe pain in the calf, thigh or buttock muscle caused by ischemia, 
or a lack of oxygen to the affected extremity (Fowkes, Dunbar & Lee, 1995; Garcia, 
2006). PAD is a fairly common disease affecting 21-67% of nursing home residents in 
estimates in the USA (Vouyouka & Kent, 2007) and is a major cause of disability, loss of 
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work, and lifestyle changes (Garcia, 2006). It has been estimated that up to 50% of 
patients with PAD also have CAD though they may not know it (Brevetti et al., 2008). In 
fact, the majority of patients with PAD die from CAD (Leng et al. , 1996; Monreal et al. , 
2008) but not before suffering through the severe pain and tissue gangrene and 
amputation associated with PAD (Garcia). Major risk factors for PAD, which are very 
similar to CAD, are hypertension, smoking, hypercholesterolemia, dyslipidemia, and 
increased body mass index (BMI) (Coughlin, Gulati, Mavor, Gough, & Homer-
Vanniasinkam, 2007; Garcia; Hirsch et al. , 2006; Leng et al. ; Monreal et al. ; Murabito et 
al. , 2002; Selvin & Edinger, 2004; Willigendael, Teijink, Bartelink, Kuiken, & Boiten et 
al. , 2004). One of the primary contributors to PAD is diabetes, which is also a common 
contributor to CAD due to the same pathophysiological process of glycosylation of the 
capillary basement membrane of arteries which sets up the process of athersclerosis 
(McCance & Huether, 2006). 
The prevalence of diabetes in Canada in 2005 was 1.8 million Canadians, 5.5% of 
the population (Public Health Agency of Canada [PHAC], 2007). By the year 2016, this 
is expected to increase to 2.4 million Canadians with diabetes (Canadian Diabetes 
Association [CDA], 2008). With increased numbers of patients with diabetes, the rate of 
PAD will possibly also rise requiring more patients to undergo vascular surgery assuming 
there is no improvement in the prevention of diabetes or alternate therapies for better 
glycemic control discovered. Because CAD and PAD have such a similar 
pathophysiological process, it would seem reasonable that risk factors for SSI in CABG 
surgery, about which there is a lot of information, may also be similar to risk factors in 
vascular surgery, about which there is very little known. 
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Chain of Infection, Host Defenses, and Pathogenesis ofSSJ 
To understand risk factors, an understanding of the chain of infection, host 
defenses, and the pathogenesis of infection is necessary. As outlined in the introductory 
chapter, the chain of infection involves an infectious agent (microorganism) in the 
reservoir, transmission of the infectious agent through a portal of entry, and a susceptible 
host to receive the infectious agent. For an SSI to occur, there must be microbial presence 
in the wound that cannot be handled by available white blood cells (WBCs) and 
transmission of the infectious agent from a reservoir into the patient' s surgical incision at 
the time of surgery (Mangram et al. , 1999). Most often, the reservoir implicated in SSI 
development is the patient' s own skin or gastrointestinal tract. Frequently, Gram-positive 
staphylococci are the offenders but if a groin incision is involved, there may also be 
Gram-negative bacteria due to close proximity to the perineum (Mangram et al.; Wong, 
2004). However, other reservoirs with microorganisms may be in the operating room 
(OR) environment with transmission from the air or from contaminated equipment or 
surgical gloves. These microorganisms may then be transmitted to the patient undergoing 
surgery, the susceptible host in the chain of infection. 
The probability that an infection may occur is increased by 3 factors: 1) host 
defenses, 2) the virulence of the microorganism, and 3) the microbial load (Goering et al. , 
2008). Host defenses include physiological defenses that enable the individual to fight off 
the offending mircroorganism and not allow an infection to take hold, such as adequate 
white blood cells to phagocytose the microorganism or adequate blood supply to bring 
nutrients and oxygen to the area affected. Thus, any comorbidity that reduces these 
defenses in the patient becomes a risk factor. Even for a patient with adequate host 
19 
defenses, an infection still may develop if the microorganism is especially virulent or 
resistant to many antibiotics and overcomes the host defenses. Alternatively, a high 
number of microorganisms entering the wound, known as the microbial load, may also 
overcome the normal defenses of the patient undergoing surgery. Therefore, antibiotics 
are given prophylactically and skin is cleansed preoperatively with an antiseptic to 
decrease the microbial load. 
If infectious agents infiltrate the body's defenses and enter the area ofthe surgical 
incision, they will begin to replicate, damaging surrounding cells and initiating an 
inflarnmatory response. In the inflammatory response, blood vessels in the area will dilate 
leading to warm, red skin (erythema), WBCs will rush to the area to phagocytose the 
offending infectious agent leading to pus in the area, capillary membranes will become 
leaky leading to swelling (edema) in the area, and pain receptors (nociceptors) in the area 
will be stimulated by edema. In addition, chemical mediators from the inflammatory 
response will cause pain and fever (McCance & Huether, 2006). The inflammatory 
response that occurs with an infection leads to the signs and symptoms that herald the 
development of an infection: erythema, pus, edema, pain and fever. 
The criteria of the most commonly used definition of SSI (Mangram et al., 1999) 
include the signs and symptoms experienced by the patient and are outlined in Appendix 
I. These signs and symptoms brought about by the aforementioned inflammatory response 
are important to clinically diagnose a patient with an SSI. 
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SSI Risk Factors 
Regardless of the location or depth of the SSI or the signs and symptoms 
experienced by the patient, an SSI will not occur if the offending microorganism cannot 
overcome the host defenses. Any factor that decreases the host defenses is a risk factor. 
As already mentioned, there are many studies that have explored the relationship between 
risk factors and SSI in other surgical populations. What follows in this section is a 
discussion of the 4 major risk factors identified by the "Safer Healthcare Now" (SHN) 
campaign, namely, inappropriate antibiotic prophylaxis, perioperative hyperglycemia and 
hypothermia, and inappropriate hair removal. In the vascular surgery literature on SSI risk 
factors, only 6 studies were found related to risk factors for SSI. One of these 6 vascular 
surgery studies investigated the effect of hyperglycemia on SSI risk, but no other vascular 
surgery studies investigated antibiotic prophylaxis, inappropriate hair removal, or 
intraoperative hypothermia as risk factors, which were the risk factors of the SHN 
campaign. This section will conclude with a discussion of other risk factors identified in 
studies of both vascular surgeries and other surgeries, as these other risk factors were 
assessed in this study to identify their effect and control for confounding. 
Antibiotic Prophylaxis and SSI 
Antibiotic prophylaxis refers to the administration of an antibiotic before the 
surgical incision is made. By giving the antibiotic prior to the surgical incision, this 
ensures that adequate tissue levels of antibiotic are available to reduce the microbial load 
to an amount that the body's WBCs can remove from the body. Consensus guidelines on 
antibiotic prophylaxis are widely available in the literature and are based on studies that 
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have examined the effect of antibiotic prophylaxis on the reduction of infection (Blondel-
Hill & Fryters, 2006; Mangram et al., 1999). In a meta-analysis of 22 RCTs that explored 
risk factors for SSI in vascular surgery, prophylactic systemic antibiotics reduced the risk 
of wound infection by 69% (p = 0.02) (Stewart, Eyers, & Earnshaw, 2007). Guidelines 
specific for vascular surgery state that it is appropriate to use antimicrobial prophylaxis in 
vascular surgery when: 1) an intravascular prosthesis is to be placed, 2) a lower extremity 
is being revascularized, and/or 3) there is arterial surgery involving the abdominal a011a 
or a groin incision (Blondel-Hill & Fryters; Mangram et al.; Wong, 2004). In this study, 
all patients fulfilled at least one of these criteria. 
In providing antibiotic prophylaxis, close attention must be paid to: 1) the 
microorganisms most likely to be encountered during the operation and therefore the 
appropriate drug, 2) the timing of the antibiotic so that tissue levels have reached their 
peak while the incision is being made, 3) the maximum therapeutic level of the antibiotic 
to be maintained throughout the operation, 4) the dose, which should be based on patient 
weight so that the drug reaches all tissues, and 5) the timely discontinuation of the 
antibiotic after surgery to prevent the development of antibiotic resistant organisms 
(AROs) (Wong, 2004). 
The most commonly encountered microorganisms in vascular surgery are those 
found on the skin and in the groins, such as Staphylococcus aureus or Staphylococcus 
epidermidis, which are sensitive to cephalosporins (Blondel-Hill & Fryters, 2006; 
Mangram et al., 1999). Cefazolin, a first generation cephalosporin, is the antibiotic of 
choice in clean vascular surgery as it is directed against Gram-positive bacteria that are 
most commonly encountered (Bandyk, 2008; Blondel-Hill & Fryters; Bratzler & Houck, 
22 
2004; Griffin, 2005; Homer-Vanniasinkam, 2007; Mangram et al.). In the case of a 
penicillin allergy, clindamycin is the antibiotic of choice (Blondel-Hill & Fryters; 
Man gram et al.). 
The dose of the antibiotic is also very important for prophylaxis. For heavier 
patients, there is more tissue to be perfused with antibiotics. For adult patients weighing 
less than 100 kilograms (kg), 1gram (g) of cefazolin is sufficient for prophylaxis, but 
patients weighing greater than 100 kg should be given 2 g of cefazolin to reduce SSI risk 
(Bandyk, 2008; Blondel-Hill & Fryters, 2006; Bratzler & Houck, 2004; Ramiro, Kaplan, 
Guerami, Wrobel, & Marzouk, 2007). 
The half-life of cefazolin is 1.5 - 2.5 hours for those with normal kidney function 
(Bratzler & Houck, 2004; Springer, 2007). A repeat dose of antibiotics after 4 hours in the 
OR is recommended in the literature to keep therapeutic levels of the antibiotic available 
(Bandyk, 2008; Blondel-Hill & Fryters, 2006; Bratzler & Houck; Mangram et al. , 1999). 
Morita et al. (2005) reported that an SSI developed in 26.5% of patients who should have 
received a second dose but did not, compared to 8.5% of those patients who did receive a 
second dose as recommended. 
Correct timing of the antibiotic is essential to reduce SSI risk and late 
administration of antibiotics has been suggested to raise SSI risk (Bandyk, 2008; Classen 
et al., 1992; Dellinger et al., 2005; Griffin, 2005; Silver et al. , 1996; Stewart et al., 2007). 
In a study of 284 7 surgical patients, regression confirmed that preoperative administration 
of antibiotics, compared to postoperative administration, is associated with the lowest risk 
of SSI. Patients who received the antibiotic after the incision was made had 5.8 times the 
risk (p < 0.0001) of developing an SSI as those who received it before the incision was 
23 
made (Classen et a!.). The antibiotic should be given preoperatively, within 0 - 60 
minutes before the incision is made. The timing of the antibiotic in this way is essential to 
ensure that plasma levels have reached a peak and the incisional tissue is being perfused 
with antibiotic, thus providing bacteriocidal action, when the incision is made (Bandyk, 
2008; Blondel-Hill & Fryters, 2006; Bratzler & Houck, 2004; Griffin; Odom-Forren, 
2006). 
A final factor in appropriate antimicrobial prophylaxis is discontinuation of the 
antibiotic within 24 hours of surgery. Stewart eta!. (2007) reported, in a meta-analysis of 
22 RCTs that explored prevention of SSI in vascular surgery patients that continuing the 
antibiotic past 24 hours conferred no additional benefit. In a study by Harbath, Samore, 
Lichtenberg, and Carmeli (2000), continuing the antibiotic past 24 hours was also not 
significantly associated with decreased SSI risk, but patients who continued to receive 
antibiotics after 48 hours for no indication had 1.6 times (p = 0.027) the risk of having an 
ARO, compared to those patients who had their antibiotics discontinued. Other antibiotic 
protocols also recommend discontinuation of antibiotics within 24 hours to prevent 
organisms from developing drug resistance (Bratzler & Houck, 2004; Dellinger et a!. , 
2005; Plonczynski, 2005). 
Diabetes, Hyperglycemia and SSI 
Having a diagnosis of diabetes mellitus has been identified as an independent risk 
factor for SSI in studies, particularly in patients undergoing CABO surgery, with risk 
increased by 2 - 6 times that of non-diabetic patients (Fietsam, Bassett, & Glover, 1991; 
Slaughter, Olson, Lee, & Ward, 1993; Talbot, 2005; Zacharias & Habib, 1996). In a study 
24 
by Latham, Lancaster, Covington, Pirolo, and Thomas (2001), SSI risk was increased 
significantly if a CABG surgery patient was diabetic (OR: 2.72; 95% CI: 1.64- 4.66; p < 
0.001), and in a study by Borger et al. (1998), the proportion of diabetic patients having 
CABG surgery who developed a deep sternal wound SSI, 38%, was almost double that of 
nondiabetic patients, 19.3% of whom developed an SSI (p = 0.001). Zacharias and Habib 
found similar results, in which the odds of developing a sternal wound SSI with CABG 
surgery were 5.9 times that of nondiabetic patients (OR: 5.9; 95% CI: 2.8 - 12.5; p < 
0.01). The presence of diabetes as a risk factor for SSI has also been seen in general 
surgery patients (OR: 1.55; 95% CI: 1.11- 2.16; p = 0.010) (Malone et al., 2002). In a 
study that combined general and vascular surgery patients (n = 28161 vascular surgery 
patients as part of a study of 163,624 patients), having a diagnosis of diabetes was an 
independent risk factor for SSI (p < 0.0001) though this study did not report the risk for 
the vascular surgery patients separately (Neumayer et al., 2007). In only vascular surgery 
patients, there was only 1 older study of 561 patients found, in which having diabetes 
incurred 2.9 times the risk (p = 0.03) of developing an SSI (Richet et al. , 1991). 
Furnary and Wu (2006) stated that it is not the diagnosis of diabetes itself that 
raises risk but the common attributes of diabetic patients such as obesity and impaired 
renal function that increases risk. Over a 19-year period, they investigated whether it is 
actually hyperglycemia experienced by the patient and not the diagnosis of diabetes that 
raises SSI risk as well as risk for other outcomes such as death, and these studies will be 
discussed shortly (Furnary & Wu). Elevated glucose levels in the postoperative period 
have been significantly associated with: 1) a longer postoperative recovery period in the 
Intensive Care Unit (ICU) and in hospital, translated into increased cost and suffering, 2) 
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other health associated infections (HAis) of the unnary tract, bloodstream, vascular 
access devices, and lungs, 3) cardiac dysfunction, and 4) higher mortality (Dronge et al., 
2006; Estrada, Young, Nifong, & Chitwood, 2003; Furnary & Wu; Furnary, Wu, & 
Bookin, 2004; Grey & Perdrizet, 2004; Krinsley, 2003; Lazaret al., 2004; Neumayer et 
al., 2007; O'Sullivan et al., 2006; Umpierrez et al., 2002). When researchers provided 
interventions that lowered glucose levels to 11.1 mmol/L or less, decreases have been 
seen in: 1) length of ICU and hospital stay, 2) length of time on a ventilator or receiving 
inotropic medication in ICU, 3) HAl development, 4) incidence of atrial fibrillation, 
myocardial ischemia, and need for pacing, 5) mortality, 6) new organ failure and 
polyneuropathy, and 7) need for transfusion of blood (Furnary & Wu; Furnary et al. , 
2004; Grey & Perdrizet; Lazaret al.; Van Den Berghe et al. , 2001). 
With respect to infections in diabetic patients, an increased incidence in the 
numbers of infections seen in diabetic patients is owed to: 1) tissue hypoxia from micro 
and macrovascular disease, 2) elevated glucose levels in tissues promoting bacterial 
growth, 3) impaired neutrophil function with respect to chemotaxis, phagocytosis, and 
intracellular bacteriocidal activity, and 4) changes in vascular permeability leading to 
edema and promotion of bacterial growth, all of which decrease host defenses (Aragon et 
al., 2003 ; Campbell, 2007; Dronge et al. , 2006; Golden, Kao, Peart-Vigilance & Brancati, 
1999; McCowen, Malhotra, & Bistrian, 2001; Smiley & Umpierrez, 2006). 
While it is clear that hyperglycemia increases risk of infection this factor has not 
been well researched in vascular surgery patients. Of the 6 studies found that looked at 
risk factors in the vascular surgery population, only 1 explored the relationship between 
elevated preoperative glycosylated hemoglobin (HbA1c) and SSI in vascular surgery 
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patients (O'Sullivan et al., 2006). This study will be discussed later in this section. A 
study by Vriesendorp, Morelis, DeVries, Legemate, and Hoekstra, (2004) found an 
independent association between elevated post-operative glucose and all HAis (p = 
0.007), but did not specify the relationship between hyperglycemia and SSI in particular, 
so this study is not discussed further. 
To determine for this study what level was to be considered hyperglycemic and 
what timeframe of hyperglycemia during the perioperative period incurred increased risk 
of SSI, a literature review was undertaken of other surgery patients. Because diabetes is a 
common comorbidity and atherosclerosis is the same pathophysiological process in 
patients with PAD as it is with patients with CAD, a review of the literature of CABG 
surgery patients that explored risk factors for SSI, particularly hyperglycemia was 
undertaken. Twelve studies examined the effect of postoperative hyperglycemia on SSI; 8 
were studies of CABG surgery patients, and 4 were studies with other surgery or critically 
ill patients. The search also yielded 5 studies that explored the effect of preoperative 
hyperglycemia on SSI. All values in the discussion have been converted from mg/dL to 
SI units, mmol/L, for ease of comparison. Table 1 in Appendix B gives futiher details on 
these studies related to methodology, definition of SSI if available, results, and 
limitations. What follows is a discussion of the studies of postoperative and preoperative 
glucose control and their effects on SSI risk in critically ill patients or patients undergoing 
surgeries other than vascular surgery. 
Post-operative hyperglycemia and SSI. Eight studies of CABG surgery patients 
found a significant association between postoperative glucose control and the 
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development of SSI (Furnary, Gao, Grunkemeier, Wu, Zerr et al., 2003; Furnary et al., 
2004; Furnary & Wu, 2006; Furnary, Zerr, Grunkemeier, & Starr, 1999; Guvener, 
Pasaoglu, Demircin, & Oc, 2002; Latham et al., 2001; Lazar et al. , 2004; Zerr et al. , 
1997). These studies had samples of 1000-5500 participants, with the exception of Lazar 
et al., who had 141 patients. In all 8 of these studies, SSI risk was increased for glucose 
levels of 11.1 mmol/L or greater. In Furnary et al. (1999, 2003, 2004) and Furnary & Wu 
(2006), which will be collectively referred to as the Furnary et al. (1999-2006) studies, as 
well as the study by Zerr et al., data had been collected cumulatively over a nineteen-year 
period with the same significant association being found between SSI and hyperglycemic 
values of 11.1 mmol/L or greater in the first 48 hours postoperatively. In Furnary & Wu, 
for every 2.8 mmol/L increase in glucose, the risk of deep sternal wound SSI increased 
mote than two-fold (p < 0.0001). Latham et al. reported that risk of SSI was 2.5 times 
higher in patients with glucose levels of 11.1 mmol/L or greater, compared to those with 
glucose levels less than 11.1 mmol/L. Risk more than tripled when glucose levels were 
greater than 16.7 mmol/L compared to less than 11.1 mmol/L (p < 0.0001). In one study 
by Furnary et al. (2004), the value of 9.7 mmol/L appeared to be the critical point at 
which SSI risk began to increase significantly. 
Some of these studies reported on hyperglycemia in the intraoperative and early 
postoperative period immediately after surgery only, while other studies reported glucose 
values throughout the perioperative period and up to 48 hours after surgery. Glucose 
values were averaged to find a daily glucose value and glucose control was maintained 
with a continuous intravenous infusion of insulin (CII), with glucose levels being checked 
at intervals ranging from every 20 minutes to every 2 hours (Furnary et al., 1999-2006 
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studies; Latham et al. 2001; Lazaret al., 2004), or every 4 hours (Guvener et al., 2002). 
The study by Zerr et al. ( 1997) used sliding scale subcutaneous insulin for treatment of 
glucose levels that were assessed every I - 2 hours. This study served as the basis of 
comparison for the studies by Fumary et al. (1999-2006). They compared patients with 
CII who had increasingly tighter glucose control postoperatively, as low as 3.9 mmol/L, 
and investigated the effects of this increasingly tighter control on SSI risk. Comparison of 
the rates of SSI and how the varying postoperative glucose levels affected this rate is 
quite challenging with these particular studies. This challenge was due to: 1) the 
inconsistency with how hyperglycemia was defined, 2) the variation in frequency with 
which the glucose values of patients were assessed and the interventions received for 
hyperglycemia, 3) the lack of information on the criteria used to diagnose an SSI, and 4) 
the differing periods of surveillance postoperatively. All of these challenges limit the 
comparability of the studies. Regardless of these limitations, hyperglycemia greater than 
11.1 mmol/L increased SSI risk. 
The association between hyperglycemia postoperatively and SSI risk has not been 
as well studied in populations other than CABG surgery. However, 4 studies were found 
that explored this relationship in other surgeries or critically ill patients. In 2008, Vilar-
Compte et al. studied the association between perioperative hyperglycemia and SSI in 
260 patients undergoing clean mastectomy surgery. The researchers found that 
postoperative glucose levels greater than 8.3 mmol/L tripled the risk of SSI (p = 0.02) in 
multivariate analysis. The other 3 studies looked at postoperative hyperglycemia and SSI 
in critically ill patients (Collier et al. , 2005; Grey et al., 2004; Krinsley, 2004). Only 1 
study of 61 critically ill general surgery patients found that significantly more patients 
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with a mean postoperative glucose of 9.9 ± 3.4 mmol/L developed an SSI compared to 
patients with a glucose level of 6.9 ± 2 mmol/L (p < 0.05) (Grey et al.). The other 2 
studies did not find a significant association between elevated glucose postoperatively 
and SSI risk (Collier et al.; Krinsley). In both of these studies, 2 groups receiving 
different glucose control strategies were compared for SSI risk related to hyperglycemia. 
However, in both studies, independent of the treatment used, the patients' mean 
postoperative glucose levels were 8.3 mmol/L or less. This is lower than the value 
associated with an increased risk of SSI in other studies. These results suggest that tighter 
glucose control decreases the risk of SSI but this does not help identify the threshold or 
cut-off value at which SSI risk increases. 
From this review, the conclusion has been drawn that risk for SSI increases when 
glucose levels are 11.1 mmol/L or greater in CABG surgery patients in the first 48 hours 
postoperatively and greater than 8.3 mmol/L in patients undergoing mastectomy surgery. 
What is unknown is how hyperglycemia in the first 48 hours and after 48 hours 
postoperatively affects vascular surgery SSI risk because there are no studies that report 
these associations. Although Furnary et al. (2004) found that 9. 7 mmol/L was the point at 
which SSI risk began to rise, the majority of CABG surgery studies found that 11 .1 
mmol/L was the cut-off value. Therefore, 11.1 mmol/L was chosen as the definition for 
hyperglycemia in this study. This choice is further supported by recommendations from 
the CDA (2008) to maintain glucose levels of 8 - 11 mmol/L in the perioperative period. 
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Preoperative hyperglycemia and SSJ None of the 6 vascular surgery studies in the 
literature search assessed the effect of preoperative hyperglycemia on SSI risk. Five 
studies were found that did assess the effect of preoperative hyperglycemia on SSI risk in 
CABG surgery patients (Guvener et al., 2002; Latham et al., 2001; Trick et al., 2000a; 
Trick et al., 2000b; Wilson & Sexton, 2003). Table 1 in Appendix B gives further details 
on these studies related to methodology, definition of SSI if available, results, and 
limitations. 
In two separate case-control studies of 309 and 1590 patients, a preoperative 
glucose level of 11.1 mmol/L or greater in diabetic patients, compared to normoglycemic 
patients, led to a four times greater risk of SSI at the radial artery donor site (p = 0.01) 
(Trick et al., 2000a), and a ten times greater risk of a deep sternal incision SSI (p = 0.008) 
(Trick et al., 2000b ). In univariate analysis, Latham et al. (200 1 ), with a sample of 1000 
patients, found that patients with elevated preoperative glucose of 11 .1 mmol/L or greater 
were twice more likely to develop SSI than normoglycemic patients (p = 0.005) though 
elevated preoperative glucose was not identified as an independent predictor of SSI in 
multivariate analysis. 
In a retrospective cohort study of 400 diabetic CABG surgery patients, Guvener et 
al. (2002) looked at pre-operative glucose levels 2 days before surgery and found that 
patients with deep sternal wound SSI had a mean preoperative glucose level of 12.3 ± 0.6 
mmol/L (which is above the cut-off of 11.1 mmol/L), compared to patients who did not 
develop an SSI who had a lower mean glucose level of 9.2 ± 2.0 mmol/L (p = 0.006). 
They also found that these patients had increased glucose levels 1 day preoperatively, 
though these levels were not as high. Those who developed an SSI had a mean 1-day 
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preoperative glucose level of 10.1 ± 0.5 mmol/L, compared to patients who did not 
develop an SSI whose mean glucose value was 7.7 ± 1.7 mmol/L (p = 0.009). Another 
study of 258 patients found that a fasting preoperative glucose level of 7 mmol/L or 
greater incurred more than 5 times the risk of SSI than values less than this (OR: 5.25; CI 
95%: 1.82 - 15.11)(p = 0.002) when diabetes, gender and ASA score were controlled for 
(Wilson & Sexton, 2003). 
As with the studies on postoperative glucose control, comparison between studies 
is quite difficult with these studies due to differing definitions of SSI, frequency of 
glucose monitoring, and periods of SSI surveillance. Further information on the 
limitations of these studies is found in Table 1 Appendix B. Overall however, these 5 
studies support the conclusion that when glucose levels are elevated preoperatively to 
11 .1 mmol/L or greater in CABG surgery, there is increased risk of s·si development. 
What is unclear though is the actual level associated with increased risk as it varied by 
study, ranging from 7 mmol/L to 12.3 mmol/L. For this reason, as well as reasons already 
discussed in the section on postoperative glucose control, 11.1 mmol/L was chosen as the 
definition of hyperglycemia in this study. 
Hemoglobin AI c and SSI Because of the significant findings associated with 
preoperative glucose control, it would seem appropriate to speculate that an elevated 
HbA1c, as a measure of longer term glucose control over a 2 - 3 month period 
(Krishnamurti & Steffes, 2001 ), may also have a significant impact on SSI risk. An 
elevated HbA1c level has been demonstrated to significantly affect length of stay, 
mortality, adverse coronary events, cognitive impairment, restenosis of arteries after 
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angioplasty, and risk of lower limb amputation (Corpus et al., 2003 ; Kadoi, Saito, Fujita, 
& Goto, 2005; Malmberg, Norhammar, Wedel, & Ryden, 1999; Mazeika, Prasad, Bui, & 
Seidelin, 2003; Medhi et al., 2001; O'Sullivan et al., 2006). The CDA (2008) currently 
recommends that diabetics maintain HbA1c levels at less than 7% and nondiabetics at 
less than 6%. 
In a review of the literature, 3 studies were found that explored the relationship 
between elevated HbA1c and increased infection risk in surgery patients. One study of 
490 diabetic, non-cardiac surgery patients found, after multivariate analysis, that patients 
with a HbA 1 c level greater than 7% developed more than twice as many HAis as those 
patients with a HbA1c level less than 7% (p = 0.007), but the researchers did not repmi 
SSI rate specifically (Dronge et al., 2006). In a study by Latham et al. (2001) with 300 
diabetic, CABG surgery patients who had HbA1c level measured, 42% had HbA1c values 
of 8% or greater at the time of surgery. Of these patients, 78% developed perioperative 
hyperglycemia compared with 43% of the patients with lower HbA1c values (OR 1.78; 
95% CI: 1.47-2.16; p < 0.001). In this study, while an association was not made between 
HbA1c and SSI, it was made between postoperative hyperglycemia and SSI as discussed 
in a previous section, with risk more than doubling for glucose values of 11.1 mmol/L or 
greater (p < 0.0001). From this, it can be inferred that an increased HbA1c level does lead 
to perioperative hyperglycemia, which in turn leads to increased SSI risk, so an increased 
HbA1c level may lead to increased SSI risk. 
There was only 1 vascular surgery study found that measured SSI as a component 
of all-cause postoperative morbidity as an endpoint, with elevated HbA1c as a predictor 
(O' Sullivan et al., 2006). In this study of 165 vascular surgery patients, it was found that a 
------ - - ------------------------------------
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less than optimal HbA 1 c level of greater than 6% in non-diabetic patients was a 
significant predictor of postoperative morbidity, including SSI. These non-diabetic 
patients with a suboptimal HbA1c developed significantly more incisional SSis than did 
non-diabetics with normal HbA1c values (9.9% vs. 0%; p < 0.041). The study does not 
report the SSI rate in diabetic patients with suboptimal HbAlc levels. 
Thus, while there were few studies found that explored the relationship between 
elevated HbA1c and SSI, one study of vascular surgery patients did show that it was a 
significant risk factor in this patient population. Table 1 in Appendix B provides further 
details on the preceding 3 studies related to methodology, definition of SSI if available, 
results, and limitations. 
Conclusion: Hyperglycemia and SSI 
In these studies of the effect of preoperative and postoperative hyperglycemia, as 
measured by glucose levels or HbA1c on risk for SSI, glucose measurement methods, 
definitions of hyperglycemia, postoperative surveillance, and definitions of SSI varied 
widely or were not reported. Glucose readings entered for data analysis in each study 
ranged from the highest glucose reading of the day to the mean of all glucose readings 
during each day or a few days added together. Some studies identified their glucose levels 
only for the day of surgery and some studies for up to 48 hours post-operatively. HbA1c 
levels were measured anywhere from 180 days before surgery to after surgery. For 
treatment of elevated glucose, some studies used subcutaneous insulin for glucose control 
but the majority received CII. Some considered a patient hyperglycemic at glucose levels 
greater than 6.1mmol/L, while others didn't treat until the glucose was 11.1 mmol/L or 
~~~~~--~~~-----------~----~ 
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greater. Definitions of SSI did not always follow the guidelines set out by the CDC and 
post-operative surveillance ranged from hospital stay only to one-year postoperatively. 
Because of the variability in the definitions used, as well as the period of 
surveillance, it is very difficult to compare SSI rates in these studies. Overall however, 
the evidence does support the conclusion that a preoperative or postoperative glucose 
level of 11.1 mmol/L or greater is a risk factor for SSI in CABG surgery patients with less 
information on other surgical groups. 
In vascular surgery patients, there is no information available about how 
preoperative and postoperative hyperglycemia influences SSI risk. If HbA1c is 
considered a measure of preoperative glucose control though, the study by O'Sullivan et 
al. (2006) does provide evidence that HbAlc and thus, preoperative hyperglycemia is a 
risk factor for SSI. Because of this limited information on vascular surgery patients, 
research is necessary that explores these relationships further. 
Hypothermia and SSI 
Hypothermia has been defined as a core body temperature of less than 36°C 
(Kumar, Wong, Melling, & Leaper, 2005; Snyder, 2005); this is the definition of 
hypothermia that was used for this study. Hypothermia in surgical patients is caused by: 
1) effects of general and regional anaesthesia leading to dysfunction in the body's 
thermoregulatory system, 2) cool, ambient temperatures in the OR suite, 3) cooled or 
room temperature intravenous fluids and large surface areas of skin that are exposed 
during operative procedures, and 4) exposure to room temperature skin preparations 
35 
(Cooper, 2006; Kumar et al.; Leslie & Sessler, 2003; Noble, 2006). Hypothermia 
interferes with the body's defences in fighting infection by: 1) causing vasoconstriction 
which leads to a decrease in the partial pressure of oxygen in tissues and availability of 
oxygen for tissue repair, 2) impairing neutrophil function, 3) leading to shivering thereby 
causing a build-up of lactic acid and changes in pH and function of enzymes, 4) altering 
the function of platelets and the activity of clotting factors, and 5) reducing the deposition 
of collagen essential for tissue repair (Barone et al., 1999; Doufas, 2003; Griffin, 2005; 
Kumar et al.; Kurz et al., 1996; Melling, Ali, Scott, & Leaper, 2001; Sessler & Akca, 
2002). 
Research studies have shown that hypothermia is associated with: 1) adverse 
myocardial outcomes like arrhythmias and reduced cardiac output, 2) increased organ 
dysfunction, 3) higher mortality, 4) increased thermal discomfort and shivering, 5) 
increased blood loss and need for transfusions due to its effect on the coagulation 
cascade, and 6) delayed post anaesthetic recovery (Akca & Sessler, 2002; Barone et al., 
1999; D'Angelo, Braz, Modolo, Amorim, & Rodrigues, 2003; Doufus, 2003; Johansson, 
Lisander, & Ivarsson, 1999; Kumar et al., 2005; Kurz et al., 1996; Lenhardt et al., 1997; 
Schmied, Kurz, Sessler, Kozek, & Reiter, 1996; Weirich, 2008; Winkler et al., 2000). 
There were no studies found that explored the relationship between intraoperative 
hypothermia and SSI in vascular surgery. There were 3 studies found however, that 
explored the relationship between hypothermia and SSI in other patient populations, but 
their results are conflicting (Barone et al., 1999; Flores-Maldonado, Medina-Escobedo, 
Rios-Rodriguez, & Fernandez-Dominguez, 2001; Kurz et al., 1996). Further details on 
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these 3 studies are found in Table 2 in Appendix B with information provided about the 
study methodology, definition of SSI, results, and limitations. 
Kurz et al. ( 1996) studied 200 colo rectal surgery patients who were randomly 
assigned to routine intraoperative thermal care (hypothermic group) or additional 
warming (normothermic group). They found that patients in the hypothermic group (mean 
core temperature at the end of surgery 34.7 ± 0.6°C) versus normothermic patients (mean 
core temperature at the end of surgery 36.6 ± 0.5°C) developed significantly more SSis (p 
= 0.009). Another research group attributed this significant finding in SSI risk with 
hypothermia for the Kurz et al. study to the increased number of blood transfusions 
received by the hypothermic group and their immune depressing effect (Barone et al. , 
1999). Kurz et al. had already reported that there was significant difference between the 
groups with patients developing an SSI having received more blood transfusions (p = 
0.01). Furthermore, they also reported that after multivariate analysis, the requirement for 
transfusion was not found to be a predictor of SSI while assignment to the hypothermic 
group was. 
There was a second study that explored the relationship between intraoperative 
hypothermia and SSI (Flores-Maldonado et al., 2001). In this study of 290 general 
surgery patients undergoing cholecystectomy, a significant difference between groups 
that did or did not develop an SSI was found in bivariate analysis. Temperatures were 
measured on admission to the recovery room. Hypothermic patients had a mean 
temperature of 35.4 ± 0.4°C, while normothermic patients had a mean temperature of 
36.2 ± 0.2°C. Of the patients who were hypothermic, 18.8% of the patients developed an 
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SSI, compared to 5.8% of normothermic patients (p = 0.009). However, this difference 
was not found after logistic regression. It was also noted in this particular study that 
hypothermic patients had significantly longer periods of time in the OR which has been 
reported as a risk factor in other studies and may have explained the results. In addition, 
there were significantly more patients with diabetes and who were older that developed 
an SSI, also reported as risk factors in other studies, which may also have explained the 
results. 
A third study with 150 colorectal surgery patients found that there was no 
significant difference in SSI development between groups with and without hypothermia 
(Barone et al., 1999). Hypothermia was defined as 34.3°C or less at any time in the OR or 
post anesthesia care unit. In this study, whether the patients were hypothermic or not, 
12% of the patients developed an SSI in each group. However, the researchers also 
looked at the "lowest recorded temperature". Their normothermic "lowest recorded 
temperature" was 35.9 ± 0.6°C. These patients classified as normothermic in this study by 
Barone et al. , would have been classified as hypothermic in the other studies on 
hypothermia and SSI risk. The only conclusion from this study is that low temperature 
hypothermia less than 34.3°C is not a risk, but a conclusion cannot be drawn about 
temperature less than 36.0 °C. In the Barone et al. study, the hypothermic and 
normothermic groups did not receive a significantly different number of transfusions 
unlike the Kurz et al. ( 1996) study, so the effect of this as a confounding factor was not an 
ISSUe. 
Overall, from the 3 studies that have explored the relationship between 
hypothermia and SSI, there is insufficient evidence available to draw a strong conclusion 
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about the effect of hypothermia on SSI. Research studies are very few in number, have 
defined hypothermia differently, have utilized different patient populations and infection 
surveillance periods, and obtained contradictory results. There is no research available on 
the effect of hypothermia on vascular surgery patients. Despite the ability to make some 
comparisons between hyperglycemia and SSI in CABG surgery and vascular surgery 
patients because of the similar pathophysiological process of atherosclerosis, the same 
cannot be done with hypothermia. In CABG surgery, patients are intentionally cooled 
much lower than the patients in the studies discussed above and therefore do not provide 
a comparison group. Because of the gap in the literature related to perioperative 
hypothermia in vascular surgery patients, as well as the suggestion of the SHN campaign 
to reduce SSI by focusing on normothermia control in colorectal patients, the relationship 
between hypothermia and vascular surgery was also explored in this study. 
Inappropriate Hair Removal and SSI 
Historically, preoperative shaving of hair with a razor has been viewed as a risk 
factor for SSI, with clipping with a clipper or no hair removal preferred, as close to the 
surgical incision time as possible. Some reasons clippers may be beneficial are that they 
cut the hair close to the patient's skin, usually within 1 mm, without touching the skin and 
abrading it. As well, the head of the clippers can be disinfected between patients or 
thrown out after use thereby minimizing the risk of cross-contamination (Tanner, 
Woodings, & Moncaster, 2006). When compared to razors that may cause microscopic 
nicks or abrasions, or depilatory solutions that may cause irritation and disrupt skin 
integrity, the use of clippers does seem like the best choice. 
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In 2006, the Cochrane Collaboration undertook a literature review of 11 
randomized controlled trials (RCTs) to determine if routine pre-operative hair removal 
resulted in fewer SSis than not removing hair at all, or if different methods of hair 
removal such as depilatory solutions, shaving, or clipping hair increased SSI risk (Tanner, 
Woodings, & Moncaster, 2006). In 2 RCTs reported in the Cochrane Review, removal of 
hair by a depilatory solution or razor compared with no hair removal did not produce a 
statistically significant difference for SSI risk when results were pooled, with a total 
sample size of 358 patients (Court Brown, 1981 ; Rojanapirom et al. , 1992). These studies 
were not considered of high quality due in part to randomization methods, but they were 
also insufficiently powered to detect a significant difference (Tanner, Woodings, & 
Moncaster). There were no trials found in the Cochrane review that compared clipping to 
no hair removal. 
One of the 2 previously mentioned studies also compared different hair removal 
techniques, as did 9 other studies. In 7 trials comparing shaving with the use of depilatory 
solution for hair removal, there was no statistically significant difference found when 
study results were pooled (total n = 1420) (Breiting & Hellberg, 1981; Court Brown, 
1981; Goeau-Brissonniere et al. , 1987; Seropian & Reynolds, 1971 ; Thorup et al. , 1985; 
Thur de Koos & McComas, 1983). However, a significant difference in hair removal 
techniques was found in 3 trials that compared shaving with clipping (Alexander et al., 
1983; Balthazar, Colt, & Nichlos, 1983; Ko, Lazenby, Zelano, Is am, & Krieger, 1992). 
Overall, these 3 studies, with a pooled sample size of 3193 patients, found SSI risk was 
significantly increased when hair was shaved rather than clipped, with 2.8% of patients 
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developing an SSI when hair was shaved, compared to 1.4% of patients whose hair was 
clipped (RR: 2.02; 95% CI: 1.21-3.36). 
The Cochrane review reported on only 1 study about the timing of hair removal as 
a risk factor for SSI. In that study by Alexander et al. (1983) of 537 patients undergoing 
clean surgery, shaving on the day of surgery was compared to shaving the day before 
surgery and no significant difference was found in the development of SSI. In the same 
study of 476 other patients undergoing clean surgery, 4% of the patients who had hair 
clipped the day before surgery developed an SSI, compared to 1. 7% of the patients that 
had hair clipped on the day of surgery. Although the proportion was more than double, 
the difference was not statistically significant. 
The final conclusion drawn by the authors of this Cochrane review was that the 
available evidence suggests that there is no difference in SSI risk for patients who do or 
do not have hair removed before surgery (Tanner, Woodings, & Moncaster, 2006). This 
conclusion must be viewed with caution though, because it is based on 2 poorly designed, 
underpowered studies that are not of sufficient quality to determine if there was a 
difference. The Cochrane review authors also concluded that if a patient is to have hair 
removed, clipping the hair is preferable to shaving and results in fewer SSis. They further 
concluded that there is insufficient evidence supporting the use of a depilatory solution as 
opposed to a razor for hair removal because there was no statistically significant 
difference found between the 2 methods when results were pooled among the 7 studies 
(Trumer, Woodings, & Moncaster). 
Pending further evidence, current recommendations by the CDC and guidelines 
most commonly used, as well as the SHN campaign, are to remove hair only when 
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necessary when it interferes with the surgical incision as close to the time of incision as 
possible (Mangram et al. , 1999; ORNAC, 2007). Recommendations for hair removal 
appear to differ based on country. Norwegian guidelines recommend using clippers or 
depilatory cream as close to the surgery time as possible, while the UK guidelines 
recommend using depilatory cream the day before surgery (Tanner, Woodings, & 
Moncaster, 2006). 
Other Risk Factors for SSI 
There are several other factors that are known to increase the risk of developing an 
SSI in surgical patients. These include but are not limited to gender, age, emergency 
surgery, insertion of an artificial graft during surgery, having a groin incision, blood loss, 
anemia and transfusion of blood, surgeon skill, certain comorbidities such as renal 
disease, increased American Society of Anesthesiologists (ASA) score, obesity and 
increased BMI, and smoking. In the remainder of this literature review, when studies are 
available that have been done with vascular surgery patients, they will be reported. If they 
are unavailable for vascular surgery patients, reports from other surgical patient 
populations will be discussed. These risk factors were not the focus of our study. 
However, their relationship to increased SSI risk in other studies necessitated control of 
these factors as potential risk or confounding factors in this study. All of these risk factors 
can be applied to the chain of infection model that guided this study; specifically, most, 
but not all, are either non-modifiable or modifiable factors that increase susceptibility of 
the host. 
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Non-modifiable risk factors. Some non-modifiable risk factors of the patient are 
gender and age. In the vascular surgery literature where gender is reported, there are more 
men than women actually in the studies (Belkin, Conte, Donaldson, Mannick, & 
Whittemore, 1995; Brevetti et al., 2008; Chang, Calligaro, Ryan, Runyan, Dougherty et 
al., 2003; Higgins & Higgins, 2003; Nicholson, Dennis, Makin, Hopkinson, & Wenham, 
1994; O'Sullivan et al., 2006; Pounds et al., 2005; Schepers, Kinkert, Peeters, & Breslau, 
2003; Sigvant et al., 2007; Turnbull, Zoutman, & Lam, 2005; van Himbeack, van 
Knippenberg, Niessen, & van Griethuysen, 1992; Vogel, Symons, & Flum, 2008; 
Vouyouka & Kent, 2007; Vriesendorp et al., 2004). It has been suggested that even 
though just as many women possibly have PVD, by the time they present with symptoms, 
their disease is not amenable to surgical reconstruction due to smaller arteries and more 
advanced disease (Allison et al., 2006; Brevetti et al.; Higgins & Higgins; Vouyouka & 
Kent). 
Although there were more men than women in the above-mentioned studies, the 
results about gender as a risk factor for SSI are contradictory. In vascular surgery studies 
by Chang et al. (2003) and O'Sullivan et al. (2006), a non-significant trend towards SSI 
risk was demonstrated in men. In a study by Vogel et al. (2008), which explored 
incidence of aortic graft infection, a significant difference was found with more men than 
women developing an SSI (p < 0.001). In contrast, a vascular surgery study by van 
Himbeeck et al. (1992) found that significantly more women developed an SSI (p < 0.01). 
A second non-modifiable risk factor related to the vascular surgery patient is age. 
Peripheral arterial disease, which may necessitate having vascular surgery, is a disease 
that increases with age (Higgins & Higgins, 2003). In one study of 603 vascular surgery 
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patients by van Himbeeck et al. (1992), older men developed significantly more SSis than 
younger men (p < 0.01). As mentioned previously, older women are not frequently found 
in these studies so it is not possible to assess age as a risk factor for SSI in women. 
Some non-modifiable risk factors related to the surgical intervention are also risk 
factors that increase the susceptibility of the host to SSI. Having an emergency or longer 
than average surgical procedure, insertion of an artificial prosthesis during surgery, 
having a groin incision, and transfusion of blood are the factors considered here. 
Having an emergency procedure has not been identified as a risk factor directly in 
the vascular surgery literature. However, in a study by Neumayer et al. (2007) in which 
vascular surgery patients (n = 28,161) were part of a much larger study with 163,624 
combined vascular and general surgery patients, having an emergency procedure was 
identified as a risk factor for SSI (p < 0.0001). There was no separate analysis repmted 
for vascular surgery patients in this study. 
For many countries that report SSI surveillance rates, patients are divided into risk 
groups based on their risk index. A higher risk index indicates that a patient is at an 
increased risk for SSI. One component of this risk index is the length of surgery. For 
surgeries that are longer than the average amount of time it would normally take a 
surgeon to complete a surgical procedure, the patient's risk index for SSI would rise to a 
higher level indicating increased risk (Coello et al. , 2005; Edwards et al. , 2008; Morton, 
Clements, Doidge, Stackelroth, Curtis, & Whitby, 2008; National Nosocomial Infections 
Surveillance [NNIS] system, 2004; Neumayer et al. , 2007). As well, in a vascular surgery 
study by Chang et al. (2003) of 365 patients, longer operative time was identified as a risk 
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factor for SSI (p = 0.02). As a result of this set of studies, increased length of surgery is 
considered a risk factor for SSI. 
Artificial implants inserted during surgery have also been reported to increase SSI 
risk (Bandyk, 2008). It is thought that artificial implants produce a microenvironment that 
favours bacterial attachment and biofilm formation, which can protect infectious agents 
from host defenses and antibiotics (Bandyk). There was only 1 vascular surgery study 
found that reported an assessment of the effect of insertion of an artificial graft on SSI 
risk. In this vascular surgery study of 365 patients, it was found that artificial implants 
were actually protective against SSI, as significantly more patients with a vein graft 
developed an SSI than did those with an artificial graft (p = 0.02) (Chang et al. , 2003). 
This finding cannot be attributed to patients with artificial grafts receiving better 
antibiotic prophylaxis, as the overall antibiotic prophylaxis rate reported was quite good 
at 92% of patients. The finding of this study that artificial grafts are protective against SSI 
development should be viewed with some caution though as they may have 
underestimated the SSI rate in the implant group. While the authors of this study used 
standard CDC definitions for identification of SSis, they reported that the period of 
surveillance ranged from 1 - 16 months with a mean follow-up of 6 months. For patients 
who did not have an artificial graft, their follow-up is probably quite good because they 
received a full 30 days of surveillance as recommended by the CDC. However, for 
patients who had an artificial graft inserted who should receive follow-up for a full year 
according to the CDC, it is unclear how many of these patients actually received the full 
follow-up so there may be an underestimation of the true SSI rate in this group. 
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The presence of an incision in the groin is a non-modifiable risk factor inherent to 
the surgical procedure. In most vascular surgeries of the lower extremity, the femoral 
artery needs to be accessed requiring a groin incision. In the vascular surgery study by 
van Himbeeck et al. (1992), the groin was the most common location for SSI 
development (p <0.01) in vascular surgery patients. Two other vascular surgery studies by 
Pounds et al. (2005) and Nicholson et al. (1994) reported that 64% and 85.7% of SSis, 
respectively, involved the groin incision. In the study by Pounds et al., the presence of a 
groin incision was an independent risk factor for SSI (p = 0.04). Some reasons for the 
increased incidence of SSI in the groin include difficulty draping the area, rich lymphatic 
supply, and overhanging adipose tissue which creates a moist environment for bacteria to 
flourish (Nicholson et al.; van Himbeeck et al.; Yeung et al. , 2008). 
Modifiable risk factors. There are many modifiable risk factors for SSI as well. 
However for some factors, it is not easy to determine if they are modifiable or not. 
Transfusion of blood products is one such example. Blood transfusion may be non-
modifiable or modifiable depending on the patient situation. Blood loss during surgery 
that necessitates blood transfusion may be related to a multitude of factors including, but 
not limited to, surgeon skill and experience, a difficult surgical procedure, or other patient 
hematological factors such as impaired blood clotting. While blood transfusion has not 
been explored in the vascular surgery literature, in the general surgery literature, receipt 
of blood is associated with SSI as well as other HAis (Blumetti et al., 2007; Insler, 
O'Connor, Leventhal, Nelson, & Starr, 2000; Jensen et al. , 1992; Marik & Corwin, 2008; 
Olsen et al. , 2008; Tang et al., 2001; Walz, Paterson, Seligowski, & Heard 2006). 
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Furthermore, in the Kurz et al. (1996) study already discussed, patients who developed an 
SSI received significantly more transfusions of blood (p = 0.01), although it was not a 
significant independent predictor for SSI. 
A second factor that may be modifiable or not depending on the situation is 
surgeon skill. There are variations in surgeon specific rates, partly explained by the risk 
index of patients the surgeons care for, partly because of the surgeon' s experience in 
performing particular procedures, but also because of other reasons such as individual 
surgeon judgement to operate on patients with broken skin, or to prescribe antibiotic 
prophylaxis. Mangram et al. (1999) identified that reporting the surgeon specific rate back 
to the surgeon leads to a decrease in SSI rates, suggesting that surgeons pay attention to 
unspecified details. 
A final factor that may be modifiable or not in terms of SSI risk is patient 
comorbidities. Modifying the risk of development of a disease such as renal disease may 
be possible in some instances such as good glycemic control in diabetes or adherence to 
treatment strategies such as dialysis or diet control. However, in other cases of renal 
disease, this may not be possible making this a non-modifiable risk factor. Whether 
modifiable or not, certain comorbidities are risk factors for infection. 
In their vascular surgery study, O'Sullivan et al. (2006) identified a non-
significant trend towards increased postoperative morbidity including SSI, for patients 
with renal disease. In another study that investigated the factors that led to increased 
wound complications in vascular surgery for patients with renal disease, an SSI rate of 
43% for patients with renal disease was reported (Blankensteijn et al., 1996). 
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The ASA score is an index of the seriousness of comorbidities and their effect on 
risk of death during surgery, with an ASA score of 1 indicating that a patient is healthy, 
and an ASA score of 5 indicating that a patient has severe systemic disease (Aronson, 
McAuliffe, & Miller, 2003; Woodfield, Beshay, Pettigrew, Plank, & van Rij , 2007). The 
ASA score because it is calculated based on the effect of comorbidities, can provide 
information on the effect of comorbidity on SSI risk. A general review article by Bandyk 
(2008) suggested that the higher the ASA score is, the higher the SSI risk is in a vascular 
surgery patient. This relationship has not been explored in vascular surgery studies. In a 
study by Neumayer et al. (2007), having an increased ASA score was identified as an 
independent predictor of SSI (p < 0.0001). The increased SSI risk in this study, however, 
was with combined general and vascular surgery patients, and did not assess vascular 
surgery patients separately. Besides renal disease, other comorbidities that would increase 
the ASA score include but are not limited to diabetes, CAD, and hypertension. 
Obesity in patients increases the probability of having these above-mentioned 
comorbidities but is also an independent risk factor and is considered modifiable. When 
patients are obese, they have an increased BMI, which is a measure of body mass index in 
kg/m2• A healthy BMI is 25 or less, while a BMI of greater than 25 is associated with 
increased risk of diabetes, CAD, and hypertension (Vuorisalo, Haukipuro, Pokela, & 
Syrjala, 1998). Increased BMI and obesity have been reported to increase SSI risk 
(Bandyk, 2008; Chang et al., 2003; Haas, Evans, Preston, & Larson, 2005; Kent, Bartek, 
Kuntz, Anninos, & Skillman, 1996; Russo & Spelman, 2002; Slaughter et al. , 1993; 
Vuorisalo et al.) with significant differences found between healthy BMI and high BMI in 
a vascular surgery study by Nicholson et al. (1994) (p < 0.05). This study found that 
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dehiscence of the wound from an SSI occurred more often in overweight or obese patients 
when wounds became infected (p < 0.01 ). The authors attributed this increased risk of SSI 
with overweight/obese patients to increased wound size, difficulty in obliterating dead 
space during wound closure, poor blood supply to fatty tissue, and longer OR time 
(Nicholson et al.). 
A final modifiable risk factor is smoking. Smoking was found to be an 
independent predictor of SSI in CABG surgery patients, and has been suggested as a risk 
factor for SSI in the vascular surgery literature (Bandyk, 2008; Haas et al., 2005; Wipke-
Tevis, 1999). There are several effects of smoking that could contribute to SSI. Firstly, 
chemicals in cigarettes cause direct endothelial damage to arteries, which sets up the 
process of atherogenesis. Secondly, the chemicals in cigarettes mimic catecholamines, 
which increase peripheral vascular resistance in arteries. Both of these factors decrease 
the amount of blood that is available to bring red and white blood cells to the area to 
promote wound healing and phagocytose any infectious organisms. In addition, carbon 
monoxide, which is produced as a by-product of cigarette smoke, competes with oxygen 
and binds to hemoglobin thus making cells hypoxic. When cells are hypoxic, there is 
decreased oxygen and thus decreased cellular energy available for cell repair (McCance 
& Huether, 2006). While there were no studies of vascular surgery patients alone that 
explored this relationship, the previously discussed study by Neumayer et al. (2007) that 
combined vascular and general surgery patients, did find that smoking was an 
independent predictor ofSSI (p < 0.0001). 
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Risk Factors and SSI: Conclusion 
As previously stated, one focus of this study was a description of risk factors for 
SSI in vascular surgery patients, particularly those risk factors of interest identified in the 
SHN campaign. Evidence was found that antibiotic prophylaxis is appropriate for 
vascular surgery patients with coiTect drug, timing, and dose being important aspects. 
Hyperglycemia is a key risk factor for SSI in CABG and other surgery patients; the 
conclusion can be generalized to vascular surgery patients as well due to the similar 
pathophysiological processes of atherosclerosis. One vascular surgery study did find 
evidence that a suboptimal HbAlc, as a marker for preoperative hyperglycemia, increased 
SSI risk in non-diabetic vascular surgery patients. There is conflicting evidence regru·ding 
hypothermia as a risk factor; it has not been studied in vascular surgery patients. Limited 
evidence was found supporting that, if hair removal was required, hair should be clipped 
instead of shaved, as close to the time of surgery as possible. 
Other factors demonstrated to increase SSI in vascular surgery patients were older 
age in men, longer than average surgical procedure, presence of a groin incision, and 
obesity. Other factors demonstrated to increase SSI risk in other patient groups that were 
not studied or unclear in vascular studies included gender, emergency procedure, artificial 
implants, receipt of blood products, renal disease, increased ASA score, and smoking. 
Overall, data available on many risk factors for SSI in vascular surgery patients is limited 
or not available. This supports the need to look at risk factors in patients so that 
interventions can be identified and implemented to decrease incidence of SSI. 
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Vascular Surgery SSI Rates 
While risk factors for SSI were the focus of this study, to interpret the SSI rate 
found in this study it was important to identify vascular surgery SSI rates elsewhere. A 
search of the published literature yielded 15 reports. For studies that reported rates based 
on risk index, which takes into account length of surgery, ASA score and wound class, 
the rate for the highest risk index is reported, as these patients are the most comparable to 
the patients in this study. There was only 1 Canadian study found of vascular surgery SSI 
rates with data gathered from 1994 - 1998; they reported an SSI rate of 7% (Turnbull et 
a!., 2005). 
SSI rates were available from other countries from studies assessing risk factors 
with SSI as an outcome measure, while others conducted surveillance only to report SSI 
rates. In the USA, 5 reports of SSI rates ranged from 4.34 -11%. Two of these 5 reports 
were research studies assessing risk factors (Chang eta!., 2003; Pounds eta!., 2005). Both 
studies were retrospective with one study reporting an SSI rate of 11 %, (Pounds et a!.), 
and a second study reporting an SSI rate of 8% (Chang et a!.). The remaining 3 SSI rates 
from the USA were obtained from surveillance reports that reported rates of 8.1% (Hawn 
et a!., 2008), 6.69% (Edwards et a!., 2008), and 4.34% (NNIS system, 2004). In the 
Netherlands, 3 reports of SSI rates ranged from 5.3 - 21.1 %. One of these 3 reports was a 
prospective research study examining risk factors for SSI with a reported SSI rate of 5.1% 
(van Himbeeck et a!., 1992). The other 2 reports from the Netherlands were surveillance 
reports with SSI rates of 21.1% (Mannien eta!., 2006), and 5.3% (Schepers eta!., 2003). 
There were 2 reports from England. One report was a prospective study with an SSI rate 
of 16% (Nicholson eta!., 1994), and the second report was a surveillance report with an 
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SSI rate of 14.9% (Coello et al., 2005). One prospective research study from Ireland 
reported an SSI rate of 9.9% for nondiabetic patients with suboptimal HbAlc levels 
(O'Sullivan et al., 2006). A vascular research study from France reported an SSI rate of 
4.1% (Richet et al., 1991 ). The 2 remaining SSI rates from surveillance reports are from 
Australia and Italy. Australian researchers reported an SSI rate of 6.1% (Morton et al., 
2008), while Italian researchers reported an SSI rate of 5.4% (Moro et al., 2005). 
Overall, 12 of these 15 reports had SSI rates of 11% or less. Further details about 
these studies and reports are found in Tables 3 and 4 in Appendix B. Variation in SSI 
rates in studies on risk factors ranged from 5.1 - 16%. There was wider variation in SSI 
rates in the surveillance reports, ranging from 4.3 - 21.1 %. The 2 oldest studies, from 
1991 and 1992, had the lowest rates. A number of factors explained the variability seen. 
While most surveillance was done using standard definitions of SSI, some surveillance 
was done using a different definition or there was no information given as to what criteria 
had been used, thus limiting the comparability of these rates. Some studies used 
prospective surveillance only during patient hospitalization, while others used reports 
from voluntarily participating hospitals to report rates, possibly under-estimating the true 
SSI rate. Most studies did not use post-discharge surveillance, thereby underestimating 
the true SSI rate as well. The study by Mannien et al. (2006) from the Netherlands used 
post-discharge surveillance and reported an SSI rate of 21.1 %. However, it was not 
reported how many patients were lost to follow-up. Given the variation in the methods 
and results, the rates must be compared and interpreted with caution. A discussion of 
these rates and our study's results is found in Chapter 5. 
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Risk Factor Assessment, Documentation, and Intervention by Nurses 
Risk factors for SSI are identified so that interventions can be designed to 
decrease this risk. Some SSI risk reduction is amenable to intervention by nurses. 
However, before intervention occurs, the nurse must assess the patient to determine if the 
risk factor is present. This should be followed by documentation of the findings and then 
a plan of how to intervene. 
In the nursing literature, there are some opinion-based articles available that make 
recommendations on how to assess and care for the perioperative patient (Aragon et al. , 
2003; Bandyk, 2008; Chalmers & Straub, 2006; Cooper, 2006; Griffin, 2005; Noble, 
2006; Odom-Forren, 2006; Snyder, 2005; Springer, 2007; Weirich, 2008). However, the 
majority of information on how to care for the perioperative patient comes from medical-
surgical nursing textbooks (Girard, 2005, 2006). The focus of the care recommended in 
these references is related to assessment, planning, intervention, and evaluation of 
patients, as well as patient education. There is also a strong emphasis placed on the 
importance of documentation. 
Documentation is a communication mechanism between healthcare providers. 
Nursing documentation should answer 6 questions: what, why, when, where, who, and 
how (Navuluri, 2000). However, there have been some factors identified that impair the 
quality of documentation, namely: 1) nurses' attitude toward documentation, 2) 
documentation that fails to reflect the care that nurses have actually provided, 3) a feeling 
by nurses that something is not significant enough to document, 4) difficulty in 
documentation of conversations, and 5) a perceived lack of time (Taylor, 2003). 
Documentation is not necessary for intervention to occur. However, a vital piece of 
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permanent information is lost for other health care professionals who also care for the 
patient if assessment and care are not documented. 
As already discussed in this literature review, SHN has identified 4 targeted 
interventions to reduce SSI risk, namely appropriate antibiotic prophylaxis, maintenance 
of normoglycemia, maintenance of nonnothermia, and appropriate hair removal. The 
state of knowledge at this time related to these and other risk factors and their relationship 
to SSI development has also already been discussed. However, less is known about what 
role nurses can and have taken to intervene to reduce the risk of SSI development. 
Antibiotic Prophylaxis 
Nurses can provide antibiotic prophylaxis to all patients for whom it is 
recommended (Blondel-Hill & Fryters, 2006; Mangram et al., 1999). Research has found 
that interventions that increase provision of antibiotic prophylaxis include: 1) 
development of a protocol by nurses and other key staff involved in antibiotic 
prophylaxis, 2) development of a system of checks or electronic reminders to ensure that 
the patient receives the antibiotic, 3) posting of the protocol in a prominent place in the 
OR room for all to refer to, 4) body weights of all individuals being assessed so that the 
appropriate dose of antibiotic may be ordered by the physician, 5) development of a 
preprinted physician's order form for medications with the opportunity to opt out only, 
ensuring that as many surgeons as possible opt in, 6) use of a pre-printed sticker with the 
antibiotic prescription printed on it to apply to the chart, 7) instituting a time-out protocol 
during which time it is verified that the antibiotic is infusing, 8) nurses preparing and 
administering the antibiotic at the appropriate time, 9) pre-mixed doses of antibiotic, and 
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1 0) taking the time to educate the surgical team about the protocol (Ritchie, Scanlon, 
Lewis, & Black, 2004; Rosenberg et al., 2008; White & Schneider, 2007; Zvonar, Bush, 
Roth, 2008). 
Glucose Control 
The Canadian Diabetes Association (CDA) recommends that patients should 
maintain perioperative glucose levels of 7 - 11 mmol/L (CDA, 2008). Nurses have a role 
to play throughout the entire perioperative process to assist patients to achieve this 
control. Nursing assessment of the patient preoperatively includes glucose and HbA1c 
measurement as a measure of preoperative glucose control. Roles identified for nurses in 
nursing practice textbooks related to glucose control in the perioperative process center 
around patient education, monitoring of glucose and appropriate treatment, and 
advocating for patients if hyperglycemia is not controlled (Girard, 2005, 2006). 
Temperature Control 
The goal of nursing care m the perioperative process 1s to assist patients to 
maintain normothermia. If patients are hypothermic, active warming interventions can be 
provided. If patients are normothermic, blankets should be provided to ensure they remain 
this way. Passive warming with blankets has not been demonstrated to be an efficient way 
to warm patients. However, active warming with forced air or warming of solutions has 
been shown to be effective at maintaining normothermia in the operative setting (Kumar 
et al. , 2005; Negishi et al. , 2003). There is also some evidence that preoperative warming 
55 
for 1 - 2 hours before surgery is effective in reducing hypothermia, increasing patient 
comfort, and decreasing anxiety (Just, Trevien, Delva, & Lienhart, 1993; Weirich, 2008). 
Assessment is important to perform on patients throughout the perioperative 
process due to the exposure of patients to cold, as already discussed, as well as the use of 
certain anesthetic medications. Because patient shivering due to a cold sensation may be 
decreased by some anesthetic medications, reliance on visual cues that the patient is cold 
should not be the only assessment performed by nurses. As well, because warming 
interventions are provided, the assumption should not be that the patient is normothermic. 
When patients are transferred from the OR to PARR or PARR to the postoperative unit, 
this should be done as quickly as possible. Patients should be actively kept warm as active 
warming helps to maintain or increase core body temperature on transfer from one unit to 
another. Because hypothermia can occur on transfer from one unit to another, the nurse 
can ensure that the patient is kept normothermic during transfer with active warming 
interventions (Kumar et al., 2005). Nurses can also ensure that all patients have achieved 
a normothermic state before discharge from the PARR (Eastern Health Perioperative 
Program Policy, VII-a-20, 2008). 
Hair Removal 
Nurses provide hair removal when it interferes with the surgical incision area. 
Published standards from the CDC, current literature, and ORNAC should be adhered to 
for recommendations on appropriate hair removal. Clippers should be used in the OR to 
remove hair only when hair interferes with the surgical incision to be made. Hair removal 
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should also be performed as close to the surgical incision time as possible (Mangram et 
al., 1999; ORNAC, 2007; Woodings & Moncaster, 2006). 
Nurses can educate patients about the avoidance of shaving near the surgical 
incision site prior to surgery to avoid causing microscopic nicks and abrasions. Nurses 
can also assess the skin integrity of all individuals, with special attention to obese 
individuals, and these findings should be documented. Nurses should and do report any 
adverse findings to the surgeon performing the surgery prior to the surgery start (personal 
e-mail communication with G. Tapp, Clinical Educator for the Perioperative Program, 
Feb 4, 2009). Finally, nursing and medical staff requires education about the importance 
of appropriate hair removal and its effect on SSI risk. 
Other Risk Factors Amenable to Intervention by Nurses 
There are other patient risk factors that are amenable to intervention by nurses. 
Two examples would be smoking cessation and weight control. Preoperatively, nurses 
can recommend that patients quit smoking 30 days before surgery and maintain 
abstinence to reduce SSI risk, as well as other complications (Mangran1 et al. , 1999). 
Nurses can assist patients with strategies to cease smoking such as referrals to other 
healthcare providers, nicotine replacement therapy, and support groups (Doolan & 
Froelicher, 2008; Lemmens, Oenema, Knut, & Brug, 2008). In the short term before 
surgery, nurses can assist patients who are obese to optimize their skin integrity before 
surgery. Education on the importance of cleansing skin folds, with avoidance of harsh 
chemicals or brushes can be recommended (Baugh, Zeulzer, Meador, & Blankenship, 
2007). As a long-term strategy, referrals can be made to Public Health nurses to assist 
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patients to achieve a healthy body weight through education programs on diet and 
exercise which will help in preventing comorbidities such as diabetes that often develop 
with excess body weight and therefore raise SSI risk. 
Other Nursing Roles 
Nurses have an important role to play in ensuring optimal wound care is provided 
through utilization of basic wound care principles (Nelson, 2002). As well, nurses have a 
key role to play in the identification of SSis. During incisional care, assessment for signs 
and symptoms of infection can be performed and then documented. These signs and 
symptoms can then be reported to the surgeon, and a C&S swab can be requested and 
taken by the nurse. Based on the results of the C&S swab, appropriate antibiotic therapy 
can be prescribed by the physician and administered by the nurse (Goering et al., 2008). 
Summary 
In conclusion, SSis are a concern for patients and their families and the 
individuals who care for them in the health care system. As well, there are key factors that 
increase SSI risk. Nurses are involved at all stages of the peri operative process and have a 
role is assessing patients and deciding on appropriate interventions to reduce this SSI risk. 
While there is a lot of information in the literature about certain surgery patient groups 
and their risk factors for SSI, vascular surgery patients have not been as well studied. It is 
unknown if vascular surgery patients possess these same risk factors for SSI or if there 
are other factors that exert an influence. Once SSI risk factors are identified in vascular 
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surgery patients, nursing interventions may be developed to reduce this risk, thereby 
decreasing personal and monetary cost associated with SSis. 
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Chapter 3: Methodology 
This chapter describes the methods used including the study design, target 
population, data collection method, definitions, ethical considerations, and data 
management and analysis. 
Study Design 
This was a exploratory, descriptive study that used a retrospective chart review of 
paper and electronic inpatient and outpatient charts to collect information on each 
patient's glycemic and temperature status, other risk factors for surgical site infection 
(SSI), practices related to the management of risk factors with emphasis on blood glucose 
and temperature, and incidence of SSI. 
Target Population 
The target population for this study was all patients over age 19 who underwent 
selected vascular surgery over a 12-month period between January 1 and December 31, 
2005 at St. Clare's Hospital, a St. John's adult, acute care hospital of Eastern Health. 
Excluded patients were those who were younger than 19, had a surgical classification 
other than Class I (clean), or had a preoperative infection in the area of the body to be 
incised during surgery. Patients who had received steroid or chemotherapy in the four 
weeks prior to surgery were included but had these risk factors controlled for in the data 
analysis. As well, patients who had an rutificial graft inserted into the body were also 
included; these patients are often excluded in other studies due to the extended period it 
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may take for infections to develop and thus the longer surveillance period required. 
Surveillance was conducted for one year for such patients as is recommended by the 
Centers for Disease Control (CDC). 
Over a 12-month period from January 1 to December 31,2005, according to a list 
provided by the Surgery Program Director, there were 236 vascular surgeries of interest 
perfonned at St. Clare's Hospital. The list of surgeries of interest was decided in 
consultation with the relevant Program Director, the Discipline Chair for Surgery and the 
Infection Control Program of Eastern Health. These surgeries included peripheral arterial 
bypass surgery and abdominal aortic aneurysm (AAA) repair surgery, with a complete list 
of surgeries found in Appendix III. A sample size calculation was done initially using the 
prevalence of hyperglycemic and normoglycemic patients and their rates of SSI 
development based on results from the literature. Using these proportions and assuming a 
similar distribution here, in addition to the prevalence of hyperglycemia in this study 
group as found in the first 50 patient charts examined, it was calculated that a sample size 
of more than 1000 patients would be needed to find such statistically significant 
differences (power 80%, a = 0.05). It was not feasible to include this many patients as this 
would have comprised 5 years worth of vascular surgery patients at this hospital in 
Eastern Health and resources were not available for this amount of data collection for this 
descriptive, exploratory study. A convenience sample was therefore used. Every second 
patient was selected from a list of all patients who underwent the selected surgeries 
provided by the Medical Records staff at St. Clare's Hospital. Data was collected on half 
of the patients but some were dropped because they were classified as clean-contaminated 
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or dirty and didn't meet the criteria for inclusion into the study. The final study san1ple 
consisted of 116 selected vascular surgery patients, over age 19 that had a Class I (clean) 
surgery performed in 2005. 
Data Collection Method 
Medical Records staff at St. Clare's Hospital pulled applicable patient charts from 
a list provided by the Surgery Progran1 Director. The researcher or research assistants, 
who were previously trained by the researcher, then reviewed the patient's electronic and 
paper chart to gather data on risk factors, practices, and signs and symptoms of SSI. 
These were recorded on the Data Collection Form developed by the researcher, which is 
found in Appendix D. The specific items included on this form were based on the 
literature that was reviewed that identified risk factors for SSI in vascular as well as other 
surgeries. It also included all of the items that are found on other surveillance instrw11ents 
used by the Infection Prevention and Control Progran1 of Eastern Health. The initial draft 
of the form was pilot tested on charts of 10 patients and then revised slightly in terms of 
ordering of information and addition of missing items considered important for the study. 
The items on this form included information on: a) demographics, b) glucose and 
temperature measurements, c) interventions provided for glucose and temperature control, 
d) antibiotic prophylaxis and hair removal, and e) potential confounding factors such as 
body mass index (BMI), blood transfusions and comorbidities to list a few. 
The preoperative glucose level recorded was the closest measurement done prior 
to the surgery. The postoperative glucose measurements recorded included all 
measurements during the intraoperative and Post Anesthesia Recovery Room (PARR) 
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periods, and any readings of 11.1 mrnol/L or greater in the postoperative period, up to and 
including the seventh day postoperatively. All interventions provided for glucose control 
during these times were also recorded. 
Temperature readings recorded were those that were the closest preoperative 
temperature measurement done prior to the surgery, all temperature measurements in the 
intraoperative and PARR periods, and temperatures less than 36°C during the first 48 
hours postoperatively. All interventions provided for temperature control during these 
times were also recorded. 
The standard definitions for SSI from the CDC were used and are found in 
Appendix A (Mangram et al., 1999). These definitions have had some very minor 
changes made that created additional categories for the primary incision that did not 
affect this study (Horan, Andrus, & Dudeck, 2008). However, because the data for this 
study were collected on patients from 2005, it seemed appropriate to use the 1999 
definitions. To collect data on SSI, patient records were reviewed for any pertinent 
laboratory or microbiology results indicative of infection, any progress notes, discharge 
summaries or physician correspondence about signs and symptoms or diagnosis of 
infection, and any medication orders for antibiotics. This was done for the hospitalisation 
period, as well as any post-discharge visits to the Emergency or Outpatients Department 
(OPD), or Non-Invasive Vascular Laboratory. Records were reviewed for a one-year 
period if the patient had an artificial implant inserted, and for a minimum of 30 days for 
all other surgeries. Any visits made to the Non-Invasive Vascular Laboratory at 6 weeks 
were available for 95.7% ofthe patients in this study. 
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Definitions 
The terms used in this study were defined as follows: 
Surgical site infection: Standard definitions were used and classified as superficial or 
deep. Details of the CDC definition used are found in Appendix 1. 
Hyperglycemia: A serum or capillary blood glucose reading of 11.1 mmol/L or greater. 
Ever hyperglycemic: A serum or capillary blood glucose reading of 11.1 mmol/L or 
greater, and/or a serum glycosylated hemoglobin level of 6% or greater in non-diabetic 
patients or 7% or greater in diabetic patients at any point in the perioperative period. 
Hypothermia: A body temperature less than 36°C. 
Ever hypothermic: A body temperature less than 36°C at any point immediately prior to, 
during, or after surgery up to the first 48 hours after surgery. 
Complete post-discharge surveillance: Surveillance of every patient after discharge from 
hospital, for a full 30 days if there is no artificial graft inserted during surgery, and for a 
full year if there is an artificial graft inserted during surgery. Data are collected to verify 
either absence of an infection or the presence of one. 
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Ethical Considerations 
Protection of each patient's privacy and maintenance of confidentiality were 
rigidly adhered to throughout all stages of this research study. All researchers and 
research assistants signed an oath of confidentiality from Eastern Health and Memorial 
University. Prior to the commencement of the study, approval was received from the 
Human Investigation Committee of Memorial University of Newfoundland (HI C) and the 
Research Proposal Approval Committee (RP AC) of Eastern Health. Letters of support for 
this study were also obtained from the Program Directors of the Surgery and 
Perioperative Programs. All letters of approval and support are found in Appendix V. 
Because this was a chart audit, HIC specified that consent was not required from 
individual patients, because there was minimal risk to the patients involved. Charts were 
not removed from the author-review designated area. Each data collection form contained 
a tear-off section with the name and provincial medical number of the patient as well as a 
research code. A master list containing the name, provincial medical number, and 
research code of each patient was then compiled. The names and provincial medical 
number were used only to verify and correct any information accessed from the chrui. 
The research code on the tear-off section of the data collection form corresponded to the 
research code on the rest of the data collection form. Once the chart was accessed and all 
data were collected on an individual patient, this tear-off section was removed and 
shredded. 
All confidential material was kept in a secure, locked area. Computers used to 
store information and conduct analysis were password protected and accessible only to 
the researcher and research assistants. Only research codes, i.e., no provincial medical 
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numbers, names, or other patient identifiers, were entered into the computer. As well, 
specific surgeon names were not entered into the computer but instead a surgeon code 
was entered. Once all data were entered into the computer, the data collection forms were 
locked in a secure area and will be kept for the required time frame of five years until 
20 12, and then destroyed. 
Unrestricted funding for support of data collection and data entry was obtained 
from 3 sources: Association of Registered Nurses of Newfoundland graduate research 
study award ($1000.00), the Health Care Foundation research fund for new researchers 
($5000.00), and the Canadian Institutes of Health Research summer graduate student 
award ($4000.00). 
Data Management and Analysis 
A database was created using ST A TA software (StataCorp, 2005), and data were 
entered by the researcher and a research assistant. Data were verified and cleaned by the 
researcher prior to running statistics. Descriptive statistic commands were used to 
identify: a) the current practices relating to glycemic and temperature control, b) 
percentages of patients who experienced hyperglycemia and hypothermia, and c) 
percentages of patients who developed an SSI. Frequencies and cross-tabulations were 
done on all variables to determine the number of patients with the risk factors of interest 
and then their association with SSI. Relative risk was the appropriate measure of risk, 
rather than odds ratio, as patients were followed from exposure to outcome. Chi squared 
testing was used to test for statistically significant differences in SSis between groups 
where these differences appeared large enough to be clinically important which will be 
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discussed more in Chapter 5. This would be groups in which the proportion of patients 
with an SSI in one group was 1.5 times or more than that of another group or there was a 
difference of 10 percentage points or more between groups. Differences for 3 types of 
continuous variables: 1) length of stay, 2) length of surgery, and 3) hemoglobin level, 
were assessed for statistical significance. As the distributions were skewed, the medians 
were recorded for each variable and the differences tested using the Wilcoxan ranksum 
test. An alpha level of p ~ 0.05 was chosen as the level of statistical significance for 
comparison. 
This study was exploratory and descriptive in nature, not hypothesis testing. As 
such, extensive multivariate analysis was not warranted. However, logistic regression was 
used to identify the effects of hyperglycemia and hypothermia on SSI risk, while 
controlling for other potential confounding factors. Results of these analyses are 
presented in Chapter 4 and discussed in Chapter 5. 
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Chapter 4: Results 
Chapter 4 summarizes the results of the univariate analyses related to: 1) 
characteristics of the surgical interventions, 2) characteristics of the vascular patients, 3) 
intraoperative blood loss, anemia and treatment, 4) antibiotic prophylaxis, 5) patient 
glucose, patient glycosylated hemoglobin, and maintenance of normoglycemia, 6) patient 
temperature and maintenance of normothermia, and 7) hair removal. This is followed by a 
description of the bivariate and multivariate analyses related to surgical site infection 
(SSI) development and key risk factors of interest. When distribution was skewed, 
median is reported. Testing for statistical significance was conducted on associations 
related to antibiotics, glucose and temperature control or when differences in percentages 
looked potentially clinically meaningful. Because of the amount of data in each section, 
brief summaries are included throughout the chapter. 
Characteristics of the Surgical Intervention 
There were 116 patients who had a vascular surgical intervention. About half of 
the patients, 51.7% (n = 60), had a femoral-tibial or femoral-popliteal bypass with 
saphenous vein graft. The second most common procedure performed, in 23.3% (n = 27) 
of the patients, was a femoral-tibial or femoral-popliteal bypass with artificial graft. The 
list ·of procedures is summarized in Table 1. 
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Table 1: Types of Vascular Surgical Procedures 
Surgical Procedure n• 0/o J. 
Femoral-tibial or femoral-popliteal bypass with 60 51.7 
saphenous vein graft 
Femoral-tibial or femoral-popliteal bypass with 27 23.3 
artificial graft 
Femoral-femoral bypass 13 11.2 
Abdominal aortic aneurysm repair 9 7.8 
Aortobifemoral bypass 7 6.0 
Tot~ I 116 100.0 
Number of vascular surgery pattents havmg spectfied surgery 
2 Percent of 116 vascular surgery patients having specified surgery 
Of the 116 procedures performed, 87.1% (n = 101) were elective and 12.9% (n = 
15) were done as an emergency procedure. All procedures (n = 116) were classified as 
clean procedures. About half, 47.4% (n = 55), had artificial implants and the remaining 
52.6% (n = 61) did not. 
The majority of patients, 94% (n = 1 09), had an epidural catheter for anaesthesia. 
Of these 109 patients, 62.4% (n = 68) had a combined epidural and spinal anaesthetic, 
whfle 17.4% (n = 18) of the patients had a combined epidural and general anaesthetic. 
Epidural anaesthetic was administered to all of the patients who had femoral-tibial or 
femoral-popliteal bypass with artificial graft (n = 27), and to 95% (n = 57) of the patients 
who had femoral-tibial or femoral-popliteal bypass with saphenous vein graft. General 
anaesthetic was administered to 23.3% of patients (n = 27). All of the patients (n = 9) who 
had abdominal aortic aneurysm (AAA) repair received general anaesthetic. Table 2 
summarizes the combinations of anaesthetics received by the 116 patients. 
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Table 2: Types of Anaesthetics Received 
Anaesthetic Type ni o;o 1. 
Epidural/Spinal combined 68 58.6 
Epidural alone 21 18.1 
Epidural/General combined 19 16.4 
General alone 7 6.0 
Epidural/General/Spinal combined 1 0.9 
Total 116 100.0 
Number of vascular surgery patients havmg specified anaesthetic 
2 Percent of 116 vascular surgery patients having specified anaesthetic 
The length of surgery ranged from 43 - 357 minutes with a median length of 115 
minutes (IQR: 80- 145 minutes). As Table 3 shows, almost half of the surgeries, 47.4% 
(n =55), were 61 - 120 minutes in length. 
Table 3: Length of Surgery 
Category of length of Range of actual length of 
surgery (minutes) surgery (minutes) n ' o;o 2 
1 - 60 43 - 60 8 6.9 
61- 120 64- 120 55 47.4 
121 - 180 125 - 178 38 32.8 
181 -240 184-235 10 8.6 
241 - 300 266 - 278 4 3.4 
> 300 357 1 0.9 
Total 116 100.0 ~ 
Number of vascular surgery patients undergomg surgical procedure for specified amount of time 
2 Percent of 116 vascular surgery patients undergoing surgical procedure for specified amount of time 
For the 112 patients for whom OR staff recorded information on break in sterile 
technique, 4.5% (n = 5) had a reported break in technique during the procedure. The 
nature of the break was not recorded. 
In summary, the majority of patients in this study had a bypass procedure of a 
lower extremity performed with half having an artificial graft and half having a 
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saphenous vein graft. Most procedures were elective, with most taking between 1 - 3 
hours to complete. Just about all patients had an epidural anaesthetic either alone or in 
combination with another anaesthetic. 
Characteristics ofthe Patients 
The majority, 80.2% (n = 93), of the vascular surgery sample were men, with 
19.8% (n = 23) women. Ages ranged from 48 - 89 years with a mean age of 66.5 years. 
The ages of the men and women were similar, with the mean age of the men being 66.7 
years (range 48 - 89) and the mean age of the women being 65.9 years (range 52 -84). 
The distributions of age were normal as shown in the boxplot in Figure 2. 
0 
en 
0 
00 
ruO 
e>"-
ro 
0 
tD 
0 
l.O 
male female 
Figure 2: Distribution of Ages of Vascular Surgery Patients, by Sex 
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Data were gathered on the 10 different comorbidities listed in Table 4. All of the 
patients had at least one comorbidity. As expected, peripheral vascular disease (PVD) 
occurred in every patient having bypass surgery done, as well as every patient having 
AAA repair done. The second most common comorbidity was hypertension with 73.3% 
(n = 85) of the patients having this condition. Coronary artery disease (CAD) occurred in 
64.7% (n = 75) of patients and diabetes mellitus was a comorbidity for almost half, 45.7% 
(n = 53), of the patients. About half, 49.1% (n = 57) had 1-3 comorbidities, 41.4% (n = 
48) had 4-5 comorbidities, and the remaining 9.5% (n = 11) had 6 - 7 comorbidities. 
Table 4: Number and Types of Comorbidities 
'-'UillUI uidity n4 o/o 5 
Peripheral vascular disease 116 100.0 
Hypertension 85 73.3 
CAD 1 75 64.7 
Diabetes 53 45.7 
COPD 2 24 20.7 
Renal Disease 10 8.6 
Stroke 8 6.9 
Arrhythmias 7 6.0 
Inflammatory bowel disease 3 4 3.5 
Liver disease 2 1.7 
C01onary artery disease mcludmg angma and past MI 
2 Chronic obstructive pulmonary disease including asthma 
3 Inflammatory bowel disease including ulcerative colitis, Crohn's disease and diverticulitis 
4 Number of vascular surgery patients having specified comorbidity 
5 Percent of 116 vascular surgery patients having specified comorbidity. Percentages do not total to I 00% 
because patients may have had one or more comorbidities. 
The American Society of Anesthesiologists (ASA) score was not recorded on 25% 
of patients (n = 29). The majority of patients for whom an ASA score was recorded, 
80.5% (n = 70 of 87), had a score of 3 or greater on a scale of 1 - 5. 
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Prior to the day of the surgical procedure, 37.1% (n = 43) of the patients were 
admitted to an inpatient unit, referred to as pre-admitted. The range of pre-admitted 
length of stay (LOS) for this group of patients was 2 - 39 days, with a median of 7 days 
(IQR: 3 - 9). Table 5 shows the postoperative length of stay (LOS) (number of days from 
surgical procedure to discharge) for patients pre-admitted to an inpatient hospital unit 
prior to the surgical procedure and for those who were not pre-admitted. As can be seen 
from Table 5, the median length of stay postoperatively for both groups is quite similar, 
but the range is much larger for patients who were not pre-admitted prior to their surgical 
procedure than for those who were pre-admitted. 
Table 5: Length of Stay 
Patients Patients Not 
Pre-admitted 1 Pre-admitted 1 
n(%r 43 (37.1%) 73 (62.9%) 
Postoperative Median (IQR) 8 days (7 - 11) 7 days (5-9) 
length of stay 3 Range 3 - 29 days 3 - 40 days 
Pre-admitted patients were admitted to a hospital untt on a day pnor to the day of surgery, whereas 
patients not pre-admitted were admitted to hospital on the same day as their surgery 
2 Number and percent of 116 vascular surgery patients who were pre-admitted or not 
3 Length of time after surgical procedure that patient remained in hospital 
Three known patient risk factors for SSI are steroid therapy, body mass index (BMI), 
and smoking. Only 6.9% (n = 8) of the patients were receiving steroid therapy at the time 
of their vascular surgery. Almost all of the patients, 94% (n = 1 09), had a height and 
weight measurement recorded from which a BMI was calculated. BMI ranged from 18.6 
to 40.7 with a median BMI of 26.7 (IQR: 24 - 29.5). As can be seen in Table 6, more 
than two thirds of patients, 67% (n = 73), were either overweight or obese with a BMI 
--~~-~~-- -- ---
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>25. There were 34.5% (n = 40) of the patients who self-reported to be smokers. The 
amount smoked per day was recorded on only 72.5% (n = 29) of the smokers. Table 6 
also summarizes the amount smoked by these patients. The number of cigarettes smoked 
per day ranged from 1 - 80 cigarettes. The majority of patients who reported the amount 
they smoked, 86.2% (n = 25 of29), reported smoking 20 or fewer cigarettes per day. 
Table 6: BMI and Number of Cigarettes Smoked 
Category 1 n 2 /U 
18-25 36 33.0 
BMI 25.1-30 50 45.9 
>30 23 21.1 
Total 109 100.0 
<10 10 34.5 
Cigarettes 10-20 15 51.7 
smoked >20 4 13.8 
per day Total 29 100.0 
Range of BMI or of ctgarettes smoked per day 
2 Number of vascular surgery patients in specified category of BMI 
or number of cigarettes smoked per day 
3 Percent of I 09 vascular surgery patients in specified category of BMI or of29 
vascular surgery patients in specified category of number of cigarettes smoked per day 
In summary, every patient in this study had at least 1 comorbidity, with PVD 
occurring in all patients. This was followed closely by three quarters of patients having 
hypertension, two thirds having coronary artery disease (CAD), and half having diabetes. 
Comorbidities corresponded to ASA score with over 80% having an ASA score of 3 or 
greater. Postoperative LOS was very similar for patients who were pre-admitted 
compared to those admitted on the day of the surgical procedure. However, the range of 
the LOS postoperatively was longer for patients who were not admitted preoperatively. In 
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this sample, more than two thirds of patients were overweight or obese. Only one third 
reported to be smokers with most reporting that they smoked less than 20 cigarettes per 
day. 
Blood Loss, Anemia, and Treatment 
This section outlines hemoglobin and ferritin assessment as indicators of anemia. 
Blood loss in the operating room (OR) is also discussed followed by the treatments used 
to treat anemia. 
Anemia Assessment and Treatment: Preoperative 
Preoperative hemoglobin levels were recorded on all patients and ranged from 88 
- 182 g/L with a median preoperative hemoglobin level of 138 g/L (IQR: 122 - 150). 
Anemia, defined as a hemoglobin level of less than 100 g/L, occurred in 9.1% (n = 1 0) of 
the 116 vascular surgery patients. Only 1 patient in this anemic group received packed red 
blood cells (PRBC) preoperatively. 
Table 7 shows the number of days preoperatively that patients had their 
hemoglobin level assessed. Slightly more than half of the patients, 56.9% (n = 66), had 
the level done more than 3 days and up to 6 days before the day of the surgical procedure. 
One quarter of patients, 25% (n = 29), had a preoperative hemoglobin level measured 
more than 7 days before the day of their surgical procedure. 
Table 7: Time of Measurement of Preoperative Hemoglobin 
Time of Measurement 1 n 2 o;o 3 
OR Day 12 10.3 
1 Day 21 18.1 
2Days 6 5.2 
3 Days 11 9.5 
4-6 Days 37 31.9 
7-14Days 20 17.2 
15-21 Days 6 5.2 
22-26 Days 3 2.6 
Total 116 100.0 
When preoperative hemoglobm level was measured 
2 Number of vascular surgery patients who had preoperative 
hemoglobin measured at specified time 
3 Percent of I 16 vascular surgery patients who had preoperative 
hemoglobin measured at specified time 
Blood Loss, Anemia Assessment and Treatment: Intraoperative 
75 
There was no intraoperative blood loss in 54.3% (n = 63) of the patients, while 
blood loss during surgery occurred in 45.7% (n = 53) of patients. For those patients who 
lost blood, blood loss ranged from 30 millilitres (mL)- 25 litres (L) of blood. 
Table 8: Amount of Blood Loss During Surgical Procedure 
II B_lood loss Range of actual 
1ry (mL) 1 blood loss (mL) 2 n 4 
0 0 63 
1-299 30-250 21 
300-1199 300-1100 21 
1200-4499 1200-4499 8 
2:45003 4500;10000;25000 3 
TOTAL 116 
Categones dec1ded by the researcher 
2 Actual amount of blood lost by the patients in each group 
3 Only 3 patients l ost ~ 4500 mL of blood: 4500 mL, I OL, and 25L 
4 Nu.mber of vascular patients in each blood loss category 
5 Percent of 116 vascular patients in each blood loss category 
o;o 5 
54.3 
18.1 
18.1 
6.9 
2.6 
100.0 
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Table 8 summarizes the amount of blood lost during the surgical procedure. While most 
patients who lost blood lost less than 4500 mL of blood, there were three patients who 
lost larger amounts: 4500mL, 1 OOOOmL and 25000 mL. 
An intraoperative hemoglobin level was done on only 2.6% (n = 3) of patients; 
these were the 3 patients who also lost the largest amounts of blood in the OR ranging 
from 4500 mL - 25L of blood. Intraoperative hemoglobin levels for these patients ranged 
from 63 - 83 g/L with each patient receiving PRBC and other blood products for 
treatment. None of these patients had been anemic preoperatively with hemoglobin levels 
ranging from 124- 128 g/L. 
Anemia Assessment and Treatment: Post Anaesthesia Recovery Room (PARR) 
The hemoglobin level for patients in each of the blood loss categories is shown in 
Table 9. The categories in this table were based on the distribution of data after 
preliminary assessment of which categories were most relevant for the data as there is no 
standard category system to use. The number of patients having a PARR hemoglobin 
level assessed, increased as the amount of blood lost during the surgical procedure 
increased, but the number who received PRBC did not. As the amount of blood lost 
during the surgical procedure increased, the median hemoglobin level and range increased 
in the PARR, despite the fact that there were not more patients receiving PRBC in the 
PARR. 
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Table 9: Amount of Blood Loss in OR and PARR Hemoglobin Level 
Blood loss n in n with %with Median n (%) n to ICU 
category PARR Hgb Hgb (IQR) receiving postop 
(mL)1 postop assessed assessed Hgb level PRBC in with no 
in PARR in PARR2 PARR2 PARR 
0 - 63 6 9.5 101 g/L 3 (4.8%) -
(80-125) 
1 -299 21 2 9.5 84 g/L 1 (4.8%) -
(77-91) 
300-1199 21 8 38.1 99 g/L 1 (4.8%) -
(87-105) 
1200-4499 6 4 66.7 109 g/L 0 2 
(1 04-117) 
~4500 - - - - - 3 
TOTAL 111 20 5 
Categones decided by the researcher 
2 Percent of vascular surgery patients in each specified category; totals I 00% per row, not column, as it is 
the % of patients in each category 
Anemia Assessment and Treatment: Postoperative 
Postoperatively, whether in the postoperative unit or the ICU, most patients had a 
hemoglobin level assessed as seen in Table 10. The lowest median hemoglobin level was 
seen in patients with 1200-4499 mL of blood loss during the surgical procedure. In this 
group, 75% (n = 6) of the 8 patients received PRBC postoperatively. 
The patients with the greatest amount of blood loss, 4500mL - 25L, were only 
slightly anemic with a median postoperative hemoglobin of 99 g/L, and only 1 patient of 
the 3 in this group received PRBC postoperatively. However, these patients had received 
several units ofPRBC to h·eat low hemoglobin in the intraoperative period. 
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Table 10: Amount ofBlood Loss in OR and Postoperative Hemoglobin 
Blood loss n in n having %having Median 2 Range n (%)in each 
category each a postop a postop (IQR) (giL) blood loss 
(mL)1 blood Hgb Hgb category 
loss assessed assessed receiving 
category PRBC 
0 63 60 95.2 119giL 81-153 0 
(110-129) 
1 -299 21 20 95.2 113 giL 88-145 2 (9.5%) 
(101-134) 
300-1199 21 21 100.0 100 g/L 76-132 4 (19.0%) 
(83-1 07) 
1200-4499 8 8 100.0 89 giL 88-115 6 (75.0%) 
(88-94) 
~ 4500 3 3 100.0 99 g/L 88-129 I (33.3%) 
(88-129) 
TOTAL 116 112 
Categones dec1ded by the researcher 
2 A mean hemoglobin level was calculated for each patient having > I hemoglobin level assessed. The 
distribution of these means was skewed; the median is reported. 
Anemia: Postoperative Hemoglobin 
As can be seen from Table 11 , the greatest proportion of patients, 37.9% (n = 44), 
had only 1 hemoglobin level assessed postoperatively. The patient group with the greatest 
number of hemoglobin levels assessed also had the greatest proportion of patients with 
anemia postoperatively. For example, 4 patients had 8 hemoglobin levels assessed post-
operatively and all 4 of these patients were anemic. In comparison, only 1 of 44 patients 
having only one test done was anemic. There were 22 patients who were anemic on the 
first postoperative hemoglobin level assessed. Of this group, 27.3% (n = 6) of the 22 
patients were given PRBC. 
Table 11: Number of Hemoglobin or Ferritin Levels and Postoperative Anemia 
Number n (%)having n (%)with n (%)with n with serum 
ofHgb specified Hgb < 100 postop serum ferritin level 
tests done number of Hgb giL having ferritin test < lOOmcg/L 
tests done• specified done having having specified 
number of specified number of Hgb 
Hgb tests number ofHgb tests done4 
done2 tests done3 
8 4 (3.4) 4 (100) 2 (50.0) 0 
7 2 (1.7) 2 (100) 0 0 
6 1 (0.9) 1 (100) 0 0 
5 6 (5.2) 5 (83.3) 0 0 
4 12(10.3) 11 (91.7) 1(8.3) 0 
3 19(16.4) 8 (42.1) 1(5.3) 0 
2 24 (20.7) 5 (20.8) 1(4.2) 1 
1 44 (37.9) 1 (2.3) 1(2.3) 1 
0 4 (3.4) - - -
IUIAL 116 37 (31.9%) 6 2 
Number and proportion ofpattents who had the spectfied number ofhemoglobm levels assessed as 
indicated in column I 
2 Number and proportion of patients who had the specified number of hemoglobin levels assessed as 
indicated in column I that had a hemoglobin level < I OOg/L 
3 Number and proportion of patients who had the specified number of hemoglobin levels assessed as 
indicated in column I that had a serum ferritin level assessed 
4 Number and proportion of patients who had the specified number of hemoglobin levels assessed as 
indicated in column I that had a serum ferritin level < I OOmcg/L 
Anemia: Postoperative Serum Ferritin 
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Also seen in Table 11 is the low number of patients (n = 6) having a serum ferritin 
level assessed postoperatively despite the fact that 31.9% (n = 37) of the patients had 
anemic hemoglobin levels. Of the 6 patients having a serum ferritin level assessed, only 2 
patients had a serum ferritin level of less than 100 mcg/L and neither of these 2 patients 
had a postoperative hemoglobin level less than 100 g/L. However, of the other 4 patients 
in this group with a nom1al serum ferritin level, all 4 had an anemic postoperative 
hemoglobin level for which 2 had received PRBC. Not one of the 116 vascular surgery 
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patients, despite the fact that almost one third of patients were anemic according to their 
hemoglobin level, was started on iron post-operatively. 
Anemia, Blood Loss and Treatment: Summary 
In summary, very few patients had preoperative anemia. Three quarters of the 
patients had a preoperative hemoglobin level assessed within a week preoperatively. Half 
of the patients in this study had no reported blood loss in the OR and for those that did the 
majority had lost less than 1200mL. For patients who lost 4500rnL or more of blood, each 
was treated with PRBC in the OR. Postoperatively, slightly more than one third of 
patients had only one hemoglobin level assessed with just about all patients having at 
least one hemoglobin level assessed. For those patients who lost 1200 - 4499 mL of 
blood in the OR, 75% received PRBC post-operatively. Close to one third of the patients 
had an anemic postoperative hemoglobin level but serum ferritin levels were assessed in 
very few patients. No patients were started on iron replacement therapy. 
Risk Factors of Interest 
The following section outlines the findings of the univariate analyses of specific 
risk factors of interest in this study: inappropriate antibiotic prophylaxis, perioperative 
hyperglycemia and hypothermia, and inappropriate preoperative hair removal. 
Risk Factor: Inappropriate Antibiotic Prophylaxis 
Antibiotics were given in the OR or PARR to 66.4% (n = 77) of the patients. 
There was no prophylactic antibiotic given to 33.6% (n = 39) of the patients. Of 55 
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patients with an artificial graft, 87.3% (n = 48) received a prophylactic antibiotic. In 
contrast, of 61 patients with no artificial graft, only 47.5% (n = 29) received a 
prophylactic antibiotic. The difference between these groups was statistically significant 
(p < 0.0005). 
Table 12 shows the time of administration of antibiotics relative to the surgical 
incision time for patients who were given antibiotics. 
Table 12: Administration Time of Antibiotic Relative to Surgical Incision Time 
Time Antibiotic Given n2 Ofo 3 
NOT GIVEN 39 33.6 
UNKNOWN 3 2.6 
EARLY > 2 h pre-incision 1 0.9 
> 1 - 2 h pre-incision 4 3.4 
RECOMMENDED I 30-60 min pre-incision 12 10.4 
0-30 min pre-incision 42 36.2 
0-30 min post-incision 9 7.8 
LATE 30-60 min post-incision 4 3.4 
> 60 min post-incision 2 1.7 
Total 116 100.0 
0 0 The recommended t1me for prophylactiC antibiOtiCS to be g1ven IS w1thm 60 mmutes 
prior to surgical incision being made 
2 Number of vascular surgery patients receiving an antibiotic at the specified time 
3 Percent of I 16 vascular surgery patients receiving an antibiotic at the specified time 
As can be seen from Table 12, less than half of the vascular surgery patients, 
46.6% (n = 54), received the prophylactic antibiotic as recommended within 0 - 60 
minutes prior to the surgical incision being made. Antibiotic prophylaxis was given after 
the surgical incision was made (too late) to 12.9% (n = 15) of the patients, and too long 
before the surgical incision was made (too early) to 4.3% (n = 5) of the patients. For 2.6% 
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(n = 3) of the patients, an antibiotic was recorded as given in the OR, but the time was not 
recorded. 
The appropriate antibiotic to be given for prophylaxis prior to vascular surgery is 
cefazolin unless there is an allergy, at which time another antibiotic is to be selected. Of 
the 77 patients who received an antibiotic, 74 patients received the correct antibiotic. For 
the patients who did receive the correct antibiotic, 71 of these patients received cefazolin 
and the other 3 received clindamycin due to penicillin allergy. Of 116 patients, only 
63.8% (n = 74) of the patients received the correct antibiotic and 36.2% (n = 42) either 
received the incorrect antibiotic (n =3) or no antibiotic (n = 39). 
Antibiotic dosages should be given based on body weight. Any patient weighing 
greater than 100 kg should be given cefazolin 2 g, instead of cefazolin 1 g, which is the 
standard dose. The correct weight based dose of cefazolin was given to 61.2% (n = 71) of 
the 116 vascular surgery patients. Weight was not recorded on 3.4% (n = 4) of the 
patients so it is unknown if they received the correct dose of antibiotic, and 1. 7% (n = 2) 
of the patients did not receive the correct weight based dose. 
The 2 patients with an incorrect dose for their weight were patients who weighed 
100 kg or more and received the standard dose of cefazolin 1 g, instead of cefazolin 2g. 
There were 7 other patients weighing more than 1 00 kg, 2 of who received the correct 
dose of antibiotic and 5 patients who received no antibiotic at all. 
Five patients were in the OR for longer than 4 hours and should have received a 
second dose of antibiotic for prophylaxis. However, none of these patients received a 
second dose of antibiotic. 
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Antibiotic continuation is not recommended after 24 hours postoperatively 
without a clear indication for use. There were 59 patients who were given antibiotics after 
the 24-hour period postoperatively. Of these 59 patients, 78% (n = 46) were receiving 
antibiotics after 24 hours postoperatively for no documented indication. Only 22% (n = 
13 of 59) of the patients were receiving postoperative antibiotics because they had a 
preoperative infection that was continuing to be treated or because they had developed an 
SSI. 
Table 13 shows the number of patients who received the correct drug, at the right 
time and the right dose, and if it was discontinued (D/C) within 24 hours as 
recommended. As can be seen from Table 13, only 16.4% (n = 19) of the patients met all 
4 criteria for correct administration of antibiotics. There was no patient with a weight 
greater than 100 kg who received antibiotics meeting all 4 criteria. 
Table 13: Number of Patients Meeting Criteria for Correct Antibiotic Prophylaxis 
Criteria n' Ofo 2 
Right drug, right dose, right time, D/C > 24h 19 16.4 
Right time, right drug, right dose, not D/C > 24h 30 25.9 
Right time, right drug, wrong or unknown dose 2 1.7 
Right drug only, wrong dose and time 15 12.9 
Wrong drug, right dose or time 11 9.5 
Not given 39 33.6 
I Total I 116 ltoo.o I 
Number of vascular surgery pattents who met spectfied cntena 
2 Percent of 116 vascular surgery patients who met specified criteria 
In summary, slightly more than two-thirds of patients received an antibiotic 
around the time of incision in the OR, but less than half received it at the recommended 
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time. Less than two-thirds of the patients, who received an antibiotic, received the correct 
dose and ofthe 9 patients weighing more than 100kg, only 2 received the correct dose. Of 
patients who continued to receive an antibiotic after 24 hours from the surgical incision 
time, more than three-quarters of patients received these for no clear indication. There 
were only 16.4% of all patients in the study who received the correct drug, at the correct 
time and dose, and had the antibiotic discontinued within 24 hours. 
Risk Factor: Hyperglycemia 
A preoperative glucose level was measured on 71.6% (n = 83) of the vascular 
surgery patients. A glycosylated hemoglobin (HbA1c) level was measured within 120 
days of surgery on 33.6% (n = 39) of the vascular surgery patients. Diabetic and non-
diabetic patients will be discussed separately. 
Preoperative glucose control in diabetic patients. Of 53 diabetic patients, 94.3% 
(n = 50) had a preoperative glucose level assessed; readings ranged from 4.8 - . 15.7 
mmol/L, with a median level of 8.7 mmol/L (IQR: 6.3 - 11). There were 20.8% (n = 11) 
of the 53 diabetic patients with a preoperative glucose reading of 11.1 mmol/L or greater. 
The time that the preoperative glucose level was measured ranged from 2 hours 
prior to surgery to greater than 7 days preoperatively. As shown in Table 14, 54.7% (n = 
29) of all 53 diabetic patients had the preoperative glucose level done on the OR day but 
not within 2 hours of surgery, with 3 diabetic patients having no preoperative glucose 
assessment at all. For the 11 diabetic patients with a preoperative glucose of 11.1 
mmol/L or greater, 2 patients had the glucose measured 2 hours before surgery, 7 patients 
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had it done at another point on the OR day, 1 patient had it measured 3-4 days pre-
operatively, and 1 patient had it measured 5 - 6 days preoperatively. 
Table 14: Length ofTime from Preoperative Glucose Assessment to Surgical Incision 
Time in Diabetic Patients 
Time of Pre-Operative Glucose n' %2 
Within 2 hours of surgery 6 11.3 
On OR Day (>2 hours from surgery) 29 54.7 
1-2 days preoperatively 7 13.2 
3-4 days preoperatively 4 7.5 
5-6 days preoperatively 3 5.7 
~ 7 days preoperatively 1 1.9 
Not done 3 5.7 
Tot~ I 53 100.0 
Number of dtabettc pattents havmg a pre-operative glucose level done 
at the specified time 
2 Percent of 53 diabetic patients having a pre-operative glucose level 
done at the specified time 
Intraoperative glucose control in diabetic patients. Intraoperatively, only 7.5% (n 
= 4) of the diabetic vascular surgery patients had a glucose reading measured. One patient 
had 3 readings done and the other 3 patients had 1 reading done each, with no elevated 
intraoperative glucose readings noted. These 4 diabetic patients also had normal 
preoperative glucose levels measured on the OR day. None of the 11 diabetic patients 
with an increased preoperative glucose (greater than or equal to 11.1 mmol/L) had an 
intraoperative glucose level measured. 
PARR glucose control in diabetic patients. PARR glucose levels were done on 
73 .1% (n = 38) of the 52 diabetic patients who went to the PARR, with the other diabetic 
patient going to ICU. 
Table 15: PARR Glucose Readings ofDiabetic Vascular Surgery Patients 
nl Ofo2 
1 35 92.1 
Number of glucose readings 2 1 2.6 
done per patient in PARR 1 3 1 2.6 
4 1 2.6 
Total 38 100.0 
Number of glucose readings 0 28 73.7 
~ 11.1 mmol/L in PARR 2 1 9 23.7 
2 1 2.6 
Total 38 100.0 
Number of treated glucose readings 0 0 
~ 11.1 mmol/L in PARR 
Specified number of PARR glucose levels measured w1th correspondmg 
nand% of patients in each category 
2 Specified number of PARR glucose levels ? 11.1 mmoi/L with corresponding 
n and % of patients in each category 
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Table 15 above shows the number of glucose readings done per patient in the 
PARR and that 92.1% (n = 35) of the 38 patients having a glucose level assessed in the 
PARR had only 1 measurement done. At least 1 glucose level of 11.1 mmol/L or greater 
in the PARR occurred in 26.3% (n = 10) of the diabetic patients. No diabetic patients with 
glucose levels of 11.1 mmol/L or greater received treatment in the PARR for their 
elevated glucose reading. Seven patients with an elevated PARR glucose level had also 
had an elevated preoperative glucose level. 
Postoperative unit I ICU glucose control in diabetic patients. In the first 7 days 
postoperatively, all diabetic patients had a glucose level assessed and 73.6% (n = 39) of 
53 diabetic patients had glucose levels of 11.1 mmol/L or greater. As seen in Table 16, 
almost two-thirds of the diabetic patients who had an elevated glucose level 
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postoperatively, 64.2% (n 25), had more than 5 elevated glucose levels m the 
postoperative period. 
Table 16: Postoperative Glucose Readings for Diabetic Vascular Surgery Patients 
Number of glucose values 
~ 11.1 mmol/L on nl Ofo 2 
postoperative unit 
1 7 17.9 
2 3 7.7 
3 2 5.1 
4 2 5.1 
5-9 9 23.1 
10-15 8 20.5 
16-20 4 10.3 
>20 4 10.3 
Total 39 1UU.U 
Number of diabetic patients havmg specified number of postoperative 
rlucose levels > 11.1 mmoi/L 
Percent of 39 diabetic patients havmg specified number of 
postoperative glucose levels ~ 11.1 mmol/L 
Treatments used for elevated postoperative glucose levels included oral 
medication, subcutaneous (S/C) insulin given both as regularly scheduled and stat doses, 
and IV insulin. There were also many patients who received no treatment. S/C insulin or 
an oral medication was effective for 100% of the readings that were done on patients 
having only 1 reading assessed and lowered the next glucose reading to less than 11.1 
mmol/L. However, for patients having between 5 to more than 20 elevated glucose 
readings, more patients had continued elevated glucose levels compared to those with 
fewer measurements, indicating ineffective treatment. For patients having more than 20 
glucose levels of 11.1 mmol/L or greater, S/C insulin was ineffective in reducing 80% of 
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the elevated glucose levels it was given to treat, and oral medication was ineffective for 
100% of the hyperglycemic levels it was given to treat. When no treatment was given, the 
next glucose level remained elevated in 82.8- 100% of the readings for patients who had 
more than one glucose level assessed. 
Table 17: Treatments Received Post-Operatively for Glucose Values > 11.1 mmol/L in 
Diabetic Patients 
SIC Insulin Oral medication No treatment 
n• n2 pts n3 n3 n3 
glucose with glucose n4 (%)5 glucose n4 (%)5 glucose n4 (%)5 
levels specified levels effective levels effective levels effective 
~11.1 glucose treated treated treated 
mmoi/L level 
1 7 1 1 (100) 2 2 (100) 3 3 (100) 
2-4 9 6 5 (83.3) 9 7 (77.8) 5 1 (20.0) 
5-9 9 17 6 (35.3) 21 6 (28.6) 29 8 (27.6) 
10-15 8 53 21(39.6) 1 0 (0) 29 5 (17.2) 
16-20 4 69 16(23.2) 3 1 (33.3) 19 5 (26.3) 
> 20 4 30 6 (20.0) 13 2 (15.4) 13 0 (0) 
1 Number of glucose levels that were ~ 11.1 mmol/L 
2 Number of patients having at least that number of glucose levels that were ~ 11 .1 mmol/L 
3 Number of patient glucose levels treated with the specified treatment or no treatment for that number of 
flucose levels that were ~ 11 .1 mmol/L 
Number of patients who received effective specified treatment or no treatment for that number of glucose 
levels that were ~ I 1. 1 mmol/L 
5 Percent of patients who received effective specified treatment or no treatment for that number of glucose 
levels that were ~ 11.1 mmol/L 
Glycosylated hemoglobin level- diabetic patients. HbA1c values were measured 
on 52.8% (n = 28) of 53 diabetic patients, with a range of 4.2 - 10.1 %, and a mean value 
of 7.4% (SD ± 1.5). The Canadian Diabetes Association (2008) recommends that all 
individuals with Type I or II diabetes should maintain a HbA1c of less than 7%. In 28 
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diabetic patients for whom a HbA 1 c level was available, 57.1% (n = 16) of these patients 
were above the recommended target. Of the 16 diabetic patients with an elevated HbA1c, 
81.3% (n = 13) of the patients had at least 1 elevated glucose reading on the postoperative 
unit. Despite the fact that 13 of 16 patients with an elevated HbA1c also had an elevated 
postoperative glucose level, only 6 patients received treatment on their first elevated 
reading. These 6 patients continued to have from 8 - 35 glucose readings of 11.1 mmol/L 
or greater postoperatively. The other 7 patients, who had an elevated HbA1c level and an 
elevated postoperative glucose level and received no treatment, had from 1 - 13 elevated 
glucose readings of 11.1 mmol/L or greater postoperatively. 
There were 25 diabetic patients who did not have a preoperative HbA1c level 
measured. In this group, 2 diabetic patients did not have a preoperative glucose level done 
either. Of the remaining 23 diabetic patients with a preoperative glucose measured but no 
HbA1c, 17.4% (n = 4) had a hyperglycemic level of 11.1 mmol/L or greater. 
Summary: Glucose control and treatment in diabetic patients. In summary, 
preoperatively most diabetic patients had a glucose level assessed with 20% of the 
patients having a level of 11.1 mmol/L or greater. Slightly more than half of the patients 
had the preoperative glucose level measured on the OR day, but more than one third had 
it measured 1 day to more than 7 days preoperatively. Intraoperatively, only 7.5% of 
diabetic patients had a glucose level measured and none were elevated. None of the 
patients with an increased preoperative glucose level had intraoperative glucose levels 
assessed. In the PARR, almost three quarters of the diabetic patients had a glucose level 
assessed with over one quarter having a level of 11.1 mmol/L or greater and none 
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receiving treatment. There were 7 patients who had increased preoperative glucose levels, 
who also had increased PARR levels. Postoperatively, all patients had their glucose level 
measured with three quarters of the diabetic patients having a level of 11.1 mmol/L or 
greater. More than two thirds of patients had had more than 5 elevated glucose levels on 
the postoperative unit. 
As the number of elevated postoperative glucose levels a patient experienced 
increased, treatment for the elevated glucose reading remained ineffective. Patients with a 
high number of elevated glucose readings largely received ineffective treatment ranging 
from 80% ineffectiveness for patients receiving subcutaneous insulin to 100% 
ineffectiveness for patients receiving oral medication. For patients who never received 
any intervention for elevated glucose levels, most of their glucose levels remained high as 
well. Half of the diabetic patients had a HbA 1 c level done with more than half of these 
having a level > 7%. Overall, 75.5% (n = 40) of 53 diabetic patients were "ever 
hyperglycemic" which includes any glucose measurement during the perioperative period 
of 11.1 mmol/L or greater or a HbA 1 c level of 7% or greater. 
Glucose control in non-diabetic patients. Of 63 non-diabetic vascular surgery 
patients, 52.4% (n = 33) had a preoperative glucose level done with levels ranging from 
4.4- 11.9 mmol/L, and a median level of 5.8 mmol/L (IQR: 5.2 - 6.9). There were 6.1% 
(n = 2 of 33) of the non-diabetic patients with a preoperative glucose level greater than or 
equal to 11.1 mmol/L. The greatest proportion of preoperative glucose readings for non-
diabetic patients, 48.5% (n = 16 of33), were done 1 -4 days preoperatively. 
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Intraoperatively, none of the non-diabetic patients had a glucose level assessed 
including the 2 patients with an increased preoperative glucose. Of 59 non-diabetic 
patients going to the PARR, 12 had a PARR glucose level assessed and none had elevated 
levels. Included in this group of 12 patients is 1 of the non-diabetic patients who had an 
elevated preoperative glucose level. The other non-diabetic patient with the elevated 
preoperative glucose level did not have a PARR glucose level measured. 
On the postoperative unit, there were 3 non-diabetic patients with elevated glucose 
levels. One patient had 4 elevated glucose levels that were treated successfully each time 
with an oral medication. This patient also had an elevated preoperative glucose level. The 
2 other non-diabetic patients had 1 elevated glucose level each; one patient was 
successfully treated with an oral medication and one successfully treated with IV insulin. 
HbAlc values were measured on 17.5% (n = 11) of 63 non-diabetic patients, with 
a range of 4. 7 - 11.1 %, and a mean value of 6.1% (SD ± 1.8). In non-diabetic patients, 
the CDA (2008) recommends that HbA1c values should be maintained at less than 6%. 
For the sample of 11 non-diabetic patients for whom a HbA1c was available, 27.3% (n = 
3) were above the recommended target. Of the 3 non-diabetic patients with an elevated 
HbA1c, 1 patient had an elevated preoperative glucose reading and 4 elevated 
postoperative readings for which he received an oral medication. 
Summary: Glucose control and treatment in non-diabetic patients. In summary, 
slightly more than half of the non-diabetic patients had a pre-operative glucose level 
measured with 2 patients having an elevated level of 11.1 mmol/L or greater. Patients 
with an elevated preoperative glucose level did not have an intraoperative glucose level 
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assessed. Less than one-quarter of the non-diabetic patients had a glucose level assessed 
in the PARR and all glucose levels were less than 11.1 mmol/L. Postoperatively, 3 non-
diabetic patients with a glucose level of 11.1 mmol/L or greater were treated successfully 
with oral medication or insulin. Less than one-fifth had a HbA1 c level measured with 
more than one-quarter of these having a level> 6%. Overall, 12.5% (n = 5) of 40 non-
diabetic patients for which there were glucose and/or HbA1c readings available, were 
"ever hyperglycemic" which includes glucose readings of 11.1 mmol/L or greater and 
HbA1 c levels of 6% or greater in the peri operative period. 
Risk Factor: Hypothermia 
Preoperative temperature. Of 116 patients having vascular surgery, 10.3% (n = 
12) of the patients did not have a preoperative temperature recorded. 
Table 18: Preoperative Temperatures ofPatients 
Temperature Category n• o;o 2 
< 36°C 4 3.4 
36- 36.5°C 54 46.6 
>36.5°C 46 39.7 
Not recorded 12 10.3 
1 Total 116 100.0 
Number of vascular surgery patients havmg a preoperative 
temperature measurement in each category 
2 Percent of 116 vascular surgery patients having a preoperative 
temperature measurement in each category 
The mean preoperative temperature for the 104 patients for whom temperatures 
were recorded was 36.4°C (SD ± 0.36). Preoperative temperatures ranged from 35.6 -
37.6°C with preoperative hypothermia (temperature less than 36°C) occurring in 4 of 
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these patients, and no temperatures greater than 3 7 .6°C recorded. Table 18 demonstrates 
the number of patients in each temperature category. 
While there were 104 preoperative temperatures recorded, only 63.5% (n = 66) of 
the patients had the time when the temperature was taken recorded. The length of time 
from the preoperative temperature measurement to surgical incision start time ranged 
from 10 - 1220 minutes (20.3 hours) with a median time of 149 minutes (IQR: 105 -
235). There were 4 patients with pre-operative hypothermic temperature measurements 
less than 36 °C, measured between 95- 210 minutes pre-operatively. 
Intraoperative temperature and warming interventions. Intraoperatively, three 
warming techniques were used on patients: a forced air blanket in 69.8% (n = 81) of the 
patients, an intravenous fluid warmer/forced air blanket combination in 5.2% (n = 6) of 
the patients, and a warm thermal blanket/forced air blanket combination in 2.6% (n = 3) 
of the patients. A combination of the three interventions was used in 1. 7% (n = 2) of the 
patients, while 20.7% (n = 24) of the patients received no interventions. The time these 
interventions were applied was not noted on the OR record. 
Despite warming techniques being used intraoperatively, intraoperative 
temperatures were recorded on only 8.6% (n = 10) ofvascular surgery patients. Ofthe 10 
patients, 2 patients had an AAA repair and 8 patients had a bypass procedure performed. 
Intraoperative temperatures ranged from 34.7 - 36.4°C, with a mean intraoperative 
temperature of 35.4°C (SD ± 0.6). The number of temperatures recorded intraoperatively 
on these 1 0 patients ranged from 1 - 6 measurements. 
-----------------------------~-
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Of the 10 patients who had an intraoperative temperature recorded, 8 patients 
were hypothermic at some point during the surgical intervention despite the fact that 7 of 
the patients had a warming intervention in place. Patients remained hypothermic 
intraoperatively ranging from 60 - 150 minutes, with a mean length of 119 minutes (SD ± 
31minutes). The total length of time in surgery for these 8 hypothermic patients ranged 
from 95 - 278 minutes with a median time of 123 minutes (IQR: 107 - 173). Two of the 
10 patients who had an intraoperative temperature recorded did not experience 
hypothermia with only one of these 2 patients having a warming intervention in place. Of 
the 4 patients with hypothermic preoperative temperature measurements, only 1 patient 
had an intraoperative temperature measured and this patient was hypothermic despite the 
use of a forced-air blanket. 
PARR temperature and warming interventions. Five patients went directly to ICU, 
so there is no PARR temperature data recorded for these patients. An initial temperature 
was recorded in the PARR within the first five minutes on 90.1 % (n = 1 00) of the 111 
patients, between 5 -10 minutes on 4.5% (n = 5) of the patients, and after 10 minutes on 
the other 5.4% (n = 6) of the 111 patients. One patient did not have a temperature 
recorded until he was in the PARR for 25 minutes. 
Hypothermia on arrival to the PARR from the OR occurred in 29.7% (n = 33) of 
the patients. As the length of time that patients awaited transfer from the OR to the PARR 
increased, so did the proportion of patients who were hypothermic on arrival to the 
PARR. Hypothermia on arrival to the PARR was noted in 25% (n = 4) of 16 patients who 
waited less than 5 minutes for transfer, in 29.3% (n = 22) of 75 patients who waited 
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between 5 - 10 minutes, and in 36.8% (n = 7) of 19 patients who waited more than 10 
minutes for transfer from the OR to the PARR. There were 4 patients who waited longer 
than 20 minutes in this last group. A greater proportion of patients, 33.3% (n = 29) of the 
87 who received at least 1 warming intervention in the OR were hypothermic on arrival to 
the PARR, compared to 16.7% (n = 4) of the 24 patients who did not receive any 
warming interventions in the OR. 
Hypothermia during the patient stay m the PARR occurred on at least one 
temperature measurement in 41.4% (n = 46) of the patients. The PARR temperatures for 
these 46 hypothermic patients ranged from 33.8 - 35.9°C, with a median temperature of 
35.7°C (IQR: 35.2- 35.9). Only 21.7% (n = 10) of these 46 hypothermic PARR patients 
had another temperature measured within 15 minutes to assess if temperature had 
returned to normal. 
Only 8.1% (n = 9) of the 111 patients received warming interventions in the 
PARR such as forced air blanket, warm thermal blanket, or fluid warmer and all of these 
patients were hypothermic on at least 1 measurement in the PARR. Patients only received 
one intervention; there were no recorded combinations of interventions. A fluid warmer 
was used on 2 hypothermic patients, with both patients remaining hypothermic despite its 
use. Of the 2 patients with a forced-air blanket in use, only 1 patient returned to 
normothermia while the other remained hypothermic. Warm, thermal blankets were used 
on 5 more PARR patients, with 2 patients remaining hypothermic despite its use. Overall, 
55.6% (n = 5) of the 9 patients with hypothermia who received a warming intervention 
remained hypothermic despite its use. 
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For the patients who experienced hypothermia in the PARR, the median length of 
time spent there was 94 minutes (IQR: 80- 123), with a range of 58 - 222 minutes. The 
non-hypothermic PARR patients' median PARR time was less at 85 minutes (IQR: 70 -
96), ranging from 12 - 1450 minutes. The PARR length of stay for the 111 patients 
ranged from 12 - 1450 minutes with a median PARR length of stay of 86 minutes (IQR: 
75-110). 
According to the final recording of patient temperature in the PARR, hypothermia 
was experienced on discharge from the PARR in 18.9% (n = 21) of patients. Ofthese 21 
patients, one patient had also been hypothermic on arrival to the postoperative unit, 1 
patient's vital sign measurement sheet was missing so information was not available, and 
the other 19 patients had been normothermic. 
One of the patients who had been hypothermic preoperatively and intraoperatively 
did not arrive hypothermic to the PARR, but did become hypothermic while there and 
was discharged from the PARR with a hypothermic temperature. This patient had not had 
any recorded warming intervention provided in the PARR. 
Postoperative unit temperature. Two of the 111 patients who went to the post-
operative unit after PARR did not have a temperature recorded. The length of time from 
discharge from the PARR to the first time temperature was recorded on the postoperative 
unit ranged from 0 - 695 minutes (11 hours, 35 minutes) with a median time of 5 minutes 
(IQR: 0 - 15). As Table 19 shows, 56.8% (n = 63) of patients had a temperature assessed 
on the postoperative unit within the first five minutes. There were 6 patients whose 
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temperature was not recorded on the postoperative unit for more than one hour after their 
arrival with a range oftime of 75 minutes- 11 hours, 35 minutes. 
Table 19: Time Temperature Recorded on Postoperative Unit 
Time ofTemperature1 n z Ofo 3 
0-5 minutes 63 56.8 
> 5- 10 minutes 13 11.7 
> 10 minutes 33 29.7 
Not recorded 2 1.8 
Total 111 100.0 
T1me temperature was assessed relative to arnval time on 
postoperative unit 
2 Number of vascular surgery patients having a surgical unit 
temperature recorded in each time category 
3 Percent of Ill vascular surgery patients having a surgical unit 
temperature recorded in each time category 
On the first recorded temperature on the postoperative unit, 7 of the 109 patients 
for . whom a temperature was available were hypothermic. Of these 7 hypothermic 
postoperative unit patients, only 1 of these patients had been hypothermic on discharge 
from the PARR, which means that the other 6 patients developed hypothermia during 
transfer from the PARR to the postoperative unit. These 6 patients had their temperatures 
assessed on the postoperative unit within 0 - 20 minutes of their arrival on the 
postoperative unit. 
Of the 5 patients who went directly to the ICU, 2 were hypothermic on arrival. 
Both of these patients had been hypothermic intraoperatively as well despite the use of a 
forced air blanket on each patient. The other 3 patients who went to ICU were 
normothermic on arrival and had not had their temperature assessed intraoperatively; each 
98 
patient had a forced air blanket in use in the OR. In ICU the initial temperature reading 
ranged from 34.6 - 36.0°C. 
Summary: Temperature and warming interventions. In summary, a preoperative 
temperature was not recorded on 1 0% of patients. Of the patients with a preoperative 
temperature reading, only 66% had the time the temperature was taken recorded with 
most of these within 2 hours of the beginning of surgery. Four patients had preoperative 
hypothermia. Intraoperatively, almost 70% of patients had a recorded warming 
intervention but no time of application recorded and only 10 patients had intraoperative 
temperatures recorded; 8 registered as hypothermic on average for 2 hours of the surgical 
intervention despite 7 of the 8 patients having a warming intervention in place. 
Most patients in the PARR had a temperature measured immediately on arrival 
with almost one third registering as hypothermic. As the length of time a patient waited 
for transfer from the OR to the PARR increased, so did the number of patients who were 
hypothermic on arrival to the PARR. When hypothermic temperatures were recorded in 
the PARR, which occurred in 40% of patients, only 20% of this group had a temperature 
reassessed within 15 minutes to assess if the patient had returned to normothermia. Only 
8% of patients in the PARR had a warming intervention recorded and of these patients, 
half remained hypothermic despite the use of the warming intervention. The median 
length of time on the PARR was slightly less than 1.5 hours. On discharge from the 
PARR, almost one fifth (n = 21) were hypothermic even though 19 of these patients had 
been normothermic on arrival to the PARR. 
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Postoperatively, slightly more than half of the patients had a temperature recorded 
within 5 minutes of arrival on the surgical unit, but almost 30% were not recorded until 
more than 10 minutes after arrival. There were 7 patients who were hypothermic on 
arrival to the postoperative unit even though only 1 of these patients had been 
hypothermic on discharge from the PARR. The other 6 patients developed hypothermia 
on transfer from the PARR to the surgical unit. Overall, for the 116 vascular surgery 
patients, 44.8% (n = 52) were "ever hypothermic" which is a body temperature less than 
36°C at any point immediately prior to, during, or after surgery up to the first 48 hours 
after surgery. 
Risk Factor: Inappropriate Hair Removal 
Hair removal is included as part of the preparation of the surgical area where the 
skin is to be incised for surgery. Only 12.9% (n = 15) ofthe 116 vascular surgery patients 
had no hair removal, while 87.1% (n = 101) had hair clipped at the operative site. Shaving 
is not recommended and none of the vascular surgery patients had hair shaved near the 
operative site. Intact skin at the operative site at time of surgery was reported on 90.5% (n 
= 105) ofthe patients. Conversely, 7.7% (n = 9) of the patients had abrasions, 1.7% (n = 
2) ofthe patients had redness, and 0.9% (n = 1) of the patients had a nick at the operative 
site. 
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Surgical Site Infection 
This section describes the SSI rate in this sample of vascular surgery patients, 
followed by a presentation of results related to the diagnosis of SSI, the treatment of SSI, 
the characteristics of the surgical intervention and SSI, the characteristics of the patient 
and SSI, and anemia, blood loss, and SSI. 
Diagnosis of SSI 
A surgical site infection developed in 17.2% (n = 20) of the vascular surgery 
patients. A superficial SSI developed in 14.7% (n = 17) of the 116 vascular surgery 
patients and a deep incision SSI developed in 2.6% (n = 3) of the patients. Almost half of 
the infections, 45% (n = 9), involved the groin/thigh area of the incision, 50% (n = 10) 
involved another area of the leg, and only 5% of infections (n = 1) developed in an 
abdominal incision. 
Of the 20 infections identified, 60% (n = 12) were identified in the post-operative 
surgical unit and 40% (n = 8) in the emergency department (ER). Post-operatively, only 
15% (n = 3) of the SSis were diagnosed within 2 - 5 days of surgery, while 55% (n = 11) 
of the SSis were identified within 6 - 10 days postoperatively, and 30% (n = 6) were 
identified 11 days or greater. Of the 2 patients who developed a SSI after 30 days, 1 had 
an artificial implant and was diagnosed in the ER at 98 days. The other patient did not 
have an implant and presented t~ the ER at 33 days post-operatively reporting that the 
signs and symptoms of infection had been present by 30 days. For this reason, an SSI was 
diagnosed. 
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Diagnosis was made based on Centers for Disease Control (CDC) Guidelines for 
Diagnosis of SSI found in Appendix I. A physician documented a diagnosis of SSI in 9 
of the patients, 9 additional patients had documented purulent drainage and 2 patients had 
a positive microbiology swab for culture and sensitivity (C&S). 
Overall, 13 of the patients with an SSI had purulent drainage in the wound with 
only 50% (n = 7) having a swab for C&S taken. Of the 7 remaining patients with no 
purulent drainage reported, 3 had a swab for C&S done of the wound. Of the 1 0 patients 
who had a C&S swab done, 5 patients had positive C&S results: 2 patients had methicillin 
resistant staphylococcus aureus (MRSA), 1 patient had a moderate growth of beta 
haemolytic streptococcus - group G, 1 patient had a heavy growth of pasteurella 
multocida, 1 patient had a heavy growth of bacillus species. The other 5 patients had 
negative C&S swabs. 
Treatment of SSI 
Table 20 shows that 30% (n = 6) of the patients who developed an SSI needed to 
be re-hospitalised. All 6 of these patients had been diagnosed in the ER. There were 2 
additional patients who were not re-hospitalised who had been diagnosed in the ER; both 
these patients were given a prescription for oral antibiotics to take at home. IV antibiotics 
in combination with other treatments were required for 50% (n = 1 0) of the patients who 
developed an SSI. Of these 10 patients, 6 patients were re-hospitalized and 4 were not. 
Table 20: Treatment of SSI 
I Treatment 
IV antibiotics, re-operation and re-hospitalisation 
IV antibiotics, dressings and re-hospitalisation 
IV antibiotics and re-hospitalisation 
Oral and IV antibiotics and re-hospitalisation 
Oral and IV antibiotics and dressings 
IV antibiotics and dressings 
IV antibiotics 
Oral antibiotics 
No treatment 
Total 
Number ofpattents wtth an SSI havmg spectfied treatment 
2 Percent of patients with an SSI having specified treatment 
I 
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n' I %:!1 
1 5 
1 5 
3 15 
I 5 
1 5 
1 5 
2 10 
6 30 
4 20 
20 10 
Also of note in Table 20 is that there were 4 patients who did not receive any 
treatment at all. These 4 patients all had documented purulent drainage, 1 of which had a 
C&S swab done that showed a heavy growth of bacillus species. These patients also had 
other signs and symptoms of SSI including redness, swelling, heat, fever, and pain and 
met the CDC criteria for SSI. 
Characteristics of the Surgical Interventions and SSI 
Patients who had a femoral-tibial or femoral-popliteal bypass with an artificial 
graft comprised the largest proportion of patients, 25.9% (n = 7 of 27), who developed an 
SSI. An SSI developed in 22.2% (n = 2 of 9) of the patients with an AAA repair, and in 
7.7% (n = 1 of 13) of the patients with a femoral-femoral bypass. None of the 7 patients 
with an aorto-bifemoral bypass developed an SSI. 
Charts were reviewed for a full year after surgery for patients with artificial grafts, 
and for a full 30 days for patients with saphenous vein grafts. Artificial grafts were 
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inserted during surgery on 56 patients undergoing femoral-tibial or femoral-popliteal 
bypasses, aorto-bifemoral bypasses, femoral-femoral bypasses and AAA repairs. Of the 
56 patients with these particular surgeries, 17.9% (n = 1 0) of the patients developed an 
SSI compared to 16.7% (n = 1 0) of 60 patients without an artificial graft who developed 
an SSI. 
There were 25.9% (n = 7 of 27) of the patients who had a femoral-tibial or 
femoral-popliteal bypasses with an artificial graft alone, excluding the other surgeries, 
that developed an SSI, compared to 16.7% (n = 1 0) of 60 patients without an artificial 
graft who developed an SSI; the results were not statistically significant (RR: 1.56, CI 
0.66 - 3.65; p = 0.3136). There was only 12% power to detect a statistically significant 
difference. 
Of the 15 patients who had an emergency procedure performed, 33.3% (n = 5) 
developed an SSI compared to 14.9% (n = 15 of 101) of patients with an elective 
procedure. The difference was not statistically significant (RR: 2.24, CI 0.95 - 5.28; p = 
0.0770). There was only 34% power to detect a statistically significant difference. There 
was no noted difference in type of anaesthetic received by those who did or did not 
develop an SSI. 
A break in technique during the surgical procedure was reported for 4.3% (n = 5 
of 116) of the patients and none of these 5 patients developed an SSI. An SSI occurred in 
1 of the 4 patients who did not have information reported on a break in technique during 
the surgical procedure. Of the 1 07 patients who had no break in technique reported, 
17.8% (n = 19) of the patients developed an SSI. Surgeon SSI rates ranged from 12.5 -
19.4%. 
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The length of surgery for the 20 patients who developed an SSI ranged from 53 -
266 minutes, with a median time of 87 minutes (IQR: 77- 151). For the 96 patients who 
did not develop an SSI, the length of time in the surgery ranged from 43 - 357 minutes, 
with a median of 119 minutes (IQR: 85 - 145). Patients who developed an SSI thus 
usually had shorter surgeries but this difference was not statistically significant (p = 
0.3475). 
Characteristics of the Patients and SSI 
Patients were assessed for the presence of preoperative infections. Of the 12 
patients with a preoperative infection, 16.7% (n = 2) developed an SSI, compared to 
20.9% (n = 18) of 86 patients without a preoperative infection but this was not identified 
as a risk factor (p = 0.9556). One patient had a preoperative infection in ulcers on his left 
foot that was treated with antibiotics, and a second patient had purulent drainage in a left 
heel cavity that was also treated with antibiotics. Both patients had bypass procedures 
performed and the SSI in each case developed in the incision, in an area separate from the 
preoperative infected area. 
Overall, 18.3% (n = 17) of 93 men and 13% (n = 3) of 23 women developed an 
SSI. A similar proportion of patients with 1 - 3 comorbidities, 18.3% (n = 1 0), and 4 - 5 
comorbidities, 20.8% (n = 1 0), developed an SSI. No patients with 6 - 7 comorbidities 
developed an SSI. 
Vascular surgery patients had multiple comorbidities and 16 - 18% of patients 
having one or more comorbidities developed an SSI. The exception to this was the 10 
patients with renal disease, 30% (n = 3) of whom developed an SSI, and the 4 patients 
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with liver disease, 50% (n = 2) of who developed an SSI. The difference between those 
patients with liver and/or renal disease and other comorbidities and those without liver or 
renal disease but with other comorbidities was not statistically significant (RR: 2.17, CI 
0.86 - 5.43; p = 0.1191). There was only 25% power to detect a statistically significant 
difference. There were no patients with stroke, arrhythmias, or inflammatory bowel 
disease who developed an SSI. 
Of the 29 patients with no ASA score recorded, 2 patients developed an SSI. Of 
the 17 patients with an ASA score of 2, 11.8% (n = 2) developed an SSI, compared to 
24.6% (n = 16) of 65 patients with an ASA score of 3. The difference was not statistically 
significant (RR: 2.09, CI 0.53 - 8.23; p = 0.2544). There was only 9% power to detect a 
statistically significant difference. None of the 5 patients with an ASA score of 4 or 5 
developed an SSI. There were 2 of these 5 patients that went to ICU postoperatively. 
Of the 43 patients that were pre-admitted to a surgical unit prior to the operative 
day, 18.6% (n = 8) developed an SSI compared to a similar proportion, 16.4% (n = 12), of 
the 73 non pre-admitted patients. The median preoperative length of stay (LOS) for pre-
admitted patients both with and without an SSI was 7 days (IQR: 3 - 11). 
The median postoperative LOS for the 8 preadmitted patients who developed an 
SSI, 10.5 days (IQR: 7.5 - 13), was longer than those patients who were preadmitted and 
did not develop an SSI, 8 days (IQR: 7 - 1 0). This difference approached statistical 
significance (p = 0.0648). For the patients who were not preadmitted who developed an 
SSI, the median postoperative LOS for those patients was 8 days (IQR: 6 - 1 0), which 
was only slightly longer than those patients who were not preadmitted and did not 
develop an SSI, 7 days, (IQR: 5 - 8). 
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Other known risk factors for SSI include steroid therapy, BMI and smoking. 
None of the 8 patients receiving steroid therapy developed an SSI. Of 7 patients with no 
BMI measurement, 3 patients developed an SSI. SSI developed in a greater proportion of 
those patients with a BMI measurement of 25.1-30, 18% (n = 9 of 50), than in those 
patients with a BMI of 25 or less, 13.9% (n = 5 of 36), or those with a BMI of greater 
than 30, 13% (n = 3 of23). 
Of the 40 self-reported smokers, 20% (n = 8) developed an SSI compared to 
15.8% (n = 12) of 76 non-smokers. The amount smoked by 11 patients is unavailable; 2 
patients in this group developed an SSI. Table 21 shows the number of patients who 
developed an SSI in each of the categories of number of cigarettes smoked per day. 
Table 21: Number of Cigarettes Smoked and SSI 
n cigarettes n patients 
smoked per smoking specified SSI No SSI 
day number of cigs nl Ofo 2 nl o;o 2 
<10 10 1 10.0 9 90.0 
10-20 15 3 20.0 12 80.0 
>20 4 2 50.0 2 50.0 
Unknown 11 2 18.2 9 81.8 
Total 40 8 32 
Number of vascular surgery patients m each specified category that d1d or d1d not develop an SSI 
2 Percent of vascular surgery patients in each specified category that did or did not develop an SSI; 
proportion values are added per row, not column, and total I 00% as it is the% of patients in each category 
As the number of cigarettes smoked per day increased, the proportion of patients 
developing an SSI also increased. Although 50% (n = 2 of 4) of those who smoked 
greater than 20 cigarettes per day developed an SSI compared to 10% (n = 1 of 1 0) of 
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those who smoked less than 1 0 cigarettes per day, the difference was not statistically 
significant (RR: 2.5, CI 0.20 - 31.00; p = 0.4687). There was only 17% power to detect a 
statistically significant difference. One of 4 patients who smoked more than 20 cigarettes 
per day, 25%, developed an SSI compared to 15.8% (n = 12 of 76) of non-smokers but 
this difference also was not statistically significant (RR: 1.58, CI 0.27- 9.34; p = 0.6265). 
There was only 7% power to detect a statistically significant difference. 
Blood Loss, Anemia, and Transfusion of Blood and SSI: Preoperative, Intraoperative and 
PARR 
The hemoglobin range for the 20 vascular surgery patients who developed an SSI 
was 89 - 182 g/L, with a median of 137 g/L (IQR: 118-146). This was very similar to the 
96 patients who did not develop an SSI; their hemoglobin levels ranged from 88 - 175 
g/L, with a median level of 139 g/L (IQR: 122-153). Only 10% (n = 1) of the 10 patients 
with preoperative anemia developed an SSI compared to 17.9% (n = 19) of 106 patients 
without preoperative anemia with no statistically significant difference found. 
Intraoperative or PARR hemoglobin levels were not assessed on any patients who 
developed an SSI and none received PRBC in e'ither the OR or PARR. 
Intraoperative blood loss, postoperative anemia, and SSI As seen in Table 22, the patient 
group that lost between 1200 - 4499 mL of blood during the surgical procedure had the 
greatest proportion of patients, 25% (n = 2 of 8), that developed an SSI. In the group that 
lost 300 - 1199 mL of blood, 9.5% (n = 2 of 21) of the patients developed an SSI. 
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However, the difference was not statistically significant (RR: 2.63, CI 0.44 - 15.61; p = 
0.2800). There was only 11% power to detect a statistically significant difference. 
Table 22: Blood Loss During Surgical Procedure, Postoperative Hemoglobin and SSI 
Blood loss SSI NoSSI 
category ni n2 o;oJ Median4 n2 o;oJ 
(IQR) 
0 60 13 21.7 118 g/L 47 78.3 
(115-125) 
1-299 20 3 15.0 102 giL 17 85.0 
(88-114) 
300-1199 21 2 9.5 81 g/L 19 90.5 
(80-83) 
1200-4499 8 2 25.0 89 giL 6 75.0 
(88-89) 
>4500 3 0 0 - 3 100.0 
Total 112 20 92 
Number of vascular surgery pattents m each blood loss category that had a postoperative 
hemoglobin level assessed 
Median4 
(IQR) 
119 giL 
(108-131) 
119g/L 
(101-141) 
101 giL 
(84-1 07) 
90 g/L 
(89-99) 
99 giL 
(88-129) 
2 Number of vascular surgery patients in each specified blood loss category that did/did not develop an SSI 
3 Percent of vascular surgery patients in each specified blood loss category that did or did not develop 
an SSI; proportion values are added per row, not column, and total I 00% as it is the % of patients in each 
category 
4 Median hemoglobin level of all patients in each blood loss category 
Postoperatively, the median hemoglobin levels for patients who lost 1200 - 4499 
mL of blood were anemic; hemoglobin levels were similar whether the patient developed 
an SSI or not with a median postoperative hemoglobin level of 89 giL and 90 giL 
respectively. The patient gr~up with an SSI who lost 300-1199 mL of blood were also 
anemic postoperatively with a median hemoglobin level of 81g/L, compared to patients in 
the same blood loss group without an SSI who had a median postoperative hemoglobin 
level of 101 g/L. This difference approached statistical significance (p = 0.0722). 
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Of the 22 patients who received PRBC at any time during hospitalisation, 22.7% 
(n = 5) developed an SSI compared to 16.0% (n = 15) of 94 patients who never received 
PRBC. This difference was not statistically significant (RR: 1.42, OR 0.58 - 3.50; p = 
0.4492). There was only 8% power to detect a statistically significant difference. 
There were 22 patients who were anemic on their first post-operative hemoglobin 
level that was assessed. There were 27.3% (n = 6) of this group of 22 patients who 
developed an SSI. To treat the anemia in this group of 22 patients, 5 patients were given 
PRBC. Of those receiving PRBC, 40% (n = 2) of 5 patients developed an SSI compared 
to 23.5% (n = 4 of 17) of the anemic patients who never received blood. The difference 
was not statistically significant (RR: 1.7, CI 0.43 - 6.71 ; p = 0.4673). There was only 5% 
power to detect a statistically significant difference. 
Risk Factors of Interest and SSI 
Risk Factor: Antibiotic Prophylaxis and SSI 
Of 77 patients who received antibiotics in the OR or PARR, 14.3% (n = 11) 
developed an SSI compared to a greater proportion, 23.1% (n = 9), of the 39 patients that 
never received antibiotics in the OR or PARR who developed an SSI. The difference was 
not statistically significant (RR 1.62, CI 0.73 - 3.57; p = 0.2364). There was only 16% 
power to detect a statistically significant difference. 
Of 55 patients with an artificial graft, 87.3% (n = 48) received a prophylactic 
antibiotic. In contrast, of 61 patients with no artificial graft, only 47.5% (n = 29) received 
a prophylactic antibiotic. For patients without an artificial graft, the SSI risk was higher in 
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those who did not receive antibiotics compared to those who did. The relative risk was 
1.7, with a 95% CI of 1.11 - 2.6, indicating an elevated risk, although the difference did 
not achieve significance (p = 0.0565). 
Risk of getting an SSI was not increased in the same way in patients with an 
artificial graft. There were 14.3% (n = 1 of 7) of the patients that never received an 
antibiotic and developed an SSI, compared to 18.8% (n = 9 of 48) of the patients who did 
receive an antibiotic (p = 0.7748) 
Table 23 shows that the highest proportion of patients developing an SSI, 44.4% 
(n = 4 of 9), occurred in patients who received an antibiotic late, specifically 0 - 30 
minutes after the surgical incision was made. 
Table 23: Antibiotic Administration Time and SSI 
Time antibiotic SSI NoSSI 
given relative n2 n J Ofo 4 n J Ofo 4 
to incision time 
Not Given 39 9 23.1 30 76.9 
Unknown 3 1 33.3 2 66.7 
Early > 2 h pre 1 0 0 1 100.0 
> 1 - 2 h pre 4 0 0 4 100.0 
Recommended1 3 0-60 min pre 12 2 16.7 10 83.3 
0-30 min pre 42 4 9.5 38 90.5 
0-30 min post 9 4 44.4 5 55.6 
Late 30-60 min post 4 0 0 4 100.0 
> 60 min post 2 0 0 2 100.0 
I I Total I 116 I 20 I I 96 I I 
I .. .. The recommended ttme of anttbtOttc admmtstrattOn ts wtthm 0- 60 mmutes pnor to surgtcal mciston 
2 Number of vascular surgery patients receiving antibiotics in specified time period 
3 Number of vascular surgery patients receiving antibiotics in specified time period, with or without an SSI 
4 Percent of vascular surgery patients receiving antibiotics in specified time period, with or without an SSI; 
proportion values are added per row, not column, and total 100% as it is the% of patients in each category 
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Patients who received the antibiotic late, specifically 30- 60 minutes late (n = 4) 
and more than 60 minutes late (n = 2) did not develop an SSI. Of the patients who 
received the antibiotic more than 60 minutes prior to the surgical incision being made (n 
= 5), none ofthese patients developed an SSI as well. 
Table 24 shows that receiving an antibiotic 0 - 30 minutes after the surgical 
incision was made, was a risk factor for SSI. Patients who received an antibiotic anytime 
after the surgical incision was made also had a higher relative risk of infection when 
compared to any time periods prior to the incision. Differences between patients who 
received the antibiotic anytime early (p = 0.0519) or 0 - 30 minutes prior to the incision 
(p = 0.0576) compared to anytime after the incision approached statistical significance. 
Table 24: Relative Risk for Antibiotic Administration Time 0 - 30 Minutes Post Incision 
versus Prior to Incision and SSI 
Time n Rate Relative Risk (95% Cl) 
Anytime early 1 6 of 59 10.2% 4.37 (1.52 - 12.53) 
0-30 min pre 4 of42 9.5% 4.67 (1.43 - 15.25) 
0-60 min pre 2 6 of 54 11.1% 4.60 (1.40 - 11.43) 
Early (before 60 min) 0 of5 0% Comment 3 
30-60 min pre 2 of 12 16.7% 2.67 (0.62 - 11.49) 
Anyttme early IS a combmat10n of0-60 mm pre and early (before 60 mm) 
2 0-60 min pre is a combination patients 0-30min pre and 30-60 min pre 
3 Because zero patients of 5 developed an SSI, unable to calculate relative risk 
p 
0.0068 
0.0089 
0.0113 
0.0778 
0.1632 
In addition to correct timing of antibiotic administration, patients should receive 
the correct drug and appropriate dose for their body weight. There were 74 patients who 
received the correct prophylactic antibiotic, cefazolin, or in the case of a penicillin 
allergy, clindamycin. Of these 74 patients, 14.9% (n = 11) developed an SSI. Of the 3 
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other patients who did not receive the correct prophylactic antibiotic, none of these 
patients developed a SSI. The correct weight-based dose of cefazolin was given to 71 
patients and of these patients, 14.1% (n = 1 0) developed an SSI. Of the 3 patients for 
which it is unknown if they received the correct weight-based dose because they did not 
have a weight recorded, 1 patient developed an SSI. Of the 9 patients weighing more than 
100 kg, 5 patients did not receive antibiotics and 2 developed an SSI. Of the remaining 4 
obese patients who did receive antibiotics, 2 received the correct dose and 2 received the 
incorrect dose, but none of the 4 patients developed an SSI. Correct dosing also includes 
giving a second dose of antibiotic if the patient's surgical time is longer than 4 hours. 
None of the 5 patients in the OR for longer than 4 hours received a second dose of 
antibiotics and 1 ofthese patients developed an SSI. 
Table 25 shows the criteria for correct administration of antibiotics and SSI. 
Table 25: Criteria for Correct Administration of Antibiotics and SSI 
r<.. • 
..__. u .... ria SSI No SSI 
01 0]. 0/o 3 0]. 
Right drug, right dose, rig_ht time 49 6 12.2 43 
Right time, right drug, unknown or wrong 2 0 0 2 
dose 
Right drug only, wrong dose or time 15 5 33.3 10 
Wrong drug, right dose or time 11 0 0 11 
Not given 39 9 23.1 30 
Tnfnl 116 20 96 
Number of vascular surgery pattents wtth spectfied cntena 
2 Number of vascular surgery patients with specified criteria that did or did not develop an SSI 
3 Percent of vascular surgery patients with specified criteria that did or did not develop an SSI; 
total is I 00% per row, not column, as it is the% of patients in each category 
Ofo j 
87.8 
100.0 
66.7 
100.0 
76.9 
----------------------------- -- ---
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As can be seen from Table 25, 12.2% (n = 6) of the 49 patients who received the 
correct drug and dose at the correct time developed an SSI compared to those patients 
who received the correct drug only with the incorrect dose and time, 33.3% (n = 5 of 15) 
of whom developed an SSI. The difference was not statistically significant (RR: 1.75, CI 
0.56- 5.54; p = 0.3400). There was only 10% power to detect a statistically significant 
difference. There was also no statistically significant difference between patients who did 
not receive an antibiotic and those who received the correct drug, at the correct dose and 
time (RR: 1.48, CI 0.90- 2.43; p = 0.1660). 
Risk Factor: Glucose and SSI 
Preoperative glucose control in diabetic patients and SSI Of 53 diabetic vascular 
surgery patients, 18.9% (n = 10) developed an SSI, compared to 15.9% (n = 10) of 63 
non-diabetic patients. The difference was not statistically significant (RR: 1.19, CI 0.54 -
2.64; p = 0.6706). Eleven of the diabetic patients had an elevated preoperative glucose 
level greater than 11.1 mmol/L, and of these patients, 18.2% (n = 2) developed an SSI. Of 
the other 39 diabetic patients with a normal preoperative glucose level, 17.9% (n = 7) 
developed an SSI. One of 3 patients who did not have a preoperative glucose level 
measured developed an SSI. 
Intraoperative and PARR glucose control in diabetic patients and SSI 
Intraoperative glucose levels were assessed on only 4 diabetic patients. There were no 
glucose levels greater than 11.1 mmol/L and none of the 4 patients developed an SSI. Of 
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the 52 diabetic patients who went to PARR, 73.1% (n = 3 8) had a PARR glucose level 
assessed. Of 10 diabetic patients that had at least 1 PARR glucose level of 11.1 mmol/L 
or more, 10% (n = 1) of the patients developed a SSI. In comparison, of 28 diabetic 
patients with normal PARR glucose levels, 17.9% (n = 5) developed an SSI. The other 14 
diabetic patients never had a PARR glucose assessed and 28.6% (n = 4) of these patients 
developed an SSI. 
Postoperative unit glucose control in diabetic patients and SSJ At least 1 
postoperative glucose level was elevated in 39 of 53 diabetic patients and of these 
patients, 15.4% (n = 6) developed an SSI. The elevated glucose values for these 6 patients 
ranged from 12 - 15.4 mrnol/L, with a median of 13.2 mrnol/L (IQR: 12.1 - 14.4). Of the 
14 remaining diabetic patients without an elevated postoperative glucose level, 28.6% (n 
= 4) developed an SSI. 
Glycosylated hemoglobin level and SSI - diabetic patients. Of the 28 diabetic 
patients with a HbA1c level assessed, 57.1% (n = 16) had a HbA1c level above 7%. SSI 
developed in 3 7.5% (n = 6) of these 16 diabetic patients. In comparison, 16.7% (n = 2) of 
the 12 diabetic patients without an elevated HbA1c developed an SSI. The difference 
between the groups was not statistically significant (RR: 2.25, CI 0.55 - 9.26; p = 
0.2272). There was only 11% power to detect a statistically significant difference. 
Ever hyperglycemic - diabetic patients and SSJ There were 40 diabetic patients 
who were "ever hyperglycemic" meaning they had an elevated glucose of 1l.lmmol/L or 
~----------------------------------------------------------------
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HbA 1 c level greater than 7% in the peri operative period. Of these 40 diabetic patients, 
20% (n = 8) developed an SSI, compared to 15.4% (n = 2) of 13 diabetic patients who 
were "never hyperglycemic". The difference between groups was not statistically 
significant (RR: 1.3, CI 0.32- 5.36; p = 0.7118). 
Glucose control in non-diabetic patients and SSI Of 63 non-diabetic patients, 
15.9% (n = 1 0) developed an SSI. Of 2 nondiabetic patients with an elevated preoperative 
glucose level greater than 11.1 mmol/L, 1 patient developed an SSI and 1 did not. There 
were no intraoperative glucose levels measured on non-diabetic patients. Of the 59 non-
diabetic patients who went to the PARR, 20.3% (n = 12) had a glucose level assessed in 
the PARR with none having an elevated PARR glucose level. Three non-diabetic patients 
had an elevated glucose reading on the postoperative unit and 1 of these patients 
developed an SSI. For the 20 non-diabetic patients for whom no glucose measurement 
' 
was available, 15% (n = 3) developed an SSI. 
HbA1c levels were measured on 11 of 63 non-diabetic patients and of these 
patients, 27.3% (n = 3) had a HbA1c level above 6%. One patient, 33.3% developed an 
SSI. Eight non-diabetic patients had HbA1c levels within normal limits and of these 8 
patients, 12.5% (n = 1) developed an SSI. The difference between the groups was not 
statistically significant (RR: 2.67, CI 0.23 - 30.40; p = 0.4250). There was only 5% 
power to detect a statistically significant difference. 
Overall, 12.5% (n = 5) of 40 non-diabetic patients for whom there were glucose 
and/or HbA1c readings available were "ever hyperglycemic". Of these 5 "ever 
hyperglycemic" patients, 40% (n = 2) developed an SSI. In contrast, of the 35 non-
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diabetic patients who were "never hyperglycemic" who had levels measured, 8.6% (n = 
3) developed an SSI. This was a statistically significant difference between groups (RR: 
4.67, CI 1.02 - 21.4; p = 0.0468). 
Perioperative hyperglycemia in all patients and SSJ Of 93 diabetic and non-
diabetic patients combined for whom a glucose or HbA 1 c level was measured, 16.1% (n 
= 15) developed an SSI, compared to 21.7% (n = 5) of 23 patients who did not have a 
glucose or HbA1c levels measured. There were 45 patients in the combined group that 
were "ever hyperglycemic" and of these, 22.2% (n = 1 0) developed an SSI. In contrast, of 
the 48 patients in the combined group that were "never hyperglycemic", 10.4% (n = 5) 
developed an SSI. Although the proportion that was "ever hyperglycemic" and 
developed an SSI was almost double those who did not develop an SSI, the difference 
between groups was not statistically significant (RR: 2.13, CI 0.79 - 5.76; p = 0.1219). 
There was only 24% power to detect a statistically significant difference. 
Risk Factor: Temperature and SSJ 
Preoperative temperature and SSI A preoperative temperature was assessed on 
104 of 116 patients. There were 4 patients with hypothermic preoperatively; none 
developed an SSI. Of the group of 16 patients who did not have a preoperative 
temperature assessed, 25% (n = 4) developed an SSI, while 15.4% (n = 16 of 104) of the 
patients who did have a temperature assessed developed an SSI. The difference was not 
statistically significant (RR: 2.16, CI 0.86- 5.43; p = 0.1191). There was only 38% 
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power to detect a statistically significant difference. The median time from preoperative 
temperature being assessed to surgical incision was very similar between patients who did 
and did not develop an SSI, at 147 minutes (IQR: 100 - 179) and 150 minutes (IQR: 110 
- 245) respectively. 
Intraoperative temperature and SS! For the 10 vascular surgery patients with a 
temperature measured in the OR, 8 patients were hypothermic and did not develop an 
SSI, while 2 patients who were normothermic did develop an SSI. Of 106 patients who 
had no intraoperative temperature recorded, 17.0% (n = 18), developed an SSI. 
In the patient group with only a forced air blanket in place in the OR for 
maintenance of normothermia, 19.8% (n = 16 of81) ofthe patients developed an SSI. Of 
this group with the forced air blanket only, all 6 which had a temperature assessed while 
receiving this intervention were hypothermic, but none developed an SSI. Of the 6 
patients with a forced air blanket/ intravenous fluid warmer combination, 16.7% (n = 1) 
developed an SSI. There was only 1 patient who had a temperature assessed while 
receiving these 2 interventions and this patient was hypothermic but did not develop an 
SSI. Of the 3 patients with a forced air blanket/warm thermal blanket combination, 33.3% 
(n = 1) developed an SSI. Of the 2 patients with all three interventions, 1 patient had 
intraoperative temperatures measured and this patient was hypothermic, but neither 
patient developed an SSI. Overall, 19.6% (n = 18 of 92) of the patients with an 
intervention developed an SSI compared to those who had no interventions, 16.7% (n = 4 
of 24); the difference was not statistically significant (RR 1.04, CI 0.38 - 2.83; p = 
0.9333). 
.---------------c---------------------------------- ---~-
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PARR temperature and SSI. A greater proportion of patients who were 
hypothermic on arrival to the PARR from the OR developed an SSI, 24.2% (n = 8 of 33), 
compared to 14.1% (n = 11 of 78) of those who were not hypothermic. The difference 
was not statistically significant (RR: 1.72, CI 0.76 - 3.88; p = 0.1949). There was only 
19% power to detect a statistically significant difference. As well, a greater proportion of 
patients who were hypothermic on at least one measurement in the PARR, 20% (n = 9 of 
45), developed an SSI compared to 15.2% (n = 10 of 66) of the patients who were not 
hypothermic in the PARR. The difference was not statistically significant (RR: 1.27, CI 
0.57 - 2.88; p = 0.5646). 
Of the 9 patients receiving a warming intervention in the PARR, 5 patients 
remained hypothermic and 60% (n = 3) of these patients developed an SSI. The other 4 
patients returned to normothermia after the use of a warming intervention and none 
developed an SSI. The difference approached statistical significance (p = 0.0578). There 
was only 13% power to detect a statistically significant difference. 
The length of PARR stay for the 19 patients who went to the PARR and 
developed an SSI ranged between 50 - 195 minutes, with a median time of 86 minutes 
(IQR: 73 - 142). The length of PARR stay for the 92 patients without an SSI had an 
identical median time of 86 minutes (IQR: 75 - 11 0), with a range of 12 - 1450 minutes. 
In the final recording of temperature in the PARR, 81.1 % (n = 90 of 111) of the 
patients were normothermic and 18.9% (n = 21 of 111) were hypothermic. Of the patient 
group with hypothermia on discharge, 9.5% (n = 2 of21) developed an SSI. Of the group 
who were normothermic on discharge, double the proportion, 18.9% (n = 17 of 90), 
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developed an SSI. The difference was not statistically significant (RR 0.50, CI 0.13 -
2.02; p = 0.3049). 
Postoperative unit temperature and SSI There were 109 patients who had a 
temperature assessed on arrival to the surgical unit and of these patients, 6.4% (n = 7) 
were hypothermic on arrival. Of the 7 hypothermic patients, 42.9% (n = 3) of the patients 
developed an SSI compared to 15.7% (n = 16 of 102) of the patients who were not 
hypothermic on arrival to the post-operative unit. The difference approached statistical 
significance (RR: 2.73, CI 1.04- 7.18; p = 0.0668). There was only 35% power to detect 
a statistically significant difference. Six of the 7 patients were hypothermic on arrival to 
the surgical unit had not been hypothermic on discharge from the PARR. Conversely, 
90SYo (n = 19 of21) patients who had been hypothermic on discharge from PARR were 
no longer hypothermic on arrival to the postoperative unit and 2 of these patients 
developed an SSI. 
Five patients went directly to ICU, 2 of whom were hypothermic on arrival there 
from the OR. Neither of these patients developed an SSI. Of the 3 other normothermic 
patients in ICU, 1 patient developed an SSI. 
Ever hypothermic and SSI Of 64 patients who were "ever hypothermic", an SSI 
developed in 15.6% (n = 10) of the patients. In comparison, an SSI occurred in more, 
19.2% (n = 10), ofthe 52 patients who were "never hypothermic". The difference was not 
statistically significant (RR: 1.23, CI 0.55- 2.72; p = 0.6091). 
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Risk Factor: Inappropriate Hair Removal and SSI 
There were 101 patients who had hair clipped at the surgical incision site prior to 
surgery, 16.8% (n = 17) of whom developed an SSI. There were 15 other patients who 
had no hair removal at the surgical incision site, 20% (n = 3) of whom developed an SSI. 
Of 105 patients with intact skin, 16.2% (n = 17) of the patients developed an SSI 
compared to 37.5% (n = 3) of the 8 patients with abrasions noted at the surgical incision 
site prior to surgery. The difference was not statistically significant (RR: 2.38, CI 0.88 -
6.45; p = 0.1159). There was only 23% power to detect a statistically significant 
difference. There were 6 of 8 patients with noted abrasions from unspecified reasons on 
the OR chart who received cefazolin; 5 patients received it 0 - 60 minutes pre-incision 
and did not develop an SSI, and 1 patient received it 0 - 30 minutes post-incision and 
developed an SSI. Of the 2 remaining patients of 8 with abrasions who did not receive an 
antibiotic, both developed an SSI. There was a statistically significant difference noted 
between those patients with abrasions who received antibiotics in a timely manner (n = 
5), none of whom developed an SSI, compared to 100% (n = 3) of those patients who did 
not receive antibiotics or did not receive them in a timely manner (p = 0.0047). No 
patients with nicks' or redness noted at the surgical incision site developed an SSI. 
Risk Factors and SSI- Multivariate Analysis 
The bivariate analysis in the preceding sections showed that several factors were 
significantly associated with increased SSI risk. However, bivariate analysis cannot 
control for confounding factors. Therefore, a multivariate analysis was carried out to 
determine which factors were independent predictors of the development of an SSI. A 
121 
stepwise logistic regression process was used whereby variables were dropped and effects 
were assessed using the likelihood ratio test. All variables that showed statistically 
significant differences in effect on SSI development or variables that appeared to be of 
clinical interest were entered into the logistic regression. The variables included in the 
model were: surgeon (3 categories - surgeon having the lowest SSI rate was baseline), 
presence of an artificial graft, number of cigarettes smoked per day (no cigarettes as the 
baseline, presence of renal and/or liver disease, undergoing an emergency procedure, 
having broken skin in the surgical area prior to incision, blood loss categories (> 1200 mL, 
300-1199 mL, and 0-299 mL with this last category being the baseline), antibiotics 
categories (3 categories with wrong antibiotic time but right dose and drug as the highest 
risk, nor receiving antibiotics as the nexthighest risk, and correct time of antibiotic as the 
baseline), hypothermia on atTival to the PARR, having diabetes, hypothermia on arrival to 
the surgical unit, having hyperglycemia, and receipt of blood products. Logistic 
regression did not identify any of the variables as independent predictors for SSI, most 
likely because of the small sample size and low power. The model explained less than 
22% of the variance (pseudo-R2 = 0.2204. Table 26 shows the risk factors for SSI that 
were assessed in the logistic regression. 
Table 26: Odds Ratios for the Logistic Regression Model for the Prediction of SSis 
(n= 109) 
Variable Odds Standard 95% ClforOR 
Ratio Error 
Surgeon 2 0.8321 1.0035 0.0783-8.8453 
Sw-geon 3 2.2300 2.5514 0.2368-20.9979 
Artificial graft 2.9854 2.3353 0.6444-13 .8311 
Number of cigarettes per 0.9988 0.0316 0.9387-1.0628 
day 
Renal/liver disease 5.0046 5.2733 0.6346-39.4701 
Emergency procedure 4.0315 3.2014 0.8502-19.1163 
Broken skin 3.4937 3.7864 0.4176-29.2282 
Blood loss 300-1199 mL 0.1383 0.1789 0.0109-1.7448 
Blood loss > 1200 mL 0.5385 0.8369 0.02559-11.3295 
Right antibiotic, wrong 7.1751 6.5900 1.1859-43.4127 
dose and time 
Not receiving antibiotic 4.7019 3.9062 0.9229-23.9565 
Hypothermia on arrival to 2.1812 1.5197 0.5568-8.5453 
PARR 
Diabetes 0.5658 0.5675 0.0792-4.0406 
Hypothermia on arrival to 5.0824 5.4892 0.6119-42.2085 
the surgical unit 
Hyperglycemia 2.2493 2.2228 0.3243-15.6035 
Receipt of PRBC 1.8084 1.6586 0.2996-10.9143 
Conclusion 
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An SSI developed in 17.2% of the vascular surgery patients in this study. The 4 
main risk factors for SSI that were examined included: 1) antibiotic prophylaxis, 2) 
hyperglycemia, 3) hypothermia, and 4) inappropriate hair removal. 
Results show that antibiotic prophylaxis was not being followed as recommended 
in the literature and this contributed to increased SSI risk in vascular surgery patients. 
Antibiotics were not being given prophylactically to all patients, many were given too 
late, they were not repeated in the OR for procedures past 4 hours, and the dose was not 
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adjusted for patients with weights greater than 100 kg. Significant risk factors for SSI 
were antibiotics given after the surgical incision was made, and for patients with skin 
abrasions, not receiving antibiotics in a timely manner or at all. 
Hyperglycemia was also a problem for vascular surgery patients. Hyperglycemia, 
measured by glucose levels and HbA 1 c levels, occurred often, through all stages of the 
perioperative process in both diabetic and non-diabetic patients. In non-diabetic patients, 
hyperglycemia in the perioperative period was a significant risk factor for SSI. 
Hypothermia was a common occunence through all stages of the perioperative 
process, much like hyperglycemia. Despite the use of warming interventions, 
hypothermia persisted. While hypothermia was not shown to be a risk factor for SSI, 
trends towards increased SSI risk were seen when patients were hypothermic in the 
PARR and on transfer from one unit to another. 
Hair removal practices in the OR followed protocols that are commonly 
recommended. There were some patients with abrasions on their skin, and while this was 
not identified as a risk factor for SSI, a trend was seen. Patients with abrasions on their 
skin who did not receive correct antibiotic prophylaxis had a significantly increased risk 
of SSI development. 
Additional risk factors that approached significance included having an 
emergency procedure, anemia with blood loss between 300-1199 mL of blood, not 
receiving an antibiotic if there was no artificial graft inserted during surgery, and 
hypothermia on arrival to the postoperative unit. There were also some noteworthy issues 
with documentation. There was missing documentation with respect to ASA scores, 
patients' weights, preoperative and intraoperative temperatures, and diagnosis of SSI by 
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the physician. As well, assessment of glucose and temperature in particular was 
inconsistent, and there did not appear to be good follow-through of patients throughout 
the perioperative process if they had experienced hyperglycemia or hypothermia. 
Hyperglycemia was inadequately treated, and warming interventions used for 
normothermia were not evaluated and appeared relatively ineffective. These and other 
issues will be discussed in Chapter 5. 
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Chapter 5 Discussion 
Because surgical site infections (SSis) incur such high personal and financial costs 
on individuals who develop them, they are an area targeted by the "Safer Healthcare 
Now" (SHN) campaign to reduce preventable occurrences in hospital. Four interventions 
suggested by the SHN campaign to reduce SSI occurrence are: 1) antibiotic prophylaxis, 
2) glycemic control in the Coronary Artery Bypass Graft (CABG) surgery population, 3) 
maintenance of intraoperative normothermia in the colorectal surgery patient population, 
and 4) appropriate preoperative hair removal. There is little information available about 
the effect of these risk factors on vascular surgery patients, which is why this study was 
undertaken. This study also determined the SSI rate of vascular surgery patients 
undergoing select surgeries. With this information on risk factors and rates as well as how 
these patients are cared for, factors amenable to intervention by nurses may be addressed. 
This chapter discusses the main findings of the study, starting with incidence rates and 
focusing on the risk factors of interest. Practice is also described in each section 
pertaining to the risk factor under discussion. The factors explored in this study related to 
SSI risk will be compared to relevant studies as discussed in the literature review. 
Prior to this discussion, the aspect of "clinical importance" must be introduced. 
For the purpose of this study, clinical importance recognizes that decisions about optimal 
patient care should be made at times despite there being a lack of statistical significance. 
In my study as in many other studies, statistical significance was not achieved possibly 
because of the small sample size and therefore decreased power to find a relationship. 
The reverse is also true, a small sample size does not mean that a relationship does exist; 
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chance hasn't yet been ruled out. Deciding if something is clinically important enough to 
change practice must also take into account published guidelines, previous research 
findings, and accepted standards of care. If all clinical importance was decided based on 
statistical significance, much of nursing research would be disregarded because there is 
no statistical significance with qualitative research or descriptive research and not all of 
the human condition is amenable to a randomized, controlled study (Dyer, 1997). In this 
chapter, findings described as clinically important means that they should be addressed by 
either exploring them further or taking action until higher powered studies become 
available. 
Incidence ofSSI in Vascular Surgery Patients 
A surgical site infection (SSI) developed in 17.2% of the vascular surgery study 
patients. This SSI rate seemed high, so a comparison of rates across Canada was 
undertaken. However, there was no national SSI surveillance system for comparison of 
SSI rates available in Canada. There was only one study found with a Canadian SSI rate 
in which 7.0% of 473 patients having vascular surgery developed an SSI (Turnbull et al., 
2005). 
The primary purpose of the Turnbull et al. (2005) study was an exploration of the 
effect of antibiotic prophylaxis on SSI risk. Prospective in-hospital surveillance was 
completed through chart review and assessment of patients while they were in hospital. 
As well, any patient who was readmitted to the emergency department (ER) or to the 
hos.pital with an SSI was included in the overall SSI rate for up to 30 days if there was no 
prosthetic graft and for up to one year if there was a prosthetic graft. There were 
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similarities between the Turnbull et al. study and my study with respect to patient 
characteristics and comorbidities, and the use of standard definitions of SSI from the 
Centers for Disease Control (CDC). In the Turnbull et al. study however, despite 
indications that patients were followed for the recommended time period, the proportion 
of patients who were actually assessed post-discharge is not reported. Standard SSI 
surveillance only focuses on the number of cases that come back to the facility, but it 
does not ensure that other cases of SSI that have developed are counted. It is a possibility 
that patients returned to other hospitals or to their family physician with signs or 
symptoms of an SSI and never presented to the hospital that originally performed their 
surgical procedure. Such patients would not be counted as a patient who developed an 
SSI. This may have led to an underestimation of the proportion of SSis that truly 
developed with a lower than actual SSI rate reported in the Turnbull et al. study. 
Within six weeks after surgery, 94% of the vascular surgery patients in my study 
were seen by an attending vascular surgeon, therefore validating that those patients did or 
did not have an SSI in that time frame. As well, as recommended by the CDC, complete 
30-day post-discharge surveillance for 60 patients without an artificial graft was 
completed on 95% of patients. This indicates that there is high accuracy in the SSI rate of 
the vascular surgery study patients without a graft in my study. 
For the 56 patients with an artificial graft who the CDC recommends have 
surveillance for a full year, post-discharge surveillance was incomplete though 
comparable to methods used in most studies. While charts were reviewed for up to 1 year 
to assess for visits to the ER, outpatients department or vascular lab for signs or 
symptoms of infection, it is unknown how many patients with an artificial graft SSI may 
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have been missed because they did not return to the facility but instead went to another 
facility or their family doctor. However, 92.9% of vascular surgery patients with an 
artificial graft in my study were seen within 6 weeks after surgery. Of the 10 patients with 
an SSI who had an artificial graft, 9 of these patients were seen within 6 weeks of 
surgery, indicating that the SSI rate in vascular surgery patients with an artificial graft is 
accurate within this time period. Because every patient was not assessed after 6 weeks, 
the SSI rate from my study represents the proportion of SSis that developed in this 
particular time period only. The difference in surveillance methods and follow up in my 
study compared to the Turnbull et al. (2005) study explains, at least in part, the difference 
in SSI rates between the two studies and indicates a possible underestimation of their SSI 
rate. As discussed in the literature review, when post-discharge surveillance is not 
complete with verification of patients not having an SSI as well as identification of those 
who do, SSI rates are much lower and many SSis are missed. 
Because there were no other studies available with Canadian vascular surgery SSI 
rates and no national reporting system in place to compare the rate from my study, the 
literature was reviewed from other countries for further comparison. At first glance, the 
rate from my study appeared to be much higher than other countries. With the exception 
of 1 report of 11 in the last 10 years (since 1999), all other SSI rates were considerably 
lower than my study rate, with most being less than half this rate, ranging from II % to 
4.34%. However, on further examination of these reports, differences were again seen in 
post-discharge surveillance as with the Turnbull et al. (2005) study. There is little point in 
comparing to reports from 3 older studies, because surgical techniques, antibiotic 
protocols, and other practices differed at that time. These older studies reported SSI rates 
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of 4.1 %, 5.1 %, and 16% (Nicholson et al., 1994; Richet et al. , 1991 ; van Himbeeck et al. , 
1992). 
There were 2 studies that did do post-discharge surveillance (Mannien et al., 2006; 
Moro et al. , 2005). In the Mannien et al. study, an SSI rate of21.1 % was reported which 
was the outermost limit of SSI rates found in vascular studies. The authors indicated that 
patients were followed for the appropriate time period for development of SSI but did not 
report how many patients were lost to follow-up once discharged home suggesting that 
post-discharge surveillance was incomplete. In this case, it is likely that their SSI rate 
may be under-reported even though it was higher than the SSI rate in my study. In the 
~ 
second study that used post-discharge surveillance, a much lower SSI rate of 5.4% was 
reported (Moro et al.). However, in this study, the post-discharge surveillance consisted 
of a phone call to the patient or a form to be filled out by a physician and sent back to the 
facility, if the patient presented to them with an SSI. An SSI was only counted if both of 
these criteria were met, which would grossly underestimate the true SSI rate. 
There were 9 additional reports of SSI rates in the last 10 years that either did not 
report if post-discharge surveillance was done, or did not do any post-discharge 
surveillance (Chang et al. , 2003; Coello et al. , 2005; Edwards et al. , 2008; Hawn et al. , 
2008; Morton et al. , 2008; NNIS system, 2004; O' Sullivan et al. , 2006; Pounds et al. , 
2005; Schepers et al. , 2003). Assuming that post-discharge surveillance was not done 
because it was not reported, it is likely that the reports underestimated the true SSI rate in 
each area while making the rate from my study seem inflated, even though it is possibly 
the most accurate rate. Further details of these studies are found in Appendix B, Tables 3 
and4. 
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SSJ Risk Factors 
Because the SSI rate was 17.2% in my study, it was important to identify risk 
factors that increase SSI risk with the ultimate goal of defining interventions that may 
decrease the effect of a risk factor on SSI development, thereby reducing the SSI rate. As 
discussed in the literature review, the SHN campaign targeted four specific interventions 
to reduce SSI risk, namely inappropriate antibiotic prophylaxis, perioperative 
hyperglycemia and intraoperative hypothermia in specific patient populations, and 
inappropriate preoperative hair removal. Because there was a gap in the literature about 
the effect of these risk factors on SSI development in vascular surgery patient population 
as well, these relationships were explored. As my study's primary research questions also 
related to nursing practices, a discussion of both the risk factors <:md nursing interventions 
to reduce these risk factors will be included in this section. This discussion will begin 
with antibiotic prophylaxis because inappropriate antibiotic prophylaxis emerged as the 
greatest risk factor for SSI in my study. 
Inappropriate Antibiotic Prophylaxis 
During 2005, the time period during which patients m my study had their 
vascular surgery, the SHN campaign was just getting started and there were no specific 
protocols being followed within Eastern Health for antibiotic prophylaxis in vascular 
surgery patients. The literature at that time did recommend the administration of a 
prophylactic antibiotic within 60 minutes prior to the surgical incision, but at Eastern 
Health the decision to give antibiotics prophylactically or not was made by the physicians 
involved in the care of the patient undergoing surgery. Because the SHN campaign had 
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recommended antibiotic prophylaxis as a strategy to reduce SSI and there was limited 
infom1ation in the literature related to vascular surgery patients and risk factors for SSI, it 
was decided to explore this relationship in my study. 
An antibiotic was not received by 33.6% of the patients. Of the other 77 patients 
who did receive an antibiotic, 14.3% developed an SSI compared to 23.2% of the 39 
patients who did not receive an antibiotic (p = 0.2364). Of 55 patients with an artificial 
graft, 87.3% received a prophylactic antibiotic. In contrast, of 61 patients with no 
artificial graft, only 4 7.5% received a prophylactic antibiotic. 
For patients without an artificial graft, the receipt of antibiotics appeared to 
decrease risk although the difference did not achieve significance (p = 0.0565). Risk of 
getting an SSI was not increased in the same way in patients with an artificial graft. There 
were 14.3% of 7 patients that never received an antibiotic and developed an SSI, 
compared to 18.8% of 48 patients who did receive an antibiotic (p = 0.7748). Although 
none of these differences achieved statistical significance, it would appear that receiving 
an antibiotic was more beneficial than not, particularly in patients without an artificial 
graft. However, just receiving an antibiotic was insufficient to reduce the risk of SSI. Of 
importance also were the microorganisms the antibiotic was directed against, the time it 
was received, the dose based on body weight, and receipt of a second dose after 4 hours 
in the OR. 
Correct antibiotic choice and dose. As outlined in the literature review, cefazolin, 
a first generation cephalosporin, is the antibiotic of choice in clean vascular surgery 
because it is directed against Gram-positive bacteria that are most commonly encountered 
132 
during vascular surgery (Blondel-Hill & Fryters, 2006; Mangrarn et al., 1999). In the case 
of a penicillin allergy, clindarnycin is the antibiotic of choice (Blondel-Hill & Fryters; 
Mangram et al.). Cefazolin or clindarnycin was received by 92.2% of patients who 
received an antibiotic in my study. 
In addition to receiving the correct drug, most patients also received the conect 
dose. However, of 9 patients who weighed more than 1 OOkg, less than half received an 
antibiotic, and of those that did, less than one-quarter received the correct dose. This is 
similar to findings of another Canadian study where only 15% of patients with a high 
BMI received the conect dose (Zvonar et al., 2008). The literature is clear that patients 
weighing greater than 1 OOkg should be given 2 grams (g) of cefazolin instead of 1 g to 
reduce SSI risk (Bandyk, 2008; Blondel-Hill & Fryters, 2006; Bratzler & Houck, 2004; 
Rarniro et al., 2007), but this did not always occur in my study. 
There was no difference found in SSI risk for patients who did or did not receive 
the conect dose of antibiotic based on weight. However, of the patients with a missing 
weight measurement and therefore no BMI calculated, half developed an SSI. For this 
reason, there may be an underestimation of the effect that a weight-based dose of 
antibiotic has on SSI risk. If these patients without a BMI measurement had weighed 
more than 100 kg, a greater difference related to the effect of incorrect weight-based 
antibiotic prophylaxis and SSI risk may have been seen. It is tmclear from my study if 
receiving the correct weight based dose of an antibiotic is associated with SSI. However, 
it still may be helpful for the OR record of patients weighing more than 100 kg to be 
flagged in some way to serve as a reminder that these patients should receive a higher 
dose based on research from other patient groups. 
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Correct antibiotic timing. Maintenance of a therapeutic dose of antibiotic in the 
tissues during surgery decreases SSI risk. Key to this occurring is not only the correct 
weight-based dose as previously discussed, but also the timing of antibiotic 
administration and repeat dosing for patients in the OR for longer than 4 hours so that 
tissue antibiotic levels are optimal (Bandyk, 2008; Blondel-Hill & Fryters, 2006; Classen 
et al., 1992; Dellinger et al., 2005; Griffin, 2005; Silver et al. , 1996; Stewart et al., 2007). 
Despite the strength of the evidence in the literature regarding antibiotic prophylaxis 
timing, less than half of the patients in my study received an antibiotic at the 
recommended time of 0 - 60 minutes prior to the incision being made. The highest 
proportion of SSis occurred in patients who received antibiotics late, specifically, within 
30 minutes after the surgical incision was made. Results showed that when antibiotics 
were given after the incision was made compared to before the incision was made, the 
SSI risk was increased as much as 4.7 times (p = 0.0089). 
For patients in the OR for longer than 4 hours, a second dose of antibiotic should 
be given to maintain optimal tissue antibiotic levels as previously mentioned. However, 
of the 5 patients in the OR for longer than 4 hours, none received a second dose. Of these 
patients, 1 patient developed an SSI. Morita et al. (2005) reported that 26.5% of patients 
who should have received a second dose but did not developed an SSI, compared to 8.5% 
of those patients who did receive a second dose as recommended. 
From my study findings on increased SSI risk with incorrect timing and the 
literature already available drawing the same conclusion, it can be concluded that 
incorrect antibiotic timing in vascular surgery patients is a risk factor for SSI. However, 
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because of the small sample of patients who never received a second dose, a conclusion 
regarding the need for a second dose if the surgery is longer than 4 hours cannot be made. 
It was not assessed why antibiotics were not given to all vascular surgery patients. 
In informal discussion during a presentation with nurses from the OR, the nurses 
indicated that they felt it was the responsibility of the anaesthetist to administer the 
prophylactic antibiotic. Tan, Naik, and Lingard (2006), explored obstacles to proper 
timing of antibiotic prophylaxis with anesthetists and found recurrent themes emerged 
including low priority and inconvenience. In an opinion article by Klein (2008) that 
explored standardization of perioperative care, he indicated that there are still significant 
barriers to adopting established standards such as those related to antibiotic prophylaxis 
which involve the anaesthetist's and surgeon's opinions on what is appropriate. In a study 
by van Kasteren, Kullberg, deBoer, Mintjes-de Groot, & Gyssens (2003), a lack of 
agreement by the surgeon to the antibiotic guidelines was one of the greatest contributors 
to incorrect antibiotic prophylaxis. At the time of this study, there was no protocol 
followed at Eastern Health and antibiotic administration was at the discretion of the 
physicians in the OR. Perhaps with the development of a protocol that addresses these 
issues, antibiotic prophylaxis rates will improve and SSI rates will drop. There has been 
evidence to this effect reported in the literature with SSI rates dropping as much as 27% 
when antibiotic administration protocols were put in place (Dellinger et al. , 2005). In a 
study with vascular surgery patients, when strategies were implemented that addressed 
compliance with antibiotic prophylaxis, compliance rose by 34%, from 53% to 87% 
(White & Schneider, 2007). 
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Correct antibiotic prophylaxis -getting it all right. Addressing individual aspects 
of appropriate antibiotic prophylaxis has already been discussed, but putting it all together 
so that the patient received the correct drug at the correct dose and time was also 
explored. The greatest proportion of patients developing an SSI occurred in those who 
received the right drug only but with the wrong dose and time. Of patients who only 
received the right drug, 33.3% developed an SSI compared to 12.2% of the patients who 
received the right drug at the right dose and time (p = 0.3400). A statistically significant 
difference between conect and incorrect antibiotic administration times has already been 
reported, but it is also reasonable to conclude from this that the dose of the antibiotic in 
addition to the time is clinically important. 
To address the overall issues with inappropriate antibiotic prophylaxis, an 
exploration of where nurses and physicians initially learn about antibiotic prophylaxis and 
whether it is included in their basic educational curriculum needs to be undertaken. For 
those seasoned nurses and physicians, it is unclear how they remain current with changing 
recommendations or how the importance of antibiotic prophylaxis is recognized, so 
further exploration of this is also necessary. Research on what nurses and physicians 
envision as their role with respect to antibiotic prophylaxis is also warranted. Some 
examples of solutions would be to develop a protocol with members of the healthcare 
tean1 that will champion the effort to follow current recommendations, and identify and 
implement strategies that will promote compliance with the protocol such as having the 
protocols visible, and developing reminders throughout the perioperative period about 
antibiotic prophylaxis. This must be done involving all key members in the OR. 
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Diabetes and Hyperglycemia 
Hyperglycemia has been identified as a risk factor for SSI in the CABG surgery 
patient population as already discussed in the literature review. Hyperglycemia was one 
of the targeted interventions to reduce SSI risk in the SHN campaign as well. Because 
there is little information available about the relationship of hyperglycemia to SSI risk in 
the vascular surgery patient population, it was decided to explore this relationship in my 
study. For ease of interpretation of results and to demonstrate that it is hyperglycemia and 
not diabetes that increases SSI risk, results from diabetic and non-diabetic patients were 
separated for this discussion. 
Diabetes and SSI risk. A diagnosis of diabetes has been identified as an 
independent risk factor for SSI in the CABG, general, and vascular surgery literature 
(Borger et al. , 1998; Fietsam et al. , 1991; Latham et al. , 2001; Malone et al. , 2002; 
Neumayer et al. , 2007; Richet et al., 1991; Slaughter et al. , 1993; Talbot, 2005; Zacharias 
& Habib, 1996). In my study, a slightly higher proportion of diabetic patients, 18.9%, 
developed an SSI compared to 15.9% of non-diabetic patients (p = 0.6706). While there 
was not a big difference between proportions of diabetics and non-diabetics that 
developed an SSI, there were some greater differences found when hyperglycemia was 
the focus and not just the diagnosis of diabetes. 
Hyperglycemia and SSI risk. Furnary and Wu (2006) asserted tl1at it is not 
necessarily being diabetic that places a patient at risk, but instead it is uncontrolled 
hyperglycemia that increases the SSI risk. As already discussed in the literature review, a 
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relationship between hyperglycemia and SSI risk has been found in CABG surgery, 
general surgery and critically ill patients. This appeared to be true in this study as well. 
Regardless of diabetic status, when the groups of non-diabetic and diabetic 
patients were combined, 29.6% of the patients with either or both an increased 
preoperative glucose or HbAl c level developed an SSI, compared to 13.1% who 
developed an SSI with a' normal preoperative glucose or HbA1c (p = 0.0640). This study 
may need to be repeated with a larger sample to ensure that there is enough power to 
assess this association. Overall though, results indicate that control of preoperative 
glucose and HbA1c, and patient education efforts that can be employed by nurses about 
glycemic control, are important whether the patient is diabetic or non-diabetic. 
Hyperglycemia and SSI risk - diabetic patients. My study determined that SSI risk 
was not increased with a diagnosis of diabetes. Hyperglycemia, not diabetes, was the risk 
factor of interest. Of 40 diabetic patients who were "ever hyperglycemic", meaning at 
some point in the perioperative period they had an elevated glucose reading of 11.1 
mmol/L or greater or a HbA1c level of7% or greater, 20% developed an SSI compared to 
15.4% of 13 patients who were "never hyperglycemic" (p = 0.7118). This data suggests 
that there is no difference in SSI risk between those who are hyperglycemic and those 
who are not. For this reason, it was decided to look more closely at specific time periods 
as other studies had done. 
In the OR, there were no elevated glucose levels noted, so intraoperative 
hyperglycemia risk on SSI cannot be determined. An elevated preoperative glucose level 
did not increase the risk of SSI as 18.2% (n = 2) of the patients with an elevated 
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preoperative glucose developed an SSI, compared to 17.9% (n = 7) of the patients with a 
normal glucose level. This differs from studies that have found that an increased 
preoperative glucose level significantly increased SSI risk (Guvener et al. , 2002; Latham 
et al., 2001; Trick et al., 2000a, 2000b; Wilson & Sexton, 2003). 
When the glucose levels in the PARR and postoperative unit and their impact on 
SSI risk were assessed, surprisingly, patients who were normoglycemic developed more 
SSis than those who were hyperglycemic. In the PARR, 10% of the 10 patients with 
hyperglycemia developed a SSI compared to 17.9% of 28 diabetic patients with normal 
PARR levels. However, complete information is not available on glucose levels in the 
PARR. There were 14 diabetic patients who did not have a PARR glucose level assessed, 
28.6% of whom developed an SSI. For this reason, a conclusion cannot be drawn from 
my findings on the risk of SSI with hyperglycemia in the immediate postoperative period 
in PARR. Postoperatively, 15.4% (n = 6) of the patients with an elevated glucose level 
developed an SSI compared to 28.6% (n = 4) of the 14 diabetic patients without an 
elevated postoperative glucose level. This finding is opposite to findings from other 
studies that have shown an increased risk of SSI with elevated postoperative glucose 
(Furnary et al., 1999, 2003, 2004; Furnary & Wu, 2006; Grey et al., 2004; Guvener et al., 
2002; Latham et al., 2001; Lazaret al., 2004; Vilar-Compte et al., 2008; Zerr et al., 1997). 
However, my findings do support the findings of studies of Collier et al. (2005), and 
Krinsley (2004), in which there was no significant association found between elevated 
postoperative glucose and SSI. An explanation for the non-association between 
postoperative hyperglycemia and SSI risk in my study is that there may be a stronger 
influence from another factor in the postoperative period. 
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Overall, when looking at glucose levels, my study results did not provide support 
for the argument that hyperglycemia is a risk factor for SSI in vascular surgery patients. 
However, of diabetic patients with an elevated HbA1c level, 37.5% developed an SSI 
compared to 16.7% of the diabetic patients with a normal HbA1c level (p = 0.2272). 
Despite the fact that these differences were not statistically significant in terms of risk for 
SSI, it may still be clinically important and warrants further validation as it may have 
implications for clinical practice. This is especially true given the Canadian Diabetes 
Association (CDA) (2008) current recommendations to maintain glucose levels of 8 - 11 
mmol/L in the perioperative period and the increased incidence of SSI related to 
hyperglycemia because of 1) elevated glucose levels in tissues promoting bacterial 
growth, 2) impaired neutrophil function with respect to chemotaxis, phagocytosis, and 
intracellular bacteriocidal activity, and 3) changes in vascular permeability leading to 
edema and promotion of bacterial growth, all of which decrease host defenses to 
infectious agents (Aragon et al., 2003; Campbell, 2007; Dronge et al., 2006; Golden, Kao, 
Peart-Vigilance & Brancati, 1999; McCowen, Malhotra, & Bistrian, 2001; Smiley & 
Umpierrez, 2006). 
Assessment and occurrence of hyperglycemia - diabetic patients. Of interest in 
my study as well was how many patients had glucose levels measured, and at which 
points in the perioperative period hyperglycemia actually occurred. By determining the 
frequency with which glucose assessment was occuning and the timing of the increased 
glucose levels, nursing interventions designed to assist a patient in achieving 
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normoglycemia could be designed and implemented. This would follow the guidelines set 
out by the CDA. 
Preoperatively, 50 of 53 diabetic patients had a glucose level measured with 
20.8% of the diabetic patients having a level of 11.1 mmol/L or greater. Slightly more 
than 66% of the patients had the preoperative glucose level measured on the operative 
day. HbA1c values were measured on only 52.8% (n = 28) of 53 diabetic patients; more 
than half of these had a level greater than 7%. There is no specific protocol within the 
study hospital on when glucose or HbA1c levels should be measured preoperatively or 
which patients should have these levels assessed. A convenient time would be when 
nurses see patients in the preadmission clinic, which usually occurs at least one week 
before surgery. This would give the nurse time to obtain pertinent results and then 
provide the patient with education on strategies to reduce their glucose level before 
surgery. This could be done though education on diet, exercise, a medication regime, and 
referral to other health professionals for postoperative care. Following this initial 
assessment and appropriate interventions, the patient could then return on the day of 
surgery and the nurse could again assess the patient's glucose and report it to the 
physician who could decide on interventions to maintain optimal intraoperative glucose 
control. 
There were only 7.5% of diabetic patients in my study with a glucose level 
measured intraoperatively and none of the levels were elevated. It was surprising that 
more patients did not have intraoperative glucose levels assessed as one-fifth of the 
diabetic patients had elevated preoperative glucose levels. In the PARR, 73.1% of 
diabetic patients had a glucose level assessed and 10 of these patients had at least 1 PARR 
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glucose level of 11.1 mmol/L or more. There were 7 patients with an elevated level in the 
PARR that also had an elevated preoperative glucose level. It is not unreasonable to 
assume that these patients may have had an elevated glucose throughout the surgical 
procedure as well. It was beyond the scope of this study to explore the reasons for why 
all diabetic patients returning to the PARR did not have a glucose level assessed or why 
glucose levels remained elevated throughout the intraoperative period, but this is an area 
that warrants further research. By nurses assessing glucose in the intraoperative and 
PARR periods, interventions can then be provided based on the results which assist 
patients to achieve a state of normoglycemia. This should then thus decrease the negative 
effects of elevated glucose as reported in the literature review. 
On the postoperative surgical unit, all diabetic patients had their glucose levels 
assessed with at least 1 glucose level being elevated in 39 of 53 diabetic patients. The 
focus of this study was not to determine why diabetic patient's glucose levels were or 
were not assessed. However, because there are recommendations from the CDA (2008) to 
maintain glucose levels of 7 - 11 mmol/L in the perioperative period to decrease surgical 
risks including SSI risk, a treatment protocol would be helpful in providing direction on 
who should receive glucose assessment and when the assessment should be done. 
Management of hyperglycemia - diabetic patients. The main purpose of assessing 
perioperative glucose levels is to develop and provide interventions that reduce the 
negative effects that increased glucose can have on the patient undergoing surgery. 
Preoperatively, there was no record of patients receiving intervention for increased 
glucose. Intraoperatively, because so few diabetic patients had a glucose level assessed, 
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data were not gathered on treatment. In the PARR, despite the fact that 10 patients had an 
elevated glucose level, none were treated. This study did not explore the reasons that 
hyperglycemia was untreated but this is an area requiring further research. 
On the postoperative unit, patients received treatment but it was largely 
ineffective. Treatments included short acting, sliding scale insulin and oral 
hypoglycemics. There were some patients who received no treatment at all. More than 
two-thirds of patients had more than 5 elevated glucose levels on the postoperative unit, 
which 80-100% ofthe time were ineffectively treated, meaning the next glucose level was 
greater than 11.1 mmol/L. 
Treatment protocols to prevent hyperglycemia, particularly in CABG surgery 
patients, abound in the literature with these authors maintaining tight glucose control of 
11.1 mmol/L or less with intravenous insulin (Furnary et al., 1999, 2003, 2004; Furnary 
& Wu, 2006). It was not explored in this study if nurses intervened and requested 
treatment for elevated glucose levels in the PARR or postoperatively and if they did, why 
patients remained hyperglycemic. While the frequency of glucose assessment and 
interventions for glucose control are left to each individual physician to monitor and 
prescribe, nurses have a strong advocacy role in ensuring that optimal care is provided for 
the patient, including glycemic control. 
The development and usage of a protocol to treat hyperglycemia could help with 
providing optimal care for the patient. Consideration could also be given to using 
intravenous insulin to maintain glucose levels within an acceptable range in the 
postoperative period, particularly in the Special Care Unit. This unit is staffed with a 
registered nurse for the vascular surgery patient who stays there for 24 hours. Some areas 
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of further research could include an exploration of continuity of care in terms of glycemic 
control throughout the perioperative period, and development of protocols to guide 
decision-making in the assessment and treatment of hyperglycemia intraoperatively. 
Hyperglycemia and SSI risk - non-diabetic patients. In this study it was identified 
that it was not diabetic status that affected SSI risk, rather it was the hyperglycemia that 
the patient experienced. This has also been supported in the research as discussed in the 
literature review. For this reason, the effect of hyperglycemia on SSI risk in non-diabetic 
patients was explored. 
Of 40 non-diabetic patients with a glucose or HbA1c level measured, 5 patients 
were "ever hyperglycemic", meaning at some point in the perioperative period they had a 
glucose reading of 11.1 mmol/L or greater, or a HbA 1 c level of 6% or greater. Of these 
"ever hyperglycemic" non-diabetic patients, 40% of the patients developed an SSI. In 
comparison, 8.6% of 35 non-diabetic patients who were "never hyperglycemic" 
developed an SSI (p = 0.0468). Hyperglycemia in non-diabetic patients was identified as 
a significant risk factor for SSI, although this had not been the same for the diabetic 
patients in this study. 
There were relatively few glucose levels assessed and/or elevated in non-diabetic 
patients. Of 2 patients with an elevated preoperative glucose level, 1 patient developed an 
SSI. Postoperatively, of 3 non-diabetic patients with elevated glucose levels, 1 patient 
developed an SSI. Because of these few numbers, no conclusions can be drawn about the 
specific perioperative time period that a patient has an elevated glucose and how this 
affected SSI risk. 
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As with diabetic patients, elevated SSI rates were associated with elevated HbA1c 
levels despite differences not achieving statistical significance. However, these 
differences still warrant further attention and exploration. As discussed in the literature 
review, prolonged exposure of hemoglobin to glucose raises the HbA1c level and levels 
greater than 6% are sub-optimal in non-diabetic patients and are known to increase risk 
(CDA, 2008; McCance and Huether, 2006). Of non-diabetic patients with an increased 
HbA1c, 33.3% developed an SSI, compared to 12.5% with a normal HbA1c (p = 0.4250). 
In a study by O'Sullivan et al. (2006), non-diabetic vascular surgery patients with a 
suboptimal HbA1c developed significantly more wound infections than did non-diabetics 
with normal HbAlc values (9.9% vs. 0%; p < 0.05). 
Overall, hyperglycemia does appear to be an important risk factor in non-diabetic 
patients. Further research is needed to verify this association and clinical attention should 
be paid to glucose and HbA1c levels in non-diabetic patients. 
Assessment and occurrence of hyperglycemia - non-diabetic patients. Given the 
association between hyperglycemia and SSI risk in non-diabetic patients, it is interesting 
to note the assessments done in this group. Of 63 non-diabetic vascular surgery patients, 
52.4% had a preoperative glucose level assessed. Two of these non-diabetic patients had 
glucose levels of 11 .1 mmol/L or greater. It is of interest that 2 patients not previously 
diagnosed with diabetes would have such elevated readings. Research has shown that 
increased glucose is an independent marker of in-hospital mortality in patients with 
undiagnosed diabetes (Umpierrez et al., 2002). Because of this risk of increased in-
hospital mortality and the finding of studies demonstrating that SSI risk is increased with 
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hyperglycemia regardless of diabetic status, it would be a reasonable expectation that 
nurses would ensure that all patients' preoperative glucose levels are tested whether they 
are diabetic or not. 
HbA1c levels were measured on 17.5% of 63 non-diabetic patients. More than 
one-quarter of these patients had HbA 1 c levels greater than 6%, perhaps indicating a pre-
diabetic state. One of the 2 non-diabetic patients with an elevated preoperative glucose 
level had the highest registered HbA1c in the study at 11%. Intraoperatively, no patients 
had glucose levels assessed, despite the fact that 2 non-diabetics had elevated 
preoperative levels. In the PARR, 12 of 59 non-diabetic patients had a PARR glucose 
level assessed and there were no elevated glucose levels found. This included 1 of the 2 
patients who had an elevated preoperative glucose level. Because glucose levels were not 
assessed postoperatively on many of the non-diabetic patients, data are not available on 
the proportion non-diabetic patients who experienced postoperative hyperglycemia. 
However, there were 3 non-diabetic patients who had glucose levels assessed that were 
found to have levels in excess of 11.1 mmol/L. 
It was not surprising that most of these patients did not have glucose levels done 
as they were identified as non-diabetic. It was not explored in this study why some non-
diabetic patients had glucose or HbA1c levels done and others did not, or what the 
selection process was. Consideration should be given to checking everyone 
preoperatively with interventions provided for those with an elevated preoperative level. 
The development of a protocol to guide initial assessment and when to continue to assess 
a patient throughout the perioperative period may also be helpful 
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Management of hyperglycemia - non-diabetic patients. With respect to treatment 
for hyperglycemia in non-diabetic patients, nurses have a great responsibility to first 
assess all patients for hyperglycemia regardless of their diabetic status, and then to 
advocate for interventions to assist patients to return to a normoglycemic state. However, 
the 2 non-diabetic patients with an elevated preoperative glucose level in this study did 
not receive an intervention to reduce the glucose level preoperatively. Since there was no 
hyperglycemia in the OR and PARR in the few patients that had glucose assessed, 
treatment was only given postoperatively. In the postoperative period, there were 3 non-
diabetic patients with hyperglycemic levels who were each treated successfully meaning 
that their next glucose level was less than 11.1 mmol/L. 
Besides the advocacy role for hyperglycemia interventions that a nurse must 
assume, there is also a strong patient education role. Patients who are newly diagnosed 
with diabetes need education about diet, exercise, and medication to control 
hyperglycemia, as well as referrals for post-discharge education from other health 
professionals. Nurses can provide this education for patients and advocate for optimal 
perioperative glycemic control for patients so that SSI risk is reduced (Girard, 2005, 
2006). 
Hypothermia 
As part of the SHN campaign, maintenance of normothermia in the OR has been 
suggested as an intervention to reduce SSI risk in colorectal surgery patients. This 
recommendation is based on a study by Kurz et al. (1996), in which a significant 
association was found between intraoperative hypothermia and SSI. Because hypothermia 
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and its effect on SSI risk have not been studied in vascular surgery patients, this 
relationship was explored in my study. Included is this analysis was the effect of 
hypothermia at any point during the entire peri operative period, not just the intraoperative 
period as recommended by SHN, and its association with SSI. Part of this investigation 
looked at the time period during which hypothermia developed to assess if this increased 
SSI risk. This exploration also included an assessment of the interventions provided to 
assist a patient to return to a normothermic state, and if/when temperature was monitored. 
Hypothermia and risk for SS! Of patients who were "ever hypothermic", meaning 
they had a body temperature less than 36°C at some point in the perioperative period, 
19.2% of 52 patients developed an SSI compared to 15.6% of 64 patients who were 
"never hypothermic" (p = 0.6091). Because these proportions are so similar, the results 
suggest that being "ever hypothermic" is not a risk. However, when the temperature was 
viewed in different time periods, intraoperative hypothermia did appear to show a trend 
towards being a risk factor if arrival to the PARR with a hypothermic temperature level is 
reflective of intraoperative hypothermia. This study found that double the proportion of 
patients who arrived to the PARR hypothennic developed an SSI, compared to those who 
were normothermic (p = 0.1949). 
In the PARR, despite the use of a warming intervention, 5 patients remained 
hypothermic and 60% developed an SSI. In comparison, there were no patients who 
developed an SSI of the 4 patients that became normothermic with the warming 
intervention (p = 0.0578). Of 7 patients who were hypothermic on arrival to the 
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postoperative unit, 42.9% developed an SSI, compared to 15.7% who were normothermic 
(p = 0.0668). While none of these findings are statistically significant given the low 
sample size, trends in the results suggest that the difference may be clinically important. 
Overall, more research with a larger sample size is needed to explore these associations 
further. 
Occurrence and management of hypothermia. While it is not clear if hypothermia 
is a risk factor for SSI, interventions are warranted for patient comfort. Therefore, it is 
important to assess patient temperature throughout the perioperative process to determine 
if a patient is hypothermic or not. Once that assessment is completed, interventions to 
treat any hypothermia that has occurred can be provided and documented. 
Of the 104 patients who had their temperature assessed preoperatively, 4 patients 
were noted to be hypothermic preoperatively. None had any warming intervention noted 
in the chart. Studies have shown that preoperative warming for 1 - 2 hours before surgery 
is effective in reducing hypothermia, increasing patient comfort, and decreasing anxiety 
(Just et al., 1993; Weirich, 2008). My study did not explore why patients were not 
warmed preoperatively. 
Only 10 of 116 patients had an intraoperative temperature recorded; 8 were 
hypothermic on at least one temperature measurement. The mean length of time that 
patients were hypothermic in the OR was 119 minutes. Of these 8 hypothermic patients, 7 
were still hypothermic even with the warming intervention recorded to be in use. A 
greater proportion of patients, 33.3% of the 87, who received at least 1 warming 
intervention in the OR were hypothermic on arrival to the PARR, compared to 16.7% of 
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the 24 patients who did not receive any warming interventions in the OR. These findings 
suggest that the warming interventions provided in the OR were largely ineffective. 
Studies by Kumar et al. (2005) and Negishi et al. (2003) have found that active warming 
with forced air or warming of intravenous solutions reduces intraoperative hypothe1mia. 
These were some of the interventions provided in the OR and PARR in my study. 
Consideration may need to be given to nurses providing additional or different 
interventions to assist patients to achieve normothermia. As well, more research is 
warranted about different hypothermia interventions and when they should be applied to 
restore or maintain normothermia. 
Despite the fact that 80% of patients had some form of warming intervention in 
the OR, 29.7% of patients who arrived to the PARR from the OR were hypothermic. A 
possible explanation for this hypothermia may be that the warming intervention was 
removed during transfer, but this was not investigated in this study. The finding showed 
that the longer a patient waited for transfer from the OR to the PARR, possibly with no 
warming intervention, the more likely they were to be hypothermic on arrival to the 
PARR. It needs to be recognised that this is occurring and that patients need to be kept 
warm or transferred as quickly as possible. 
Of the 111 patients in the PARR, only 9 patients had a recorded warming 
intervention in the PARR despite the fact that 41.4% of the patients were hypothermic on 
at least one temperature measurement there. Five of the 9 patients who received a 
warming intervention in the PARR remained hypothermic despite its use, leading to the 
same conclusion that the warming intervention was ineffective and that different warming 
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interventions need to be used. For this reason, further action through additional or 
different warming interventions is warranted. 
There were close to one-fifth of patients who were discharged from the PARR 
with a hypothermic temperature. However, according to Eastern Health's Perioperative 
Program Policy, VII-a-20 (2008), patients should be returned to a normothem1ic state 
before discharge from the PARR. The reasons the policy was not adhered to were not 
explored in this study. Future research would be helpful to determine what nurses' 
attitudes are towards policies, as well as different strategies to employ to increase 
adherence to policies and protocols. 
Seven patients of 111 that went to the postoperative unit were hypothermic on 
arrival there. Only 1 of these 7 patients left the PARR hypothermic, so 6 developed 
hypothermia on transfer. No warming interventions were recorded on transfer or on 
arrival to the unit. In a report by Kumar et al. (2005) on studies that explored loss of heat 
during transfer from one hospital area to another, results showed that patients were able to 
maintain core body temperature or even raise their body temperature when active 
warming interventions were applied but not so otherwise. These study results suggest that 
more or different interventions are required during transfer. 
Overall, 44.8% (n = 52) of the patients were "ever hypothermic" in the 
perioperative period. Hypothermia occurred in a number of patients and occurred at each 
stage of the perioperative process and during transfer. While there were many 
interventions provided in the OR, these were largely ineffective, as the patients remained 
hypothermic. Elsewhere not many interventions were provided despite assessments being 
done and patients found to be hypothermic. These findings have clinical importance. 
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Hypothermia makes patients uncomfortable and leads to many other deleterious effects as 
already outlined in the literature review. Providing interventions that assist a patient to 
return to a normothermic state should be a focus of nursing care. 
Assessment of temperature. While there is limited information from this study on 
the proportion of patients who experienced perioperative hypothermia, there is still 
evidence that hypothermia is occurring and that warming interventions are not always 
working or being provided. Nurses need to focus on temperature assessment to guide their 
practice (Girard, 2005, 2006). Furthermore, this study found that 25% of patients with no 
temperature measured preoperatively developed an SSI compared to 15.4% who did have 
a temperature assessed. While it is not the fact that the temperature was not measured that 
is the risk factor for SSI, it is not unreasonable to speculate that these patients without the 
temperature measurement may possibly have been hypothermic thus increasing their risk 
of SSI. 
The American Society of Anesthesiologists basic monitoring standards indicate 
that every patient receiving an anaesthetic shall have temperature monitoring done when 
clinically significant changes in body temperature are intended, anticipated, or suspected 
(Auerbach, 2001 ). The American Society of Perianaesthesia Nurses says that all patients 
[temperatures] should be measured accurately and consistently (Weirich, 2008). Eastern 
Health's Perioperative Program Policy, VII-a-20 (2008), which is based on the American 
Society of Perianesthesia Standards, also has frequent temperature monitoring standards. 
Despite the existence of these guidelines, many patients did not have thorough 
peri operative assessment of temperature status. 
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Preoperatively, 10% of patients did not have a temperature recorded and for those 
that did, 34% did not have the time their temperature was taken recorded. For the 66% of 
patients that did have the time recorded, most of the temperature recordings were within 2 
hours of surgery. It was not explored in this study why all temperatures were not taken or 
why times weren't recorded. Some possibilities may include the increased activity in the 
preoperative period during which many other preparations are occurring for the patient 
about to w1dergo surgery. Despite this, the implications of not having a temperature taken 
are that patients may be hypothermic, but because the temperature has not been measured, 
interventions may not be provided and patient discomfort, as well as the risk of other 
negative effects ofhypothermia, may be increased. 
Only 8.6% of the patients in the OR had their temperature assessed and/or 
recorded even though almost 80% of the patients had some form of warming intervention 
applied in the OR. According to a personal e-mail communication with the Perioperative 
Program Clinical Educator, G. Tapp, there is no policy/protocol or temperature guideline 
in the Operating Room Nurses Association of Canada (ORNAC) Standards on the 
frequency of monitoring temperature in the OR and that this decision is left up to the 
individual anesthetist for each patient (February 4, 2009). Perhaps if the number of 
patients who had a temperature assessed was increased, then interventions to maintain 
normothermia or reverse hypothermia could be provided and OR staff could be sure that 
the · interventions they are providing are effective. The value of assessing patients is to 
determine if interventions are working. If they are not working, then further or different 
interventions should be used. 
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In the PARR, most patients had their temperature measured within the first five 
minutes in the PARR in keeping with Eastern Health's Perioperative Program Policy, 
VII-a-20 (2008). According to the same policy, when a patient had a hypothermic 
temperature, the patient should be re-assessed within 15 minutes, but this only occurred in 
about one-fifth of the patients who had a hypothermic temperature. Because one of the 
goals of care in the PARR is to return a patient to, or maintain a normothermic state 
before discharge from PARR, reassessing a patient who has been hypothermic should be 
followed by an intervention to warm the patient. However, interventions to warm the 
patient and at what temperature this should be done are not part of Eastern Health's 
Perioperative Program Policy, VII-a-20. If an intervention is provided by a nurse, the 
final step is to evaluate if the intervention has actually worked by re-assessing the patient. 
Only 9 patients had a recorded warming intervention in the PARR in this study. 
According to a personal e-mail communication with the PARR Clinical Educator, D. 
Whalen-Brake (February 4, 2009), nurses are taught during their orientation to the PARR 
and through ongoing education that ' aggressive' re-warming is indicated for hypothermic 
patients, and passive insulation is indicated for normothermic patients. As well, all 
patients are provided with warm blankets from the blanket warmer, and some patients 
will have the forced air warmer for low temperatures, but it is usually 35.5°C before this 
happens. Contrary to what is taught and expected though, interventions are not being 
recorded on the majority of patients if they are being provided. Even if these interventions 
are provided and not documented, there was still no record of additional or different 
interventions recorded for patients who remained hypothermic. 
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On arrival to the postoperative unit, some patient temperatures took a long time to 
be assessed and/or recorded as well. Almost 30% of the patients waited longer than 10 
minutes for the first temperature measurement; six of these patients waited more than an 
hour. The reasons for why temperatures were not assessed or recorded were not explored 
in this study. It is reasonable to assume that the longer it takes for patients to be assessed 
for normothermia and no warming intervention is applied, the longer it may take for 
patients to return to a normothermic state and the more uncomfortable they may be. 
Therefore, early assessment and warming interventions can prevent this from happening. 
There was one patient who was hypothermic in the preoperative and 
intraoperative phases, was normothermic on arrival to the PARR but became hypothermic 
while there and was discharged from the PARR with a hypothermic temperature. This one 
patient example shows how labile the vascular surgery patient' s temperature can be and 
emphasizes the importance of temperature measurement, intervention and evaluation by 
nurses throughout the entire perioperative period (Girard, 2005, 2006). Traditionally, 
nurses focus on hyperthermia (fever), with little attention paid to hypothermia. Nurses are 
advocates for patients undergoing surgery and for this reason, they can decide when and 
how often to assess a patient' s temperature, and when and how to intervene to provide 
optimal care to the perioperative patient 
Inappropriate Hair Removal 
The SHN campaign has identified appropriate hair removal as an intervention to 
reduce SSI risk. As with the other interventions previously discussed as part of the SHN 
campaign, the effect of inappropriate hair removal on SSI risk in vascular surgery patients 
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has not been explored. Current CDC recommendations are for patients to not shave hair 
in the surgical incision area prior to surgery to prevent microscopic nicks from occurring 
and thus prevent the introduction of microorganisms. From a literature review by Tanner, 
Woodings, and Moncaster (2006), not removing any hair is considered optimal, but if hair 
interferes with the surgical incision, then it should be clipped as close to the time of 
surgery as possible. The limited strength of the evidence of these studies has already been 
discussed in the literature review, but this recommendation remains as the standard of 
preoperative hair removal endorsed by the CDC (Mangram et al., 1999) and ORNAC, 
which is followed in Canada. 
Inappropriate hair removal and SSJ risk. The majority of patients in my study, 
87.1 %, had hair clipped, with no patients having hair shaved at the operative site. Because 
these patients did not have hair shaved, and current recommendations for hair removal 
were adhered to very closely, an assessment of SSI risk with respect to inappropriate hair 
removal could not be explored. It is not recorded on the paper intraoperative record from 
which data was extracted at what time the hair was clipped. It was assumed that the 
clipping was done just prior to the operation as the clipping is recorded on the 
intraoperative record and not the preoperative record. As well, in a personal e-mail 
communication with the Perioperative Clinical Educator, G. Tapp (February 4, 2009), she 
indicated that if a patient has hair clipped, it is done in the OR immediately prior to the 
procedure. However, because the time was not recorded, this study could not explore the 
effect of hair removal timing on SSI risk. It was also impossible to report if patients who 
shave near the surgical area increased their SSI risk in this study. There is no designated 
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place to record this information on the preoperative checklist and therefore, there was no 
data available to be collected on this risk factor for my study. 
While there was not a lot of information available from this study on risk 
associated with hair removal method or timing, it was identified that at the time of 
surgery, over 10% of patients had abrasions, redness, or nicks at the operative site. As 
already discussed, this may allow a portal of entry to the body that infectious agents can 
enter. Of the patients with non-intact skin, 37.5% developed an SSI compared to 16.2% 
with intact skin (p = 0.1159). While this result was not statistically significant due to 
small sample size and therefore decreased power, this information warrants further 
assessment. When applied to the chain of infection theory, it is thought that an abrasion or 
nick in the skin opens a portal of entry to infectious agents. The role of the nurse, which is 
the focus of the next section, revolves around preoperative education and appropriate hair 
removal. Nursing interventions of this type may decrease the proportion of patients with 
broken skin areas. 
Because the chain of infection theory asserts that an abrasion or nick in the skin 
opens a portal of entry to infectious agents, for this reason, patients with these nicks and 
abrasions could particularly benefit from antibiotic prophylaxis directed against the most 
common organisms to be encountered. My study findings showed that none of the 5 
patients with non-intact skin who received correct antibiotic prophylaxis developed an 
SSI, compared to all 3 of the patients with non-intact skin who received antibiotics at the 
incorrect time or not at all (p = 0.0047). This again emphasizes the importance of 
antibiotic prophylaxis, particularly with non-intact skin. 
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Management of appropriate hair removal. Interventions for appropriate hair 
removal are within the scope of nursing practice (Girard, 2005, 2006; ORNAC, 2007). An 
important intervention is preoperative patient education that is provided by nurses. A 
major focus of this patient education should be on preparation of the skin prior to surgery. 
Emphasis should be placed on avoidance of shaving or using a depilatory in the surgical 
incision area prior to surgery by the patient. As well, patients should receive instruction 
on methods to properly cleanse the skin including the avoidance of harsh chemicals or 
brushes that may abrade the skin. Patients should also be instructed to report any rashes or 
broken areas to the nurse prior to the surgery. 
Another important nursing role with appropriate hair removal is documentation 
and communication of adverse findings. At present there is no space on the preoperative 
record where a nurse can indicate what information she has provided to a patient about 
preoperative skin preparation. If such a place were available on the preoperative record, 
this could serve as a communication mechanism among perioperative staff. 
Communication of adverse findings to the surgeon prior to surgery, including any cuts, 
abrasions, rashes, or broken areas is also within the scope of practice ofthe nurse. Written 
communication about any adverse finding was recorded on the patient intraoperative 
record in my study. According to the Perioperative Program Clinical Educator G. Tapp, 
the surgeon also received notification of any of adverse findings prior to surgery 
(personal e-mail communication February 4, 2009). It is then up to the surgeon to decide 
to cancel or go ahead with the surgery. 
The decision to remove hair in the surgical incision area is collaborative between 
the nurse and the surgeon (personal e-mail communication, Perioperative Program 
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Clinical Educator G. Tapp, February 4, 2009). Because nurses are part of this decision 
making process, it is important that they decide what is most optimal for the patient to 
reduce the risk of SSI. 
Modifiable and Non-Modifiable Risk Factors for SSI 
As outlined in Chapter 2, there are many SSI risk factors that may be non-
modifiable or modifiable, with some that are not clearly identifiable as one or the other 
depending on the patient situation. Research in other studies has shown that there are 
other factors that increase SSI risk. While these factors were not the focus of the SHN 
campaign or my study, it was still interesting to explore what effect, if any, these factors 
have on SSI risk in vascular surgery patients. As well, it was also important to determine 
the effect of these risk factors on SSI as they may have confounded the effect of the key 
risk factors this study was exploring. Some examples of other risk factors include but are 
not limited to gender, age, emergency procedure, insertion of an artificial graft during 
surgery, having a groin incision, blood loss, anemia, and transfusion of blood, surgeon 
skill, obesity and increased BMI, smoking, certain comorbidities such as renal disease, 
and increased ASA score. Other risk factors were explored and the results are available in 
Chapter 4 related to these factors, but the factors discussed here were the most 
noteworthy. 
Non-Modifiable Risk Factors 
The following non-modifiable risk factors included in this discussion are: gender, 
age, emergency procedure, insertion of an artificial graft during surgery, and having a 
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groin incision. None of these risk factors were determined to increase SSI risk in vascular 
surgery patients possibly due to the small sample size and therefore, decreased power. 
However, there were some interesting findings that merit further discussion. 
In the vascular surgery sample, there were considerably more men, 80.2%, than 
women, 19.8%, which is similar to vascular studies reported in the literature review 
(Belkin et al., 1995; Chang et al. , 2003; Nicholson et al., 1994; O' Sullivan et al., 2006; 
Pounds et al. , 2005 ; Schepers et al. , 2003; Sigvant et al. , 2007; Turnbull et al. , 2005; van 
Himbeeck et al. , 1992; Vogel et al., 2008; Vriesendorp et al. , 2004). A reason offered for 
this phenomenon is that even though just as many women possibly have PVD, by the time 
they present with symptoms, their disease is not amenable to surgical reconstruction due 
to smaller arteries and more advanced disease (Brevetti et al. , 2008; Higgins & Higgins, 
2003 ; Vouyouka & Kent, 2007). For this reason, they would not be admitted for vascular 
surgery and be part of the sample. However, this does not underestimate the importance 
of paying attention to other risk factors in all patients regardless of gender. As a broader 
health goal, nurses can educate women on the risks for PAD and how to modify them 
before permanent damage has occurred. 
Neumayer et al. (2007), in their study of combined vascular and general surgery 
patients found that having an emergency procedure was identified as a risk factor (p < 
0.0001). Some possible explanations for the increase in rate of SSI with emergency 
surgery may be that the surgery is more rushed causing more damage to delicate tissues, 
lack of control over bleeding, uncontrolled hyperglycemia, or lack of provision of 
antibiotic prophylaxis. Ofthe patients who underwent an emergency surgical procedure in 
this study, 33.3% developed an SSI compared to 14.9% of patients who underwent an 
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elective procedure (p = 0.0770). Because this study had only a small sample of patients 
undergoing emergency surgery, this may have decreased the power of the study to find a 
significant difference. While the results did not reach statistical significance, they are still 
clinically important and lend support to the idea that surgery should be performed in a 
pre-planned environment if possible. 
Of the 56 patients with artificial grafts, 17.9% of the patients developed an SSI, 
compared to 16.7% of 60 patients without an artificial graft who developed an SSI, 
indicating that this was not a risk factor for SSI. A key statement made by a nurse during 
an informal presentation to the nurses in the OR suggested one possible explanation. Tllis 
nurse indicated that she thought only the patients having artificial grafts inserted were 
supposed to receive prophylactic antibiotics. However, the literature indicates that all 
patients having the vascular surgeries of interest in my study should receive prophylactic 
antibiotics as discussed in the literature review (Blondel-Hill & Fryters, 2006; Mangram 
et al., 1999; Wong, 2004). Analysis showed that patients with artificial grafts received 
more antibiotics than patients without artificial grafts, which is what this nurse had 
thought, was correct. As previously discussed in the section on antibiotic prophylaxis, for 
patients without an artificial graft, the receipt of antibiotics appeared to decrease risk 
although the difference did not achieve significance (p = 0.0565). This same trend was 
not seen in patients with an artificial graft. The conclusion to draw from these findings is 
not that the patients with artificial grafts did not have a greater risk of SSI, but that the 
receipt of prophylactic antibiotics in this group reduced their risk to a similar level as 
patients without an artificial graft. 
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Finally, the presence of a groin incision was not found to be a risk factor for SSI 
in this study. There were 92.2% of the patients with a groin incision, and 50% of the SSis 
that developed were in the groin. The increased SSI risk of a groin incision has previously 
been found in vascular surgery studies already discussed in the literature review 
(Nicholson et al. , 1994; Pounds et al. , 2005; Van Himbeeck et al. , 1992). The implication 
of this for nurses is that extra attention should be paid to preparation of the groin prior to 
surgery in terms of assessment of skin integrity and cleansing of the incisional area. 
Despite these non-modifiable risk factors not being found to independently 
increase SSI risk in this vascular surgery patient study, there was still some very valuable 
information obtained from reviewing these factors. There is further support that antibiotic 
protocols are necessary so that all patients get antibiotics as recommended in the literature 
(Blondel - Hill et al. , 2006; Mangram et al. , 1999; Wong, 2004), that a pre-planned 
surgery is better for the patient than an emergency surgery, and that special attention to 
groin incisions is required. 
Modifiable Risk Factors 
The following modifiable risk factors included in this discussion are: blood loss, 
anemia and blood transfusion, surgeon skill, obesity and increased BMI, smoking and 
number of cigarettes, particular comorbidities such as renal disease, and elevated ASA 
score. Similar to the non-modifiable risk factors, there were no modifiable risk factors 
that significantly increased SSI risk. 
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Blood loss, anemia, and transfusion of blood and SSI risk. Blood loss and need for 
transfusion is linked to SSI in the CABG surgery literature possibly due to its effect in 
contributing to hypothermia (Insler et al., 2000), though there were no vascular studies 
found that explored this as a risk factor. For half of the patients in my study, there was no 
reported blood loss in the OR and for those that did lose blood the majority lost less than 
1200 mL of blood. It is unknown if patients developed hypothermia with blood loss 
though as their temperature was not assessed in the OR. The amount of blood lost is 
affected by many causes including how quickly the patient's own blood clots because of 
the body's initiation of the coagulation cascade, difficulty of the surgical procedure, and 
how quickly the surgeon controls the blood loss based on experience and skill level. 
In terms of blood loss being a risk factor for SSI, results showed that 9.5% of 
those who lost less than 1200 mL of blood developed an SSI. In comparison, of the 
patients who lost 1200-4499 mL of blood in the OR, 25% developed an SSI (p = 0.2800), 
suggesting that greater volumes of blood loss may impose a higher SSI risk. However, 
none of 3 patients who lost 4500 - 25000 mL of blood in the OR developed an SSI. It is 
difficult to interpret these findings. Greater amounts of blood loss beyond 4500 mL did 
not appear to increase SSI risk, but a factor that may have confounded the results was the 
speed with which blood loss was treated in these patients. Patients who lost 4500 - 25000 
mL of blood were treated immediately in the OR. In comparison, of 8 patients that lost 
1200 - 4499 mL of blood, hemoglobin levels were assessed in the PARR but were found 
to be normal until they went back to the postoperative unit. Anemia, which is a 
measurement of low blood hemoglobin, did not present itself until later on the operative 
day in 4 out of 8 patients, and they all received blood products as treatment. Because of 
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the difference in times of treatment for anemia, it is difficult to determine if it is blood 
loss, or the timing of the anemia, or the time it takes to receive treatment that affects ssr 
risk. 
From a pathophysiological perspective, if a patient loses a volume of blood, they 
lose all of the erythrocytes contained in that volume of blood. Each of these erythrocytes 
presumably has normal hemoglobin content. The hemoglobin content of all of these cells 
together is what is referred to as the "hemoglobin" in a blood sample. Until the blood 
cells that have been lost are replaced, either through the body's own mechanisms called 
erythropoiesis, which may take some time, or through a transfusion of blood, the 
hemoglobin level in the blood is going to be low, also known as anemia. Some of the 
adverse effects of anemia include fatigue, poor wound healing, and decreased oxygen in 
the blood (McCance & Huether, 2006). Because the process of erythropoiesis requires 
time to produce more erythrocytes, as well as the adverse effects of anemia, it is 
important that nurses on the postoperative unit are vigilant in assessing the hemoglobin 
level of the patient postoperatively. By assessment of hemoglobin levels, anemic levels 
can be brought to the attention of the physician and blood transfusions and/or iron 
replacement may be ordered. 
As already discussed, because anemia, blood loss, and blood transfusion are 
interrelated in this study, it is difficult to determine what influence these factors 
individually have on SSI risk. In terms of transfusion of blood, of patients who received 
blood at any point during the perioperative period for anemia, 22.7% developed an SSI 
compared to 16% who did not receive blood (p = 0.4492). Of 22 patients who were 
anemic on their first post-operative hemoglobin level that was assessed, 5 received PRBC 
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and 17 did not. Of those receiving PRBC, 40% (n = 2) of 5 patients developed an SSI 
compared to 23.5% (n = 4 of 17) of the anemic patients who never received blood (p = 
0.4673). The trend with the receipt of blood seems to be that it increases risk, although 
differences were not statistically significant. Receipt of blood has been identified in the 
general surgery literature to be a risk factor for SSI though (Blumetti et al., 2007; Jensen 
et al., 1992; Marik & Corwin, 2008; Olsen et al., 2008; Tang et al., 2001; Walz et al., 
2006), but this relationship has not been explored in vascular surgery. More research in 
vascular surgery patients who do or do not receive blood transfusions and their anemia 
status would be helpful in determining this association. 
Anemia assessment. As the amount of blood lost in the OR increased, so did the 
number of patients having a PARR hemoglobin level assessed. For this reason, it 
appeared as though the nurses in the PARR were conscientious about assessment of the 
amount of blood loss in the OR. On the postoperative unit, just about all patients had at 
least one hemoglobin level assessed and slightly more than one-third of patients had only 
one level assessed. It appeared that patients did have postoperative hemoglobin levels 
assessed and when it was required, further assessment was done. 
While hemoglobin assessment was well done, serum ferritin level assessment 
needs some improvement. There were few serum ferritin levels assessed even though 
almost one-third of patients had an anemic post-operative hemoglobin level. Low serum 
ferritin is linked to weakness, fatigue, and impaired wound healing. Even with a blood 
transfusion, iron stores are not restored after substantial blood loss which may put a 
patient at risk for iron deficiency anemia, particularly if iron replacement therapy is not 
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initiated (McCance & Huether, 2006). None of the patients with previously diagnosed or 
newly diagnosed anemia were started on iron replacement therapy in this study. It is 
important that nurses advocate for patients by closely monitoring the development of 
anemia, as well as providing education around iron-rich foods and initiation of 
supplemental iron therapy as indicated. 
In keeping with the discussion on blood loss in this section, the level of surgeon 
skill is one factor that may or may not affect the amount of blood loss or how quickly it is 
controlled and how this affects SSI risk. In some ways, it seems that increased blood loss 
may be more likely to occur with newer surgeons because they would not have as much 
experience with handling this type of emergency. However, the reverse of this is that the 
more experienced surgeon may have patients with increased amounts of blood loss, 
because the patient seen by this surgeon are more acutely ill and therefore riskier to 
perform surgery on and may possibly bleed more. Surgeon SSI rates in this study ranged 
from 12.5 - 19.4%. There are many factors that affect SSI risk that the surgeon is 
involved in. For this reason, the relationship between surgeon skill and SSI risk cannot be 
determined from this study. 
More than two thirds of the patients, 67%, in this study were either overweight or 
obe.se with a BMI greater than 25, so it seemed important to explore this as a risk factor 
for SSI. For 50 patients who were overweight (BMI 25.1-30), 18% developed an SSI, 
compared to 36 patients who were a healthy weight (BMI 25 or less) in which 13.9% 
developed an SSI. Of 23 patients with a BMI greater than 30 who were considered obese, 
13% developed an SSI. There was no obvious relationship found between BMI and SSI 
risk. It is unclear why increased BMI did not increase SSI risk in the obese patient group. 
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It could possibly be explained by missing weight measurements that may underestimate 
effect in this particular group. 
An increased BMI is thought to increase SSI risk as there is an increased wound 
size, difficulty in obliterating dead space during wound closure, poor blood supply to 
fatty tissue, and longer OR time (Bandyk, 2008; Chang et al. , 2003; Haas et al. , 2005; 
Kent et al., 1996; Nicholson et al., 1994; Russo & Spelman, 2002; Slaughter et al., 1993; 
Vuorisalo et al. , 1998). In addition, because obese patients do have more skin folds that 
can harbour microorganisms, this could potentially lead to an increased microbial load 
that the patient's own defences may not be able to fight. For this reason, it is important 
for nursing interventions to focus on education of these patients on good skin care and on 
the assessment by nurses of the skin folds of these individuals before surgery (Baugh et 
al., 2007). 
Decreasing the BMI of patients is amenable to nursing intervention with the 
patient's cooperation. However, it may not always be feasible depending on how close 
the patient' s imminent surgery is. Patient education could centre on strategies to decrease 
weight while waiting for surgery. In the short term, nurses can ensure that all patients 
have their weight assessed so that optimal antibiotic prophylaxis can be prescribed and 
administered, that hyperglycemia is controlled, and that careful attention is paid to skin 
cleansing before surgery. A broader health goal is for nurses to educate patients on the 
risks associated with obesity and having an increased BMI, as well as strategies to reduce 
this risk (Turner, Thomas, Wagner, & Mosley, 2008). Education of this variety is a 
population based health goal that requires the support of many individuals including 
public health nurses, which is beyond the scope of the peri operative nurse. 
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Smoking has been suggested as a risk factor for SSI in the vascular surgery 
literature (Bandyk, 2008; Haas et al., 2005; Neumayer et al., 2007; Wipke-Tevis, 1999). 
There has also been a strong association made between smoking and PAD (Allison et al., 
2006; Murabito, D'Agostino, Silbershatz & Wilson, 1997; Vogt, Cauley, Kuller, & 
Hulley, 1993). It was surprising that only 34.5% (n = 40) of the patients reported to be 
smokers in my study. In a systematic literature review of studies that explored the 
influence of smoking on the prevalence of PAD, it was reported that in countries where 
approximately 30% of the population are smokers, 50% of the PAD prevalence can be 
attributed to smoking (Willigendael et al., 2004). The prevalence of smokers in Canada in 
1996/1997 was 29%, and in Newfoundland was 32% (Public Health Agency of Canada 
[PHAC], 1999). Because these proportions in Canada and NL are close to 30%, it was 
expected that close to 50% of this study's population would be smokers. 
Of the 40 self-reported smokers, 20% developed an SSI compared to 15.8% of 
non-smokers. This result may be related to how smoking status is recorded on the 
preoperative health history. If a patient self-identifies as a non-smoker in the health 
history, there is no section asking how recently they quit or how much and how long they 
smoked. Prior to this preoperative health history being taken by the nurse, the patient 
would have seen a vascular surgeon who would have asked about their smoking status 
and strongly encouraged them to quit. Because many of these visits to the vascular 
surgeon occur close to the time of the preoperative health history taken by the nurse, there 
may have been several recent quitters who were recorded as non-smokers even though the 
negative, long-term effects of their smoking would influence their SSI risk. If the recent 
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quitters had been identified as smokers, this may have g1ven a more accurate 
representation of the true association between smoking and SSI risk. 
Only 13.8% of the smokers in my study reported that they smoked more than 20 
cigarettes per day. The average number of cigarettes reported by smokers in 
Newfoundland in 199611997 was 16 cigarettes a day, and in Canada was 17.5 cigarettes a 
day (PHAC, 1999). Because this was the average, it was expected that a higher proportion 
of patients than 13.8% would report that they smoked more than 20 cigarettes per day. 
Some reasons for this difference may be due to the fact that these Newfoundland and 
Canadian findings are based on data gathered in 1996/1997 and that there has been an 
overall decrease in the incidence of smoking in Canada due to stronger anti-smoking 
legislation in public buildings. Another reason may be that the smokers may have under-
reported the amount they smoke due to guilt or fear of not having the operative procedure 
performed if they were not in gOod enough health. 
Findings showed that as patients smoked an increased number of cigarettes, there 
was a trend towards increased SSI risk. Of the individuals who smoked more than 20 
cigarettes per day, 50% developed an SSI compared to 10% of those who smoked less 
than 10 cigarettes per day (p = 0.4687). For the 40 self-identified smokers, 11 patients did 
not have the number of cigarettes they smoked per day recorded. If all of these patients 
were heavy smokers, this risk factor may have been demonstrated to incur more risk and a 
significant difference may have been found between groups. 
It is important for nurses to complete a full health history including the date the 
patient quit smoking, as well as the amount smoked and for how long. In this study, data 
were missing on the amount smoked by several patients, and who the recent quitters were 
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compared to non-smokers. Because smoking is a factor that is amenable to nursing 
intervention, it is helpful to know this information so that interventions can be 
individualized to each patient. There are many teachable moments during the preoperative 
and postoperative stay during which nurses can reinforce smoking cessation and nicotine 
replacement therapy and thus reduce SSI risk (Doolan & Froelicher, 2008; Lemmens et 
al. , 2008; Mangram et al. , 1999). 
In this study, certain comorbidities, rather than the number of comorbidities in 
general, affected SSI risk. Of the patients with renal disease, 30% developed an SSI, and 
of the patients with liver disease, 50% developed an SSI. While the difference in SSI 
development between those with renal disease and/or liver disease versus other 
comorbidities was not statistically significant, there was certainly a trend seen that the 
risk of SSI increased if a patient had either of these comorbidities. This same trend in 
vascular surgery patients with renal disease has been seen in O' Sullivan et al. (2006). 
Blankensteijn et al. (1996) reported an SSI rate of 43% for patients with renal disease 
undergoing vascular surgery. Patients with these comorbidities should be identified 
preoperatively to institute appropriate measures to decrease SSI risk. A key intervention 
in patients with renal disease is to dialyse individuals both before and after surgery, so 
that antibiotic prophylaxis and wound healing are optimal. 
As already discussed in the literature review, a component of the ASA score is the 
number of comorbidities that a patient is living with and how these affect the patient's 
health. Over 25% of patients did not have an ASA score recorded for unknown reasons. 
The ASA score very quickly identifies which patients, in the anesthetist's educated 
opinion, are at greatest risk for complications during and after surgery. Not having an 
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ASA score recorded is problematic in SSI surveillance and research because it diminishes 
the comparability of SSI rates when they are reported stratified by ASA score. 
For the patients with an ASA score recorded, 80.5% had a score of 3 or greater on 
a scale of 1 - 5. It has been reported that the higher the ASA score is, the increased risk a 
patient has for developing an SSI (Aronson et al. , 2003; Bandyk, 2008; Neumayer et al. , 
2007; Woodfield et al. , 2007). The same trend was seen in my study where double the 
proportion, 24.6%, of patients with an ASA score of 3 developed an SSI compared to 
11.8% of patients with an ASA score of less than 3 (p = 0.2544). While this result was not 
statistically significant, it is clinically important. It indicates that patients with multiple 
comorbidities as represented by an ASA score need to have other factors that are 
amenable to intervention by nurses dealt ~ith to optimize the surgical experience and 
decrease risk. 
Similar to the non-modifiable risk factors, modifiable risk factors in this study 
were not found to increase SSI risk in vascular surgery patients. However, of clinical 
impmiance is that patient chruis are missing information such as BMI, number of 
cigarettes smoked, and ASA score. As well, trends have been found with certain risk 
factors. Ongoing assessment by nurses and education of peri operative staff is necessary to 
reduce SSI risk and communicate important findings. 
Practice Issues 
Several practice issues that require further education, research and protocol 
development have already been discussed in the preceding sections. Three additional 
practice issues emerged when analysing the data in this study. First, there was a noted 
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lack of consistency in documentation of SSI by the physician and second, the swabbing of 
wounds for culture and sensitivity (C&S) did not appear to follow a specific protocol 
when patients had been diagnosed with an SSI by a physician or had purulent drainage 
reported by the nurse. Third, it appeared as though discontinuation of antibiotics after 
surgery did not follow current recommendations to prevent the development of antibiotic 
resistant organisms (AROs). 
Documentation of SSI by physicians. On the issue of documentation by physicians 
on SSis that have occurred, of the 20 patients categorized as developing an SSI in this 
study, only 9 patients had written documentation from a physician that they had 
developed an SSI. An additional 7 patients did not have such documentation but did have 
treatment prescribed so it can be assumed that the physician was aware of the SSI. There 
were 4 remaining patients that neither had a physician document a diagnosis of SSI, nor 
had treatment prescribed. These 4 patients were categorized in this study as having an SSI 
because they had documented signs and symptoms that met the criteria of the CDC for 
SSI, such as presence of purulent drainage. 
Swabbing of wounds for C&S. A diagnosis of an SSI is important if treatment is to 
be prescribed by a physician. Doing a C&S swab can help with diagnosis, but it is more 
important to choosing the appropriate antibiotic to treat the patient who has developed the 
SSI (Goering et al. , 2008). With respect to the swabbing of wounds for C&S, a protocol 
did not exist at the time of this study that guided decisions on whether to swab a wound or 
not when infection was suspected due to signs and symptoms experienced by the patient, 
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or when a physician diagnosed the patient as having an SSI. This is a practice issue that 
requires attention because patients need the correct microorganism identified to have 
appropriate antibiotic treatment. 
Specific antibiotics must be chosen for a specific microorganism as the antibiotics 
are often composed of products or derivatives of the same microorganism they are being 
given to eradicate. Antibiotics target microorganisms to destroy them by affecting their 
structure and function (Goering et al., 2008). When a patient is given empiric therapy, a 
broad-spectrum antibiotic is often chosen that may not be effective against the 
microorganism the patient has, so the infection is not eradicated. As well, the use of 
empiric therapy in this way contributes to the development of AROs. By swabbing 
wounds and obtaining results, specific therapy can be prescribed that is directed against 
the specific microorganism the patient has. 
In this study, 13 patients had purulent drainage reported but only 7 had a C&S 
swab taken. Of the 9 patients diagnosed with an SSI by a physician, only 4 had a wound 
swab for C&S. It was curious that approximately half of the wounds with no evidence of 
purulent drainage were swabbed, and approximately half with evidence of purulent 
drainage were swabbed. At the time of this study there were no policies or protocols 
within the hospital utilized for this study for swabbing wounds when purulent drainage is 
seen in a wound. Development of policies such as these would assist in the decision 
making of nurses on whether to swab a wound or not if an infection is suspected. As well, 
with the results of C&S swab results, optimal antibiotic therapy directed at the 
microorganism(s) in the wound could be provided. 
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Discontinuation of antibiotics. The third practice issue that was noteworthy was 
appropriate antibiotic prophylaxis which involves discontinuation of antibiotics within 24 
hours of surgery in vascular surgery patients (Blondel-Hill & Fryters, 2006; Mangram et 
al., 1999; Stewart et al. 2007). The reason for discontinuation of antibiotics within 24 
hours after vascular surgery is to prevent AROs from forming and to reduce the risk of 
Clostridium difficile infection (CDI) from occurring (Bratzler & Houck, 2004; Dellinger 
et al., 2005; Harbath et al., 2000; Plonczynski, 2005). However, in my study, antibiotics 
were continued after 24 hours post-surgery in 59 patients, and 78% (n = 46) of these 
patients did not have a clear indication for why they were receiving an antibiotic. For 
example, these patients did not have another healthcare-associated infection that was 
being treated. The reason antibiotics were continued past 24 hours was not explored. 
While AROs are not a risk factor for SSis, they are far more difficult to treat. Of the 10 
patients in this study with an SSI for which there was a C&S swab result, 2 patients were 
infected with methicillin resistant staphylococcus aureus (MRSA). For this reason, an 
antibiotic protocol that includes the proper drug, dose and time should also include the 
appropriate timeframe in which to discontinue the antibiotic. 
Strengths and Limitations 
This exploratory, descriptive study had many strengths. It examined a patient 
population that has not been researched to the same extent as other higher profile disease 
populations such as coronary artery disease. In addition, risk factors for SSI that had 
previously not been studied as extensively in this population as it has with CABG and 
other surgeries were included. This study also assessed if some assumptions about care 
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that is being provided are valid. There are recommendations in the literature about 
nursing practice and interventions in caring for surgical patients such as keeping patients 
normothermic, monitoring vital signs, providing education, and preparation for surgery. 
As a result of this study, contributions have now been made to the vascular surgery 
literature, the SSI risk literature, and nursing literature. Because of the explorations in this 
study, we now know about nursing practices and the risk factor profile of vascular 
surgery patients. This study begins a program of nursing research into the many aspects 
of caring for vascular surgery patients. 
In addition to this, the results of this study give an estimate of the SSI rate in 
clean, vascular surgery. Because this study had follow-up information on 95% of patients 
within 6 weeks after surgery, it is now known what the true SSI rate is in patients without 
an artificial graft, whereas before it could only be speculated based on anecdotal evidence 
or studies from elsewhere. Eastern Health now has a baseline SSI rate to compare future 
SSI rates against in this patient population. This result may also be useful elsewhere for 
comparison once the results of this study become available. 
Due to the simple design of this study, it is easily replicated at other healthcare 
facilities making it feasible. The data collection tool has content validity as it collects risk 
factor data based on findings from the literature. This tool had been pilot tested and data 
was collected by a researcher and research assistants who were trained in data collection 
by the researcher. Standard measures were used to measure outcomes such as glucose 
measurements with standard glucose monitoring machines, or culture and sensitivity 
testing for specific microorganisms, or diagnosis of SSI based on well-accepted criteria 
published by the CDC. This group of 116 patients is fairly representative of vascular 
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surgery patient populations described in the literature in terms of proportion of patients 
related to age, gender, diabetic and/or smoking status, and undergoing clean surgery to 
name a few. 
There were also limitations to this study. The sample size was small which in turn 
reduced the power of this study to find statistically significant findings. The explanation 
for this is that it simply was not feasible to retrospectively review over 1000 charts for 
this study, which is what would have been required as described in Chapter 3. The choice 
to include half of the patients who underwent vascular surgery in 2005 for a total of 116 
patients was a conscious one knowing that it would limit analysis. The focus of this study 
was exploration and description, not hypothesis testing. 
Another limitation of this study which has been described in other retrospective 
studies is the distortion of results because of missing data due to inconsistencies in 
documentation. This was primarily limited in this study with respect to ASA scores, 
preoperative and intraoperative temperatures, warming interventions utilized, and number 
of smokers or amount smoked and so did not impact the main research questions. This 
study was also limited by the retrospective design as it was not possible to identify 
reasons for decisions that were made in the provision of care which may have enhanced 
understanding of some of the findings. The primary focus of this study though was to 
explore and describe nursing practices so the sample size was sufficient for this purpose. 
Discussion Conclusion 
In conclusion, the primary risk factors fotmd to mcrease SSI risk in vascular 
surgery patients were: 1) incorrect timing of antibiotic prophylaxis, 2) inappropriate or no 
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antibiotic prophylaxis for patients with non-intact skin, and 3) being "ever 
hyperglycemic" in non-diabetic patients. There were also many clinically interesting 
factors found such as a trend towards increased SSI risk with having an emergency 
procedure, anemia with blood loss between 300-1199 mL of blood, not receiving an 
antibiotic if there was no artificial graft inserted during surgery, and hypothermia on 
arrival to the postoperative unit. Some of the key practice issues identified that are 
amenable to nursing intervention included assessment throughout the perioperative 
period, appropriate interventions based on these assessments, and documentation of key 
assessments and care provided to improve communication among the perioperative team. 
There were many strengths in this study as well as limitations due to sample size, but this 
study has contributed to areas that were previously understudied. 
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Chapter 6: Recommendations, Implications and Conclusion 
Chapter 6 summarizes recommendations based on the results presented in Chapter 
4 and the discussion of these results in Chapter 5. It also includes implications of the 
study findings for nursing administration, education, practice, and research. 
Recommendations for Practice 
Antibiotic Prophylaxis 
From this study, it appeared that some components of appropriate antibiotic 
prophylaxis were not consistently applied to patients undergoing vascular surgery. While 
many patients received optimal antibiotic prophylaxis, others received antibiotics late or 
not at all, or received an insufficient dose particularly so in heavier patients and patients 
without an artificial graft. For patients in surgery longer than 4 hours, optimal tissue 
concentrations of antibiotics were not maintain.ed as recommended as these patients did 
not receive a repeat dose of antibiotics. Because antibiotics were not discontinued within 
the 24 hour period as recommended, this also may have contributed to the development of 
antibiotic resistant organisms. Both incorrect timing of antibiotic prophylaxis, and 
inadequate antibiotic prophylaxis in patients without an artificial graft emerged as 
statistically significant SSI risk factors in bivariate analysis. 
Providing antibiotic prophylaxis falls under the practice domain of both the 
physician and the nurse in the perioperative process. When physicians prescribe 
antibiotics for patients, it is within the scope of practice of a nurse to prepare and 
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administer these antibiotics in collaboration with the anesthetist, who is also in control of 
other medications being delivered preoperatively. 
Recommendations. A working team consisting of key members of the 
perioperative team could be brought together to develop a protocol or policy for antibiotic 
prophylaxis. This protocol should include an identification of: 1) the correct drug, which 
is based on the microorganisms most likely to be encountered during surgery, 2) the 
correct dose, based on different body weights, and 3) the correct time, which is 0 - 60 
minutes prior to the surgical incision being made, and repeated after 4 hours for surgeries 
longer than 4 hours. Eastern Health has already developed a protocol such as this for 
colorectal surgery patients; this protocol could be very easily adapted to vascular surgery 
patients. Some additional strategies to improve antibiotic prophylaxis include pre-printed 
order forms, adding a "time-out" protocol where it is ensured that the antibiotic is ready 
to infuse before the incision is made, posting the protocol in a prominent place in the OR, 
having ready mixed antibiotic solutions, and having nurses administer the antibiotic 
instead of the physician. 
Glucose Control 
The Canadian Diabetes Association (2008) recommends that patient glucose 
levels in the perioperative period should be maintained between 8 - 11 mmol/L. This 
level was achieved for many patients in this study. However, this control did not occur in 
every patient. Many patients were provided with interventions and returned to a 
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normoglycemic state, while there were other patients that did not have interventions 
provided in the perioperative period or they were ineffective. 
The study results show that nursing practice in the area of assessment and 
evaiuation of patient glucose levels requires some improvement. While there were 
several non-diabetic patients who would not normally require glucose assessment who 
had an assessment followed by interventions in some cases, there were some diabetic 
patients who did not have glucose levels assessed or did not receive interventions. For 
those diabetic patients that did receive interventions, some received effective 
interventions and returned to a normoglycemic state. However, there were other diabetic 
patients that remained hyperglycemic for long periods despite receiving an intervention. 
For some patients on sliding scale insulin, hyperglycemia persisted for several days 
indicating the insulin therapy they were receiving was ineffective. At the time of this 
study, there was no protocol for glucose control and orders for frequency of monitoring 
were at the discretion of the physician. 
It was determined from this study that regardless of diabetic status, hyperglycemia 
was a risk factor for SSI. Non-diabetics in this study who had hyperglycemia at any stage 
of the perioperative process referred to as "ever hyperglycemic" had a significantly 
increased risk of SSI, compared to those non-diabetic patients who were "never 
hyperglycemic". 
Like antibiotic prophylaxis, maintaining optimal glucose control is also a shared 
role between the nurse and the physician. Nurses have within their scope of practice to 
assess, intervene, evaluate, and communicate both verbally and through written 
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documentation. However, the intervention to be provided to the patient must be 
prescribed by the physician before it is given by the nurse. 
Recommendations. A standard preoperative process for patients that is mailed to 
them and their family doctor for review when their vascular surgery time is booked, could 
be employed that would instruct the patient to have their glucose and HbA 1 c levels done 
regardless of diabetic status. A preoperative nurse could then examine these results and 
notify the attending surgeon if a patient needs intervention preoperatively to attempt to 
lower glucose levels. As well, all patients on admission, whether preoperatively or 
postoperatively, could have a pre-printed order sheet placed on their chart with 
instructions on when to assess glucose levels and how often. This sheet also could include 
instructions on what interventions to provide, including medication, diet orders, and 
referral to other health professionals involved in hyperglycemia interventions. This would 
remove some of the inconsistency on when to intervene and when to notify the physician 
that there is a problem. There is already such a protocol in existence within the Critical 
Care Program of Eastern Health that could be adapted to this setting for this particular 
group of patients. 
Temperature Control 
As with issues with glucose assessment and intervention, issues with temperature 
assessment and intervention occurred. Preoperatively, most patients were assessed but for 
many patients, the time they were assessed was not recorded, so it is difficult to determine 
what preoperative period of time this temperature assessment represents. In the OR most 
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patients received an intervention to maintain normothermia, indicating that hypothermia 
is ~ concern for intraoperative staff. However, only 10 of 116 patients had their 
temperature recorded. Of the 10 patients with temperature measured, 8 were still 
hypothermic with the warming intervention. This indicated that the interventions were not 
working and that an additional or different intervention was required. In the PARR, 
assessment was done, but interventions were not recorded as being provided. The issue 
here may be documentation rather than the provision of an intervention. However, even 
with intervention in the PARR, some patients were still hypothermic and additional 
warming interventions were not provided. While many patients in the PARR were 
normothermic, many patients were also hypothermic. A policy on temperature assessment 
exists in the PARR in terms of frequency of assessment. Despite the existence of this 
policy, there were still patients who were not assessed at the frequency outlined in the 
policy. As well, some patients were discharged from the PARR with their last 
temperature measured as hypothermic, which is contrary to the policy recommendations. 
Patients were also found to be hypothermic after transfer from one unit to another and it is 
unknown if interventions for warming were provided during transfer or not as it is not 
recorded. 
Temperature control is a shared practice between the physician and the nurse. As 
with glucose control, nurses have within their scope of practice to assess, intervene, 
evaluate, and communicate both verbally and through written documentation about 
temperature control in the perioperative patient. Temperature control differs from glucose 
control though, in that the nurse can decide what intervention is most suitable for the 
patient and apply it independently. 
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Recommendations. One primary recommendation from this study is to maintain 
perioperative normothermia. This should occur throughout the perioperative process 
including transfer from one unit to another. When hypothermic temperatures are found 
with a warming intervention in place, then consideration should be given to providing an 
alternative or additional intervention. A second recommendation is to assess patient 
temperatures. Assumptions should not be made that patients are normothermic because 
they are not shivering and don't look cold as this can be influenced by certain anesthetic 
medications. There are many warming interventions in use at Eastern Health in the OR 
which could be applied as soon as the patient enters the preoperative holding area instead 
of waiting until they get in the OR. Other warming strategies are the focus of future 
research that needs to be done. There are already broad recommendations available for 
intraoperative temperature care. However, a specific written protocol, such as the one for 
antibiotic prophylaxis and glucose control, could be developed that very clearly identifies 
the time and frequency with which patients are to be assessed in the perioperative period. 
A policy of this type is already in existence in the PARR. For this reason, nurses need to 
be educated about the assessment component of this policy as well as warming 
interventions that are available. Administration may need to get involved to audit 
temperature assessment and interventions and then provide feedback to the nurses caring 
for these patients. Future research could involve a study that compares different warming 
strategies or a study that evaluates what strategies are found to be the most beneficial to 
increasing nurses' adherence to policy. 
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Inappropriate Hair Removal 
Preoperative hair removal was performed following all recommendations 
currently in practice, and all patients had a documented skin assessment. However, while 
not a statistically significant difference in this study, double the proportion of patients 
with non-intact skin developed an SSI, compared to those that did have intact skin. As 
well, for patients with non-intact skin, not receiving the correct antibiotic prophylaxis was 
a significant risk factor for SSI. 
Preoperative hair removal is a task performed by the nurse which is dictated by 
protocols. However, skin assessment is a shared practice between the physician and the 
nurse because of the incisional area assessment that must be done so that a decision can 
be made about appropriate hair removal. 
Recommendations. The ORNAC and CDC guidelines are very clear in their 
recommendations about hair removal and skin assessment preoperatively and these 
should continue to be followed (Mangram et al. , 1999; ORNAC, 2007). Because not 
receiving antibiotics when a patient had non-intact skin was identified as a risk factor in 
this study, adherence to antibiotic prophylaxis is also very important. As well, serious 
consideration should be given to the decision to proceed with the surgical procedure if 
skin areas are broken in the area to be incised. 
Documentation 
While many assessments and interventions were documented, there were some 
specific aspects that require more attention. Some examples of physician documentation 
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requiring improvement are ASA score, patient temperature in the OR, and diagnosis of 
infection. Some examples of nursing documentation requiring improvement are time of 
assessment of preoperative temperature, if warming interventions were provided, patient 
weight, and components of the health history about smoking. As well, documentation 
about the effectiveness of different interventions that have been provided should also be 
included. 
Recommendations. Education should be provided to physicians and nurses about 
the legal ramifications and the lack of communication of important findings that can 
occur with incomplete documentation. Education can also be provided on how to 
complete a full health history including a smoking history with the components: amount 
smoked, length of time smoked, and how recently they quit if a recent quitter. 
Administration could audit charts for incomplete documentation and then provide 
feedback to the staff involved. 
Modifiable and Non-Modifiable Risk Factor Practice Issues and Recommendations 
A non-modifiable factor that emerged with a trend towards increased risk of SSI 
was having an emergency surgery. A very broad health goal can involve education of the 
population on risk factor reduction for peripheral arterial disease and other comorbidities, 
so that they do not require such surgery. An audit can be undertaken to determine why 
patients who have emergency surgery are at increased risk of SSI. Once these factors are 
determined, then interventions can be directed at improving processes such as optimal 
prophylaxis during an emergency surgery, which may reduce these factors. 
----------------- -------
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A risk factor that may be modifiable or not is intraoperative blood loss as has 
already been discussed in Chapter 5. A trend was seen in this study toward increased risk 
of SSI with intraoperative blood loss that led to anemia postoperatively. If increased 
blood loss is anticipated due to medications the patients is taking or hematological 
conditions a patient may have, this should be reported to the physician in advance of 
surgery. As well, any anemic patients discovered should be prescribed iron therapy with 
appropriate follow-up. 
Smoking is a modifiable risk factor. While smoking did not emerge as a risk 
factor in this study, a trend was seen which merits discussion. Patients who smoke more 
than 20 cigarettes per day develop more SSis than those who smoke less than 10 
cigarettes per day. As already discussed, health histories were often incomplete in this 
study with respect to smoking. All information related to how long a patient has smoked 
and how much they smoke, or if they quit, for how long they have maintained abstinence, 
and how much they smoked when they did smoke should be included in the health 
history. With complete information like this, then interventions to assist a patient to quit 
smoking can be individualized. Even without this complete history though, education can 
still be provided to all patients on strategies to quit smoking including the suggestion of 
nicotine replacement. In addition, nurses can counsel patients on quitting smoking and 
make appropriate referrals to smoking addiction services. 
Another modifiable risk factor is having an increased BMI. In this study however, 
this did not emerge as a risk factor but trends towards increased risk were seen. Patient 
education provided by nurses on weight reduction is complex and requires a long term 
strategy that begins in school-aged children. It is very difficult for a nurse preoperatively 
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to counsel a patient on weight loss that will have any dramatic effect on SSI risk so 
quickly. However, adherence to a healthy diet before surgery could help normalize 
glucose levels and begin a process that could be reinforced by postoperative and 
community health nurses. As well, for obese patients, nurses can reinforce the importance 
of preoperative skin care and cleansing with particular attention to skin folds. 
Administrative Implications 
From an administrative perspective, key perioperative team members could be 
brought together as a working group to develop protocols or policie.s that address areas 
needing improvement. Follow-up for adherence to the protocols or policies is also 
necessary. Development of a protocol is an important first step but it does not mean that it 
will be adhered to. Improving adherence may be done through administrators releasing 
staff for continuing education to learn about the latest research and protocols or policies 
that have been developed. Second, administrators can audit perioperative records to 
assess for adherence to the protocol with reward for those who follow the protocol and 
reminders for those who don't. Third, if protocols are not being followed, administrators 
need to determine the reason why, through an assessment with the perioperative staff 
directly involved in the provision of care under review. Actions then need to be designed 
and further support strategies put in place to increase adherence. 
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Education Implications 
Staff Education 
Education provided by staff and clinical educators in these areas should focus on 
SSI prevention and the use of antibiotic therapy in which an antibiotic is selected based 
on C&S results. Strategies should also be employed that promote and increase adherence 
to policies and protocols. Such strategies include but are not limited to in-servicing of 
staff, having journal clubs that discuss these issues, identification of leading staff 
members who reinforce education in the practice setting about the protocol or policy, and 
making the protocol meaningful to the staff that provide the care. To make the protocol 
meaningful, evidence needs to be provided to staff that demonstrates how improvements 
in SSI rates were achieved when protocols or policies were followed and care processes 
were changed and improved. In a collaborative project that addressed antibiotic 
prophylaxis, maintenance of normoglycemia and intraoperative normothermia, and 
appropriate hair removal, a reduction of 27% in the SSI rate was reported (Dellinger et 
al., 2005). Nmses and physicians tlu·oughout the entire perioperative period need to be 
educated about the importance of documentation of findings not only for legal reasons but 
also for continuity of care of the patient and communication between the perioperative 
care team. Because nmses are educators of patients, nmses also require educations about 
the best strategies to use to educate patients in their care. 
Implications for the StajjlClinical Educator 
Staff and clinical educators need to develop a diversified set of strategies to 
deliver education. Perioperative team members require different levels of detail and 
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educational support (Farrington, 2007). The message to be delivered needs to be clear, 
concise, realistic, meaningful, and inspiring towards change. Some learners are motivated 
and self-directed, while others are non-motivated and resistant to change. With 
educational interventions, it is essential to involve key perioperative team members, 
relying on the enthusiasm of new staff and the wisdom of more experienced staff. 
Basic Education 
Basic education in nursing and medical schools needs to focus on infection and 
risk factors for infection. This should include a discussion about the chain of infection 
theory, other healthcare-associated infections, and personal protective equipment. The 
implications of glycemic control and other risk factors for SSI and other infections should 
be included. The importance of antibiotic prophylaxis and the presence of new and 
emerging strains of antibiotic resistant microorganisms should be reinforced. 
Patient and Family Education 
Patients and families under the care of nurses also reqmre education in the 
preoperative clinic or postoperative setting. Patients and families need to be educated at a 
level that is understandable to them. Education must involve a discussion of risk factors 
such as obesity for example and how lifestyle may be modified to reduce this particular 
risk. Education of the patient and family is important through the entire perioperative 
process. It may begin with preoperative education on the avoidance of shaving in the 
incisional area or special cleansing of skin, to the postoperative unit education about 
smoking cessation or maintenance of normoglycemia and healthy weight. 
-----------~·---------
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Research Implications 
There were no statistically significant findings that emerged from this study after 
multivariate analysis. This may be because they are not risk factors for vascular surgery 
patients, or because this small study had insufficient power to detect if certain factors are 
actually risk factors for SSI. For this reason, a larger, multi-site study with an adequate 
sample size to do all sub-analyses is indicated using the same methods. Data should be 
gathered on the same broad range of risk factors to ensure that as many factors as possible 
are explored for their possible effect on SSI risk in this understudied population. 
As recommended previously, the use of protocols to guide practice is important. 
Another interesting and relevant study would therefore be an examination of the use of 
specific protocols aimed at dealing with risk factors for SSI. This study could assess if 
SSI outcomes are affected by changes in practice because of the use of protocols. An 
example of this kind of study would be a randomized, controlled study of 
normothermia/hypothermia interventions that compares a study group that receives 
warming interventions throughout the perioperative period including transfer from one 
unit to another, compared to a control group that only receives the warming interventions 
once the patient becomes hypothermic. These two groups of patients could then be 
compared to determine which group developed the most SSis. Another possible study 
would be to determine what strategies are the most successful to promote adherence to 
protocols such as antibiotic prophylaxis by health care professionals. Strategies such as 
education, administrative reinforcements or involvement of key health care workers in the 
provision of care could be compared in this study. 
--------------------------------
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In conclusion, this study has led to a number of recommendations for changes and 
improvements in practice that could address some of the known and hypothesized risk 
factors for SSI. This study is only the beginning of a program of nursing research that can 
be conducted to determine definite risk factors for SSI, as well as evaluate the use of 
evidence-based protocols that will improve patient outcomes. 
Infection Prevention and Control implications 
Use of Standard Criteria and Post-Discharge Surveillance 
Standard definitions recommended by the CDC were used in this study to identify 
SSis. This makes my study comparable to other studies that report SSI rates. However, 
this is only helpful when other studies report their post-discharge surveillance 
methodology as well. Surveillance in this study followed the guidelines of the CDC; 
patients without an artificial graft had surveillance for 30 days, and patients with an 
artificial graft were followed for 1 year for visits to the facility where they had their 
surgery done. This was very similar to the post-discharge surveillance completed in 
studies reviewed in the literature review, and is an accepted practice. However, optimal 
surveillance of patients in this study would have been to follow up on every patient with 
an artificial graft through phone calls to the patient or family physician, for up to a year 
after surgery to determine if they had developed an SSI or not. However, there were 95% 
of patients seen by 6 weeks by the vascular surgeon in this study so a baseline rate has 
been established. It would be interesting to study the sensitivity of this surveillance by 
once again studying vascular surgery patients but the next time, having the full follow up 
as recommended by the CDC on every single patient. 
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Recommendations: Infection Prevention & Control practitioners play a vital role 
in the surveillance of infection. However, surveillance is only helpful if interventions are 
planned to decrease the infection rate. IP&C practitioners can play an important role in 
both education about risk factors and strategies to reduce these risk factors, and in policy 
and procedure development around these interventions based on the best evidence 
available. 
Because this study had identified that the SSI rate in vascular surgery patients 
requires attention and that this is a surgical group at risk, periodic surveillance of 
infections in vascular surgery patients is warranted. Standard definitions of SSI from the 
CDC should be used to increase comparability between studies and ~P&C programs. As 
well, with feasibility under consideration, IP&C practitioners should perform surveillance 
for the maximum length of time including post-discharge, to identify as many cases of 
SSI as possible. Additionally, when IP&C practitioners are reporting SSI rates, this 
should be done with an identification of the post-discharge surveillance methodology 
used. Finally, total chart reviews are a feasible and sensitive way to obtain good 
information on SSI development. If SSis are then found, the retrospective chart review is 
very helpful in identifying the possible risk factors. Another alternative will be to use the 
electronic health record which will have this data readily available to analyze. However, 
this assumes that the information is recorded, downloadable and has capabilities for data 
extraction which is not currently available in Eastern Health. 
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Dissemination of Findings 
The purpose of this study was to determine risk factors for SSI in vascular surgery 
as well as identify nursing interventions to decrease this risk. A secondary purpose was to 
determine the SSI rate for vascular surgery patients. It is important to share these findings 
with others including the perioperative team, Eastern Health, and the larger population of 
professionals that are interested in vascular surgery, infection control, and SSI risk 
factors. 
Practice issues, SSI rates, risk factors for SSI, and interventions that are successful 
in reducing risk, will be shared with all who are interested. This may be accomplished by 
local presentations, conferences, and publication in journals that appeal to these groups of 
professionals. 
Conclusion 
Even though this study did not identify any risk factors that independently 
increased SSI risk, it did identify areas in practice, administration, education, and research 
in the care of vascular surgery patients that require improvement. If these areas are 
addressed, it is anticipated that improvements will be seen in the preoperative care of 
vascular surgery patients, with an associated decrease in the SSI rate. The implications of 
this study are that the body of research about SSI and SSI risk factors has been 
strengthened, there is a cunent Canadian SSI rate for others to compare to as a 
benchmark, there is more known about how nurses and physicians care for patients, and 
the SHN program has some added information to support their suggested interventions to 
reduce SSI risk. 
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Appendix A: Criteria for Defining a Surgical Site Infection (Mangram et al., 1999) 
Superficial Incisional SSI 
Infection occurs within 30 days after the operation and infection involves only skin or 
subcutaneous tissue of the incision and at least one of the following: 
1. Purulent drainage, with or without laboratory confirmation, from the superficial 
lllClSlOn. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the 
superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or tenderness, 
localized swelling, redness, or heat and superficial incision is deliberately opened by 
surgeon, unless incision is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending physician. 
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal inflammation and discharge confined to the points of suture 
penetration). 
2. Infection of an episiotomy or newborn circumcision site. 
3. Infected burn wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see deep incisional SSI). 
Note: Specific criteria are used for identifying infected episiotomy and circumcision sites 
and burn wounds. 
Deep Incisional SSI 
Infection occurs within 30 days after the operation if no implantt is left in place or within 
1 year if implant is in place and the infection 
appears to be related to the operation and infection involves deep soft tissues (e.g., fascial 
and muscle layers) of the incision and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space component of 
the surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon when 
the patient has at least one of the following signs or symptoms: fever (>38°C), localized 
pain, or tenderness, unless site is culture-negative. 
3. An abscess or other evidence of infection involving the deep incision is found on direct 
examination, during reoperation, or by 
histopathologic or radiologic examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician. 
Notes: 
1. Report infection that involves both superficial and deep incision sites as deep incisional 
SSI. 
211 
2. Report an organ/space SSI that drains through the incision as a deep incisional SSI. 
Organ/Space SSI 
Infection occurs within 30 days after the operation if no implant is left in place or within 
1 year if implant is in place and the infection appears to be related to the operation and 
infection involves any part of the anatomy (e.g., organs or spaces), other than the incision, 
which was opened or manipulated during an operation and at least one of the following: 
1. Purulent drainage from a drain that is placed through a stab wound into the 
organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue in the 
organ/space. 
3. An abscess or other evidence of infection involving the organ/space that is found on 
direct examination, during reoperation, or by histopathologic or radiologic examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
Appendix B: Literature Review Tables 
Table 1: Glucose and SSI studies 
Table 2: Temperature and SSI studies 
Table 3: Vascular Surgery and SSI Risk Factor Studies 
Table 4: Vascular Surgery SSI Surveillance Studies 
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Table 1: Glucose and Infection 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
samp le and SSI 
Collier et al. Prospective, consecutive-series, Hyperglycemia: SSl rate: 5.4% Limited comgarabili!)': 
historically controlled study Maximum daily l.Does not report on period of 
(2005) glucose level > Both groups (protocol and historical surveillance 
Trauma surgery patients 8.3 mmol/L control ) did not maintain glucose at 2. Does not give definition of SSI 
USA target 3. No data on pre-operative glucose 
Compared SSls in 1 historical group SST: not control 
n =818 who had physician controlled glucose provided No difference between group in SSl 
to a second group who had glucose risk: protocol group 5.0% vs 
controlled by an algorithm nonprotocol group 5.7% (p = 0.645) Underestimation of effect: 
Does not report if post-discharge 
Target glucose control: 4.4 - 6.1 surveillance was done 
mmol/L 
Dronge et al. Retrospective cohort study Hyperglycemia: HbAic >7% increased HAl risk Limited Comgarabili!)': 
(2006) HbA1c >7% in (OR: 2.13; 95%CI, 1.23-3.70; p = I. Does not report if post-discharge 
Looked at all HAl, did not specify diabetic patients 0.007) surveillance was done 
SSl 2. HbA I c is a measurement of 
USA SSI: CDC previous 2 -3 month (60-90 days) 
Mixed surgery patients including definition glucose control, this study accepted 
n = 77 vascular HbA 1 c determinations done up to 6 
months before the surgical 
Unknown how many patients had an procedure 
implant 
Underestimation of effect: 
HbA 1 c levels done within 180 days Only completed surveillance for 30 
were included days, not 1 yr 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Furnary et al. Prospective case-control study Hyperglycemia: SSI rates: Limited Comgarabili!Y: 
(1999) > 11.1 mmoVL 1. Deep sternal wound SSI: 1.3% 1. Does not report on period of 
Compared glucose control between 2 surveillance 
groups and its effect on outcomes SSI: Not given 2. Superficial sternal wound SSI: 2. Does not report if post-discharge 
USA such as SSI 0.6% surveillance was done 
3. Does not give defmition ofSSI 
n = 2467 Control group (n = 968) had sliding 3. Superficial donor site SSI: 0.6% 4. No data on preoperative glucose 
scale SIC insulin (SQI) post-op with control 
CABG surgery glucose measured q4h, with goal to en produced a significant decrease 
patients keep glucose of 11 .1 mmoi/L or lower in deep sternal wound SSI by 66% 
(p = 0.005) 
All diabetic Study group (n = 1499) received 
patients continuous IV insulin infusion (CII) POD#1 Glucose levels 
(defmed as until glucose levels of 8.3 - 11.1 of 11 .1 mmoi/L or greater are 
experiencing mmol/L were maintained significantly associated with the 
chronic development of a deep sternal 
glucose Intraoperative and postoperative wound SSI (p = 0.002) 
intoh~rance at glucose levels were prospectively 
time of monitored q 1-2h, daily.Mean blood 
surgery) glucose levels were calculated by 
averaging all daily glucose levels. 
Measured from the operative day to 
2nd post-operative day 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Furnary et 
al., (2003) Historic case-control study Hyperglycemia: SSlrates: Limited Com12arabili!Y: 
> 8.3 mmol/L I. It is unclear how many patients 
Compared glucose control between 2 Overall Mediastinitis: 0.9% received CII protocol to keep 
USA groups and its effect on outcomes SSI: Not given glucose levels between 8.3 - 11. 1 
such as SSI CII mediastinitis rate: 0.6% mrnol/L (1 51 arm of study) and 5.6 
n =3554 - 8.3 mmol/L (2"d arm of study) 
Control group (n = 942) had sliding SQI mediastinitis rate: 1.8% 
CABG surgery scale SIC insulin (SQI) post-op with 2. Does not report on period of 
patients glucose measured q4h, with goal to Difference in insulin protocols on surveillance 
keep glucose of 11 .1mrnol/L or lower mediastinits risk (p = 0.05) 
All diabetic 3. Does not report if post-discharge 
patients Study group (n = 2612) received surveillance was done 
(defmed as continuous IV insulin infusion (CII) 
history of until glucose levels of 5.6- 8.3 4. Does not give definition of SSI 
diagnosis of mmol/L were maintained- some of 
diabetes or these patients from Fumary et al 5. No data on pre-operative glucose 
persistently ( 1999) had glucose levels maintained control 
increased between 8.3- 11.1 mrnol/L) 
glucose levels 
of I 1.1 Perioperative glucose levels were 
mmol/L or measured q 30m in - 2h. Mean blood 
greater and glucose levels were calculated by 
discharged averaging all daily glucose levels. 
home Glucose levels done from operative 
requiring day to 2nd post-operative day. 
pharmacologic 
al management 
of glucose) 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Furnary et al. 
(2004) Historic case-control study Hyperglycemia: CII deep sternal wound SSI rate: Limited Comgarability: 
> 8.3 mmoi/L 0.7% 1. It is unclear how many patients 
USA Compared glucose control between 2 received en protocol to keep 
groups and its effect on outcomes SSI: Not given Glucose of 11.1 mmoVL or greater glucose levels between 8.3 - 11.1 
n = 4864 such as SSI in the first 48 hours after cardiac mmoVL (I 51 arm of study) and 5.6 
surgery was independently - 8.3 mmoVL (2"d and 3rd arm of 
Control group (n = 968) had sliding associated with a significant study) 
CABG surgery scale S/C insulin (SQI) post-op with increase in deep sternal wound SSI 
patients glucose measured q4h, with goal to (p=0.017) 2. Does not report on period of 
keep glucose of 1 1.1 mmoVL or lower surveillance 
All diabetic Identified an inflection point at 9.7 
patients Study group (n = 3896) received mmoi/L at which the incidence of 3. Does not report if post-discharge 
(defmed as continuous IV insulin infusion (CII) deep sternal wound SSI begins to surveillance was done 
history of until glucose levels of 5.6- 8.3 increase significantly 
diagnosis of mmoi/L were maintained - some of 4. Does not give defmition of SSI 
diabetes or these patients from Furnary et al 
persistently ( 1999) had glucose levels maintained en is independently protective 5. No data on pre-operative glucose 
increased between 8.3- 11.1 mmoi/L) against deep sternal wound SSI by control 
glucose levels 61% (p < 0.01) 
of 11.1 Perioperative glucose levels were 
mmol/L or measured q 30min - 2h. Mean blood 
greater and glucose levels were calculated by 
discharged averaging all daily glucose levels. 
home Glucose levels done from operative 
requiring day to 2nd postoperative day 
pharmacologic 
al management A composite 3-day post-operative 
of glucose) blood glucose value (3-BG) was 
calculated by averaging the mean 
glucose level on the operative day, as 
well as POD# I and POD#2 
---------------------
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Furnary & Historic case-control study Hyperglycemia: CII deep sternal wound SSI rate: Limited Comgarability: 
Wu (2006) > 6.1 mmoVL 0.3% I .It is unclear how many patients 
Compared glucose control between 2 received err protocol to keep 
groups and its effect on outcomes SSI: CDC For every 2.8 mmoVL increase in 3- glucose levels between 8.3 - 11.1 
USA such as SSI definition BG, the risk of deep sternal wound mmoVL (1 51 arm of study) and 5.6 
SSI is increased more than two-fold - 8.3 rnmoVL (2"d and 3'd arm of 
n = 5534 Control group (n = 1 065) had SS SIC (p < 0.0001) study) and 3.9-6.1 mmoUL (4th 
insulin (SQI) post-op with glucose arm of study) 
CABG surgery measured q4h, with goal to keep Identified an inflection point at 9.7 
patients glucose of 11.1 mmol/L or lower mmol/L at which the incidence of 2. Does not report on period of 
deep sternal wound SSI begins to surveillance 
All diabetic Study group (n = 4469) received CII increase significantly 
patients until glucose levels of3.9 - 6.1 3. Does not report if post-discharge 
(defined as mmoUL were maintained- some of CII has the independent effect of surveillance was done 
history of these patients from Furnary et a! reducing deep sternal wound SSI by 
diagnosis of (1999) had glucose levels maintained 63% (p < 0.002) 4. No data on preoperative glucose 
diabetes or between 8.3 - II. I mmoUL) and control 
persistently from Fumary et al. (2003, 2004) had 
increased glucose levels maintained between 
glucose levels 5.6-8.3 mmoVL 
of 11.1 
mmol/L or Perioperative glucose levels were 
greater and measured q 20m in - 2h. 
discharged Mean blood glucose levels were 
home calculated by averaging all daily 
requiring glucose levels. Glucose done from 
pharmacologic operative day to 2nd post-operative 
al management day. A composite 3-day post-
of glucose) operative blood glucose value (3-BG) 
was calculated by averaging the 
mean glucose level on the operative 
day, as well as POD#! and POD#2. 
Study 
a uthors, year, Definitions of 
country, Methodology Hyperglycemia 
sample and SSI 
Guvener et at. Retrospective cohort study Hyperglycemia: 
::-_ 11.1 mmol!L 
(2002) Compared glucose control between 2 
groups and its effect on outcomes SSI: Not given 
CABG surgery such as SSI 
patients 
Glucose levels were monitored 6 
diabetic times daily. Daily mean glucose 
n =400 levels were calculated by averaging 
all glucose levels in the 2 days prior 
non-diabetic to surgery and for 3 POD. 
n = 690 
Blood glucose levels of diabetic 
Turkey patients were manipulated with a Cll 
to maintain glucose levels of 8.3 -
n = 1090 11.1 mmo1/L 
Diabetes 
defined by 
history of 
diabetes on 
admission 
------------------------- --
Results 
Deep sternal wound SSI rate in 
diabetics: 1.25% vs 0.57% of non-
diabetics (p = 0.048) 
Donor site SSI rate in diabetics: I% 
vs 0.28% of non-diabetics (p = 
0.013) 
Glucose control preoperative 
day 2: for diabetics with deep 
sternal wound SSI, glucose was 12.3 
± 0.6 mmoVL compared to diabetics 
without deep sternal wound SSI 
whose glucose was 9.2 ± 2.0 
mmoVL (p = 0.006) 
Glucose control pre-operative day 1: 
for diabetics with deep sternal 
wound SSI, glucose was 10.1 ± 0.5 
mmoVL compared to diabetics 
without deep sternal wound SSI 
whose glucose was 7.7 ± 1.7 
mmoVL (p = 0.009) 
Glucose control post-operative day 
2: For diabetics with deep sternal 
wound SSI, glucose was 11.7 ± 1. 7 
mmoVL compared to diabetics 
without deep sternal wound SSI 
whose glucose was 9.3 ± 1.9 
mmol!L (p = 0.012) 
Limitations 
Limited Comgarabili!Y: 
1. Does not report on period of 
surveillance 
2. Does not report if post-discharge 
surveillance was done 
3. Unknown how often glucose 
was measured 
N 
...... 
00 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Grey et al. Prospective, randomized, controlled Hyperglycemia: Standard glucose control SSI rate Limited Comnarabilitx: 
(2004) trial 2: 7.8mmol/L 3% vs 0.8% in strict glucose control I. Does not report on period of 
group (p < 0.05) surveillance 
USA Compared glucose control between 2 SSI: CDC 
groups and its effect on outcomes defmition 2. Does not report if post-discharge 
n = 61 such as SSI surveillance was done 
Mixed surgery Standard glucose control group: 3. Unknown how often glucose 
patients received standard intravenous was measured (according to 
insulin therapy to keep glucose I 0 - algorithm) 
12.2 rnmol/L 
Strict glucose control group: received 
intravenous insulin therapy to keep 
glucose 4.4-6.7 mmoi/L 
Krinsley Historical case-control study Hyperglycemia: No significant difference seen in all Limited Comnarabili!X: 
2: 7.7rnmoVL HAl developed with or without the I . Not clear if surveillance for HAl 
(2004) Compared glucose control between 2 protocol for the period patients were continued after ICU stay 
groups and its effect on outcomes SSI: Not given in ICU 
USA such as HAl, did not report on SSI 2. Does not report on period of 
specifically surveillance 
n = 1600 
3. Does not report if post-discharge 
General Compared 800 patients admitted to surveillance was done 
surgery ICU before institution of a glucose 
patients management protocol to 800 patients 4. No defmition of SSI given 
admitted to ICU after the institution 
of the diabetes management protocol 5. Does not outline how glucose 
values were calculated (ie mean 
Glucose measured every 3 hours or glucose or single glucose) 
less depending on stability of glucose 
and protocol recommendations 
Study 
a uthors, year, Definitions of 
country, Methodology Hyperglycemia 
sample and SSI 
Latham et al. Prospective, cohort study Hyperglycemia: 
(2001) ::::_ 11.1 mmoi/L 
Compared glucose control between 4 
USA groups and its effect on outcomes SSI: CDC 
such as SSI definition 
n = 1000 
CABG surgery Pre-operative HbA 1 c obtained on all 
patients patients. HbA1c values::::_ 7 were 
considered indicative of previously 
diabetic undiagnosed diabetes 
n = 300 
non-diabetic Glucose levels were separated into 
n = 700 quartiles and quartiles 2-4 were 
compared to quartile I to assess for 
risk of infection 
Quartile I: < 11 .1 mmoi/L 
Quartile 2: 11.1 - 13.8 mmoi!L 
Quartile 3: 13.9- 16.6 mmoi!L 
Quartile 4: ::::_ 16.7 mmoi/L 
Results 
Total SSI rate: 7.7% 
Quartile 2 compared to Quartile 1 
OR of SSI 2.54 
Quartile 3 compared to Quartile I: 
OR of SSI 2.97 
Quartile 4 compared to Quartile I: 
OR ofSSI 3.32 
Of700 non-diabetics, 25% had 
HbA1c levels > 6.2 (6% oftbese 
patients had HbA I c levels ::::_ 7 
Of the known diabetics, 42% had 
HbA1c values ::::_ 8% at the time of 
surgery - of these patients, 78% 
developed perioperative 
hyperglycemia compared with 43% 
with lower HbA1c values (OR 1.78; 
95%CI, 1.47-2.16; p < 0.001) 
Patients with preoperative 
hyperglycemia did not have 
significantly more SSis than those 
with normoglycemia 
Patients with post-operative 
hyperglycemia did have 
significantly more SSis than those 
with normglycemia (OR: 2.02; 
95%CI, 1.21 - 3.37; p = 0.007). 
Limitations 
Limited Comgarability: 
1. Does not report on period of 
surveillance 
2. Does not report if post-discharge 
surveillance was done 
3. Does not outline how glucose 
values were calculated (ie mean 
glucose or single glucose) 
N 
N 
0 
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Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SST 
Lazaret al. Randomized controlled trial Hyperglycemia: Patients achieved better glucose Limited Comgarabili!Y: 
(2004) Different control with GIK immediately I. Does not report on period of 
Compared glucose control between 4 depending on before cardiopulmonary bypass (p < surveillance 
USA groups and its effect on outcomes treatment 0.0001), and at 12h after surgery (p 
such as SSI received - see < 0.0001). This persisted at 18h 2. Does not report if post-discharge 
n = 141 methods even though the solution was shut surveillance was done 
Glucose levels were measured every off(p < 0.0001). 
CABG surgery hour and treated with either a SSI: Not given 3. Does not outline how glucose 
patients - all glucose/ insulin/ potassium (GIK) IV Did not separate pneumonia and values were calculated (ie mean 
diabetic solution continuously or given wound infections, but said that in glucose or single glucose) 
sliding scale S/C insulin patients with no GIK, 9% developed 
an infection compared to 0% in the 4. Did not describe methods of 
Total study period 18 hours including GIK group (p = 0.01 0) randomization 
surgery 
GIK treated patients had 
GIK group to maintain glucose significantly less sternal and wound 
between 7.1 - ll.lmmol/L SSis at 5 years 
GIK group I% vs No-GIK group 
Sliding scale SIC group to maintain 7% (p = 0.03) 
glucose between 4.4- 13.8 
Study 
authors, year, 
country, 
sample 
O 'Sullivan et 
at. (2006) 
Ireland 
n = 165 
Vascular 
surgery 
non-diabetic 
(no history, 
plasma HbAlc 
S:7%; preop 
fasting glucose 
< 7.0 mmoVL) 
n = 122 
diabetic: 
(history of 
Type 1 or 2 on 
admission 
medical 
history and/or 
those taking 
insulin or oral 
hypoglycaemic 
agents or 2 
consecutive 
preop fasting 
glucose levels 
2.7 mmoVL 
n =43 
Definitions of 
Methodology Hyperglycemia 
and SSI 
Prospective cohort study Hyperglycemia: 
Suboptimal 
Pre-operative HbA I c values were HbAic non-
collected from all vascular surgery diabetic: 
patients on average 5.5 days before 6.1-7% 
the procedure 
Suboptimal 
Patients separated into 4 groups: HbA I c diabetic: 
Group I: HbA 1 c S:6% >7% 
Group 2: HbA lc = 6.1 - 7.0% 
Group 3: HbAlc = 7.1-8.0% SSI: Not given 
Group 4: > 8% 
Post-op blood glucose measured 2-
4 times per day 
Results 
Higher incidence (9.9%) ofpostop 
wound infection in non-diabetic 
patients with suboptimal HbA1c 
compared to non-diabetic [patients 
with optimal HbAlc (0%) (p=0.041) 
Suboptimal HbAlc found in 58.2% 
of non-diabetics and 51.2% of 
diabetics 
Limitations 
Limited Comparability: 
I. Does not report on period of 
survei I lance 
2. Does not report if post-discharge 
surveillance was done 
3. Definition of SSI not given 
N 
N 
N 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Trick et al. Retrospective case-control study Hyperglycemia: Radial artery graft site SSI: 8.3% Limited Comgarabili!Y: 
(2000a) ::::_ 11.1 mmoi!L I. Post discharge surveillance not 
Compared glucose control between 2 Independent risk factor for SSI: done on all patients 
USA groups and its effect on outcomes SSI: Used CDC preoperative glucose level 11.1 
such as SSI criteria but also mmoVL or greater (OR: 4.4; p = 2. Does not follow CDC guidelines 
n =309 included patients 0.01) for definition of SSI 
Pre-operative glucose level was the who developed 
CABG surgery level within 24 hours of surgery pre- an radial donor 
patients operatively site SSI > 30 
days 
Trick et al. Retrospective case-control study Hyperglycemia: Deep sternal wound SSI rate: 1.7% Limited Comgarabili!Y: 
(2000b) ::::_ II. I mmoVL I. Post discharge surveillance not 
Compared glucose control between 2 Independent risk factor for SSI: done on all patients 
USA groups and its effect on outcomes SSI: Not given preoperative glucose level 11 .1 
such as SSI mmoi!L or greater (OR: 10.2; 2. Definition ofSSI not given 
n = 120 95%CI, 2.4 - 43; p = 0.008) 
Pre-operative glucose level was the Overestimation of effect: 
CABG surgery level within 24 hours of surgery pre- Case pts had significantly more 
patients operatively internal thoracic artery harvests 
which has been linked to SSI in the 
literature 
Vilar-Compte Nested case-control study Hyperglycemia: Independent risk factor for SSI: At Limited Comgarabili!Y: 
et al. ::::_ 7.3 mmoi/L least 1 glucose level::::_ 7.3 mmol!L 1. Does not report if post-discharge 
(2008) Compared glucose control between 2 (OR: 3.05; 95%CI, 1.5-6.3; p = surveillance was done 
groups and its effect on outcomes SSI: Not given 0.006) 
Mexico such as SSI 2. Definition of SSI not given 
n =260 Each patient has 5 glucose levels 
done 
Mastectomy 
surgery Patients followed for SSI 
patients development for at least 30 days 
Study 
authors, year, Definitions of 
country, Methodology Hyperglycemia Results Limitations 
sample and SSI 
Wilson et al., Nested case-control study Hyperglycemia: Preoperative glucose values of Limited Comgarabili!Y: 
(2003) 7.0 mmoi!L patients who developed I . Does not report on period of 
Compared glucose control between 2 mediastinitis: 7 ± 2.8 mmoi/L surveillance 
USA groups and its effect on outcomes SSI: CDC compared to the control group 
such as SSI definition without mediastinitis 5.3 ± 1.3 2. Does not report if post-discharge 
n =258 mmoi/L; p <0.0001 surveillance was done 
Preoperative glucose was the first 
CABG surgery morning draw before 7am on the A preoperative glucose level of7 
patients operative day mmoi/L or greater is a independent 
predictor of post-operative 
mediastinitis (OR: 5.25; 95% CI, 
1.82 - 15.11; p = 0.002) 
Zerr et al. Retrospective, observational cohort Hyperglycemia: 2.1 % developed deep wound SSI Limited Comgarabili!Y: 
(1997) study ::::_ 11.1 mmoi!L before protocol I. Does not report on period of 
survei I lance 
USA Daily mean glucose levels were SSI: Not given After institution of the CII protocol, 
calculated by getting the average of at 3 years after, 0.98% developed a 2. Does not report if post-discharge 
n = 1585 levels obtained every I - 2 h. deep wound SSI surveillance was done 
CABG surgery Glucose levels were compared before Elevated BG > 11.1 mmoi/L at 48 3. Does not outline how glucose 
patients - all the institution of a strict protocol to hours was found to be significantly values were calculated (ie mean 
diabetic after the protocol stopped associated with increased risk of glucose or single glucose) 
deep wound infection (p < 0.05) 
Defined 
diabetes by 
history at time 
of surgery 
Table 2: Temperature and SSI 
Study authors, year, 
country, sample size Methodology Definitions 
Barone et al. Retrospective cohort SSI: 
study Suppuration 
(1999) (the formation 
Compared temperatures of pus) 
USA in colectomy patients to requiring the 
determine if removal of 
n =ISO hypothermia is a risk sutures 
factor for SSI 
Colorectal surgery Hypothermia: 
patients < 34.3 oc in 
OR or PARR 
Flores-Maldonado Prospective, cohort SSI: Positive 
et al. study wound culture 
(2001) Examined the Hypothermia: 
association between < 36.0 oc 
Mexico mild perioperative 
hypothermia(< 36.0 °C) 
n =290 on arrival to PARR and 
SSI 
Cholecystectomy 
patients Did post-discharge 
surveillance at 30 days 
Results 
SSI rate: 12% of patients 
categorized as hypothermic 
developed SSI compared to 
12% of patients classified as 
normothermic 
SSI rate 7.6% 
Patients who were 
hypothermic had a 
significantly longer surgery 
time (p < 0.0001 ) 
Hypothermia is a significant 
independent predictor of 
SSI (p = 0.004) 
Limitations 
Limited comparability: 
I. Definition of hypothermia is not standard of 
< 36°C 
2. Unclear as to how hypothermia measurements 
were calculated 
3. Some patients categorized as normothermic 
were hypothermic according to our definition 
4. Does not report on period of surveillance 
5. Does not report if post-discharge surveillance 
was done 
6. Does not use standard CDC defmition 
Limited comparability: 
I .Did not use CDC definition of SSI 
Underestimation of effect: 
I. I 0% of patients lost in post -discharge 
surveillance 
Overestimation of effect: 
Longer OR time for hypothermic group 
N 
N 
Vl 
Study authors, year, 
country, sample size Methodology Definitions Results Limitations 
Kurz et al. Prospective case-control SSI:Presence of 18.8% ofhypothermic Limited comparability: 
study pus and a patients developed an SSI 
(1996) positive culture compared to 5.8% of I. Definition of hypothermia is not standard of 
Compared temperatures normothermic patients (p < 36 °C 
Austria in colorectal surgery Hypothermia: = 0.009) 
patients to determine if s 34.5 oc 2. Was unclear as to how hypothermia 
n =200 hypothermia is a risk measurements were calculated 
factor for SSI 94% of patients had post-
Colorectal surgery discharge surveillance at 3. Did not use standard CDC definition ofSSI 
patients Patients were randomly 14 days after surgery. 
assigned to a Underestimation of effect: 
temperature control Of the 6% of patients who 
group did not have complete I . Surveillance only done for 15 days, not full 30 
surveillance, a call was days 
Normothermia group: made to the patient' 
temperature maintained physician to determine if 2. Some patients may have been lost to follow up -
around 36.5 oc patients bad developed an not reported if patients whose doctors were 
SSI or not contacted actually saw their patient after surgery 
Hypothermia group: 
Temperature maintained 
around 34.5 oc 
Temperature 
measurements were 
done every I 0 minutes 
intra-operatively and 20 
minute intervals during 
recovery 
Post-discharge 
surveillance done at 14 
days or a call was made 
to patient' s physician 
Table 3: Vascular Surgery and Risk Factors Studies 
Study - Authors, Methodology 
Year, Country, 
SSI definition 
Prospective cohort study 
Nicholson et al. 
Chart audit 
1994 
No post-discharge surveillance 
England 
Main focus: determination of the effect of 
n = 150 obesity on vascular surgery outcomes 
SSI definition: Definitions: 
Purulent discharge normal weight: BMI < 27 men; BMI < 25 
from the wound women 
overweight: BMI 27-29 men; BMI 25-29.9 
women 
obese: BMI ~ 30 
Retrospective case-control study 
Pounds et al. 
Chart audit 
2005 
Post-discharge surveillance not reported 
USA 
Surveillance: cases of infection were 
n = 410 identified through MD reporting, M&M 
records, and readmission to hospital for 
SSI definition: infection 
CDC definition 
Main focus: determination of risk factors for 
SSI 
Outcomes 
SSI rate overall: 16% 
SSI rate in obese patients: 31% 
Risk factors for SSI: 
Compared to normal weight: 
Overweight increased risk 
(p<0.01) 
Obesity increased risk 
(p < 0.05) 
SSI rate: 11% (2/3 were· 
organ/space) 
Risk factors for SSI: 
Previous hospitalisation (p = 
0.03) 
Younger age (p = 0.047) 
Presence of a groin incision (p 
= 0.04) 
Limitations 
Limited comQarabili!y: 
1) Used different antibiotic 
prophylaxis than standard 
2) Did not use standard 
definitions of SSI 
Underestimation of SSI rate: 
1) No post D/C surveillance 
conducted 
2) Did not follow prosthetic 
grafts for 1 year 
Underestimation of SSI rate: 
1) Unknown if post D/C 
surveillance conducted 
2) Did not follow prosthetic 
grafts for 1 year 
N 
N 
-.J 
Study - Authors, Methodology 
Year, Country, 
SSI definition 
O'Sullivan et al. Prospective cohort study 
2006 Chart audit 
Ireland Post-discharge surveillance not reported 
n = 165 Main focus: the effect of pre-operative 
hyperglycemia as measured by HbA1c on SSI 
SSI definition: 
Not provided 
Chang et al. Retrospective cohort study 
2003 Chart audit and review of postoperative 
infection surveillance surveys and a vascular 
USA registry 
n = 365 Main focus: effect of risk factors on SSI 
SSI definition: 
CDC definition 
Outcomes 
SSI rate: For nondiabetic 
patients with pre-operative 
HbA 1 c level between > 6 and ~ 
7% (suboptimal): 9.9% 
Risk factor for SSI: 
Non-diabetic patients with 
suboptimal HbA 1 c 
(p < 0.05) 
SSI rate: 8.0% 
Risk factors for SSI: 
Time in OR: 
SSI group- 318 min 
no SSI group - 265 min 
(p = 0.02) 
Vein grafts developed more 
superficial infections (9.2%) 
than artificial grafts (0.3%) p = 
0.02 
Limitations 
. . 
Limited comgarability: 
No definition of SSI given 
Underestimation of SSI rate: 
1) Unknown if post D/C 
surveillance conducted 
2) Did not follow prosthetic 
grafts for 1 year 
Underestimation of SSI rate: 
1) Did not report how many 
patients lost to followup 
2) Did not report if all patients 
with artificial graft had 1 year 
surveillance 
3) Did not look at every chart-
only looked at a registry and did 
not elaborate on what was 
included in the surveillance 
survey 
N 
N 
00 
Study - Authors, Methodology Outcomes Limitations 
Year, Country, 
SSI definition 
van Himbeeck et Prospective cohort study SSI rate: 5.1% Limited comgarability: 
al. 1) Did not use standard 
Observed by an ICN while in hospital Risk factors for SSI: definition of SSI 
1992 Female gender (p < 0.01) 2) They shaved their patients but 
Once pts were die they were followed up as did not look at this as a risk 
the Netherlands outpatients by the vascular surgeons in Older men (p < 0.01) factor or control for it in the 
collaboration with an Infection Control Nurse regression 
n = 603 (mean f/u time 45 months; range 21-75 mos) Groin incision (p < 0.01) 
Underestimation of SSI rate: 
SSI definition: 14.9% lost to follow-up Unknown what effect the 14.9% 
Purulent of patients who were lost to 
discharge/leakage Main Focus: effect of risk factors on SSI follow-up may have had on SSI 
from the wound rate 
edges which had a 
positive culture and Overestimation of SSI rate: 
signs of Period of surveillance was 
inflammation longer than standard 
Richet et al. Prospective cohort study SSI rate: 4.1% Limited comgarability: 
1991 Used non-standard antibiotic 
Patients were followed for at least 30 days Risk factors for SSI: prophylaxis 
France 
Main Focus: effect of risk factors on SSI Delayed surgery Underestimation of SSI rate: 
n = 561 IDDM Did not follow prosthetic grafts 
Past history of vascular surgery for 1 year 
SSI definition: Short antimicrobial prophylaxis 
CDC definition (p ~ 0.05) 
Table 4: Vascular Surgery SSI Surveillance Studies 
Authors, y ~ar, Methodology 
Country 
Mannien et al. Pre and post intervention study 
2006 Intervention: Strict, restrictive 
antimicrobial prophylaxis 
The Netherlands 
Post-discharge surveillance done 
n = 317 
Hawn et al. Retrospective cohort study 
2008 Post-discharge surveillance not 
reported 
USA 
n =1248 
Coello et al. Retrospective cohort study 
2005 Participating hospitals voluntarily 
reported SSI surveillance results 
England into central registry 
n = 3732 Hospital surveillance only 
(maximum 120 days for those with 
prosthetic graft; 30 days without) 
Definition of Outcomes 
SSI 
CDC definition SSI rate: 21.1% 
CDC definition SSI rate: 8.1% 
but did not follow 
prosthetic grafts 
for lyr 
Not provided SSI rate: 7.7% 
Limitatio1;1s 
Relied on voluntary reporting from 
hospitals 
Number of patients lost to follow-up 
not reported 
Post-discharge surveillance: not 
reported 
Did not fo llow prosthetic grafts for 1 
year 
Post-discharge surveillance: not done 
Did not follow prosthetic grafts for 1 
year 
Relied on voluntary reporting from 
hospitals 
N 
w 
0 
Authors, Year, Methodology Definition of Outcomes Limitations 
Country SSI 
: 
Morton et al. Prospective cohort study CDC definition SSI rate: 6.1% Post-discharge surveillance: not 
reported 
2008 Participating hospitals voluntarily 
reported SSI surveillance results Unknown if prosthetic grafts 
Australia into central registry followed for 1 year 
n=440 Hospital surveillance only Relied on voluntary reporting from 
hospitals 
Turnbull et al. Prospective cohort study CDC definition SSI rate: 7% Number of patients lost to follow-up 
not reported 
2005 ICP assessed all pts in hospital, 
reviewed charts, lab data, x rays, 
Canada observed wound for healing, 
consulted with the nurse, surgeon or 
Main focus of both q48h during admission, for l 
study: Antibiotic month if readmission occurred (to 
prophylaxis ER or hospital), or for 1 year if 
prosthetic device implanted 
n = 473 
Edwards et al. Prospective cohort study CDC definition SSI rate: 6.69% Post-discharge surveillance: not 
(National reported 
Healthcare Safety Participating hospitals voluntarily 
Network) reported SSI surveillance results Did not follow prosthetic grafts for 1 
into central registry year 
2008 
Does not report on post-discharge Relied on voluntary reporting from 
USA follow-up hospitals 
n = 3676 
Authors, Year, Methodology 
Country 
Moro et al. Prospective cohort study 
2005 Active observation of94.5% of the 
patients after D/C for up to 30 days 
Italy with no implant and 1 yr if implant 
- MD filled out form on patients 
n = 274 seen and phone call made 
Schepers et al. Prospective cohort study 
2003 Hospital surveillance only 
The Netherlands 
n = 373 
NNIS system Retrospective cohort study 
2004 Participating hospitals voluntarily 
reported SSI surveillance results 
USA into central registry 
n = 107,076 Does not report on post-discharge 
follow-up 
Definition of Outcomes 
SSI 
CDC definition SSI rate: 5.4% 
No definition SSI rate: 5.3% 
given 
CDC definition SSI rate: 4.34% 
Limitations 
Underestimation of SSI rate because 
MDs may have not sent in form or 
patients may not have been able to be 
reached by phone 
Post-discharge surveillance: not done 
Did not follow prosthetic grafts for 1 
year 
Post-discharge surveillance: not 
reported 
Did not follow prosthetic grafts for I 
year 
Relied on voluntary reporting from 
hospitals 
N 
w 
N 
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Appendix C: List of Surgeries 
Total number: 236 surgeries 
1. Aortobifemoral bypass 
2. Aorto to femoral bypass 
3. Axilla axilla bypass 
4. Bypass 
5. Femoral femoral bypass 
6. Femoral peroneal bypass 
7. Femoral politeal bypass 
8. Femoral tibial bypass 
9. Ileo femoral bypass 
10. Popliteal tibial bypass 
11. Aorto bilateral iliac bypass 
12. Aorto iliac bypass 
13. Polytetrafluoroethylene (PTFE) graft 
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Appendix D: SSI Study Data Collection and Surveillance Form 
Name: 
---------------------
MCP: ________________ _ 
Code: 
----------
....................................... tear away line .................................................. . 
Code: Date of data collection: 
----------
-------------------
Site: 0 St. Clare's 0 General Surgeon: ________________ __ 
Age: ____ _ Sex: O M 0 F 
Admission Date: 
-------------
Discharge Date: ____________ __ 
Smoker: 0 Yes 0 No Amount smoked: 
------------
Comorbidities: 0 Diabetes 0 Angina 0 Hypertension 0 CAD 
0 COPD 0 PVD 0 Asthma 0 CV A 0 MI 
0 Other Specify: ____________________________________________ __ 
Chemotherapy: 0 Yes 0 No Date: __________ __ 
Steroid Therapy: 0 Yes 0 No Date: __________ _ 
Date of procedure: 0 Emergency 0 Elective 
Procedure: Procedure Code: 
235 
Anaesthetic Type: 0 Epidural with catheter D Epidural without catheter 
D Spinal 0 General D Local Other 
-------
Tern~ e C) Mode Time/Date Intervention 
Preop 
Surgical Start Time: ______ _ Surgical End Time: ______ _ 
Height: _______ Weight: ______ _ BMI ____ _ 
Hair removal by patient near surgical site< 5 days preop: D Yes 0 No 0 Unknown 
Hair removal technique in OR: D Clipping 0 Shaving 0 None 
Condition of skin at surgical site: D Intact D Nicks D Abrasions 
D Redness D Other 
Estimated Blood Loss in OR: 
-------------
OR Exit Time: _____ _ 
Tem~e C) Mode Time/Date Intervention 
Intraop 
Intraop 
Intraop 
Intraop 
Intraop 
Intraop 
Intraoperative: Record all temperatures < 36.0 •c and readmgs after thts unhl temp returns to 
36.0"C again 
Surgical Classification: ___________ _ 
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Implants: 0 Mesh 0 Artificial graft 0 Wires 0 Artificial valve 
Break in technique: 0 Yes 0 No 0 Not recorded 
ASA Score: 0 Not recorded 
Allergy: Yes 0 No 0 If yes, type:----------------
Preop infection: Yes 0 No 0 Ifyes, location: --------------
Antibiotics received for preop infection: ________________ _ 
Antibiotics received in ORIP ARR/Surgical unit: 
Date/Time 
Antibiotics given when: 0 > 2h precut 0 >l-2h precut 0 30-60min precut 
0 0-30 min precut 0 0-30 min postcut 0 30-60 min postcut 
Was antibiotic appropriate for surgery? 0 Yes 0 No 
Received repeat AlB after> 4h in OR? 0 Yes 0 No 
Was dose appropriate for BMI? 0 Yes 0 No 
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How many doses of AlB within 24 hours postop: -------------
PARR Entrance Time: 
----
TemR CO C) Mode Time/Date Intervention 
PARR Entrance 
PARR 
PARR 
PARR 
PARR 
PARR Exit* 
PARR: Record temp on entrance to and exit from PARR and any other temp< 36.0 •c and readings 
after this until temp returns to 36.o•c again 
PARR Exit Time: 
-----
TemR e C) Mode Time/Date Intervention 
Surgical Unit 
Entrance 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical unit:_Record temp on entrance to surgical unit and any other temp < 36.0 •c and readings 
after this until temp returns to 36.o•c again 
Date of postop visit with surgeon: _________ _ 
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SSI surveillance: 
Purulent Drainage: Yes D No D Location: ___________ _ 
Painffenderness: Yes D No D Location:------------
Localized swelling: Yes D No D Location:------------
Redness: Yes D NoD Location:------------
Heat: Yes D No D Location:------------
Superficial incision deliberately opened by surgeon: Yes D No D 
Deep incision spontaneously dehisces: Yes D No D 
Deep incision is deliberately opened by the physician: Yes D No D 
Abscess/ Other evidence of infections on direct examination, during reoperation, or 
by histopathologic or radiologic exam: Yes D No D Location: _ ______ _ 
Surgeon/Attending Physician diagnosis: Yes D No D 
Mi~robiology report: Yes D No D Date done: 
---------
Type/Location of specimen: _____ _ _ 
Organism identified _______ _ 
Culture positive: Yes. D No D 
Fever (> 38 ° C): Yes D No D 
Conclusion from above data: 
Superficial SSI D Deep incisional SSI D 
Organ/Space SSI D Location of SSI: ____ ___ _ 
No infection developed D 
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Where and when was SSI identified: 
Postop unit 0 Date: ______ _ 
ER 0 Date: 
-----------
OPD 0 Date: 
----------
Vascular lab 0 Date: 
------
Treatment prescribed for infection: 
0 None 0 PO Antibiotics 0 IV antibiotics 0 Reoperation 
0 Dressings 0 Follow up with family MD 0 Rehospitalization 
Other Nosocomial Infections: 
0 Urinary 0 Pneumonia 0 VAD 0 Other ________ _ 
Date: Treatment: 
------ ----------
Laboratory Results: 
HbAlC % Date done: Not available: 0 
------ ------
Ferritin level: Date done: Not available: 0 
------ -----
WBC preop: _________ Date and Time done: ______ _ 
WBC postop: _________ Date and Time done: _________ _ 
Hemoglobin and Blood Loss 
Value Dateffime Treatment 
Hemoglobin preop 
Hemoglobin intraop 
Hemoglobin PARR 
Hemoglobin postop 
Hemoglobin postop 
Hemoglobin postop 
Hemoglobin postop 
Codes: Treatment: I - iron supplement; PRBC - packed red blood cells; W - Whole 
blood 
Glucose 
Preop- record the preop glucose measurement closest to the time of surgery 
lntraop- record all glucose levels in the OR and PARR 
240 
Postop- record the glucose measurements postop up to and including postop day# 7 for any glucose 
levels> 11.1 mmoi/L 
Codes: 
Mode: s- serum; b- bedside monitoring 
Intervention: SC- subcutaneous; IV- intravenous; PO- by mouth; ST- stat; R-
routine 
Glucose Time Intervention 
Level Date 
mmoUL 
Preop 
Intraop 
Intraop 
Intraop 
Intraop 
PARR 
PARR 
PARR 
PARR 
PARR 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
241 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Surgical Unit 
Other complications: 
Appendix E: Letters of Approval 
Human Investigation Committee (HIC) 
Research Proposal Approval Committee (RP AC) 
Program Director: Surgery Program 
Program Director: Perioperative Program 
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Hum.m Investigation Committee 
Research .md Gr.1du.1te Studies 
Faculty ot .\!edicine 
The Health Sciences Centre 
July 11, 2006 
Reference #06.129 
Ms. K. Dobbin-Williams 
Clo Dr. D. Moralejo 
School of Nursing 
Memorial Univt:rsity of Newfoundland 
Dear Dr. Dobbin-Williams: 
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Your application entitled "An exploration of the relationship between hyperglycemia and hypothermia as 
risk factors for the development of a surgical site infection" was reviewed by a Sub-Committee of the Human 
Investigation Committee and full approval was granted. 
This will be reported to the full Human Investigation Committee, for their information, at the meeting scheduled 
for July 20, 2006. 
Full approval has been granted for one year. You will be contacted to complett: the annual form update 
approximately 8 weeks before the approval will lapse on July 11, 2007. It is your responsibility to ensure that 
:!-',i.: r~n~·.·;~! !Orrn ;s for\vardcd tc t!1c I·I!C offi..:~ nv~ 1~ .. : ,. h~,i :o Ja>·;i tJr~ur tu d,c rc:nt:\\ a1 Jatt; fut rev ic~· Ultd 
approval to continue the study. The annual renewal form can be downloaded from the 1-IlC website 
http: WW\'- .mcd.mun .ca, hie 'downloads/Anmtai% 20Updatc'Y..20Form.doc. 
For a hospital-bas;;:d study, it is your responsibility to seek the necessary approval from the Health Care 
Corporation of St. John's and/or other hospital boards as appropriate. 
This Research Ethics Board (the HIC) has reviewed and approved the application for the study v.hich is to be 
conducted by you as the qualified investigator named above ut the specified study site. This approval and the 
views of this Research Ethics Board have been documented in writing. ln addition, please be advised that the 
Human Investigation Committee currently operates according to the Tri-Council Policy Statement and applicable 
laws and regulations. 
Notwithstanding the approval of the HI C. the primary r':sponsibility for the ethical conduct of the investigation 
remains with you. 
We wish you success with you r study. 
Sincerely, 
John D. Harnt!lt, ,\ID. FRCPC 
Co-Chair 
!Iuman ln\·estigation Committee 
./Dfi ;RS j J 
C Or. t' . Loomis , Vice-Pres ident ( R~:scarch ). :VI UN 
Rich:.ml S. :"-Jt:unwn. PhD 
Co-Chair 
I Iuman Im cstigario n Cnmm itrce 
\lr . W. Miller. Director of Planning & Rt.:scar~ l1. HCCSJ 
Eastern 
I-lealth 
September 13, 2006 
Ms. K. Dobbin-Williams 
5 East 
St. Clare's 
Dear Ms. Dobbin-Williams: 
St. Clk4~1ercy Hosp1tal 
154 LeMarchant Road 
St. John's, NL 
Canada A 1 C 588 
T (709) 777-5000 
F: (709) 777-521 0 
www.easternhealth .ca 
Your research proposal "HIC # 06. 129- Hyperglycaemia and Hypothermia as risk factors 
for the development of a surgical site infection"was reviewed by the Research Proposals 
Approvals Committee (RPAC) of Eastern Health at its meeting on September 12, 2006 
and we are pleased to inform you that the proposal has been approved. 
The approval of this project is subject to the following conditions: 
• The project is conducted as outlined in the HIC approved protocol; 
• Adequate funding is secured to support the project; 
• In the case of Health Records, efforts will be made to accommodate requests 
based upon available resources. If you require access to records that cannot be 
accommodated, then additional fees may be levied to cover the cost; 
• A progress report being provided upon request. 
If you have any questions or comments, please contact Lynn Purchase, Manager of the 
Patient Research Centre at 777-7283. 
Sincerely, 
Mr. Wayne Miller 
Senior Director, Corporate Strategy & Research 
Chair, RPAC 
cc: Ms. Lynn Purchase, Manager, Patient Research Centre 
Ms. Elaine Warren, Program Director Surgery 
Dr. A. Felix, Clinical Chief Surgery 
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June ::;6. ::;oo6 
DeJr Committee ~!embc.:rs of HIC Jnd RPAC. 
lhJ\e n.:,·io;:\\cd KJren Dobbin-\\'illiJms· outline tor the study she proposes looking :l t 
h: pothc.:rmiJ Jnd hypt!rglycc.:m iJ JS rish: bctors for sur::;icJI site infel.:t ion. I Jm pk:1:>cJ t1J 
,Jt ·~c r· rh ~..· ' "rr0rr ,) fthe Sur~er: PrngrJm t~1 r thi s "fud: 
Sincen.:h·. 
EL1int.: \V~mcn 
Program Director 
Surgo::ry ProgrJm 
EJstcrn HcJ!th 
Dear Committee Members of HIC and RPAC, 
P . . 246 enoperatrve F'rofj ran. 
The General Hospital S ote 
300 Prince Philip Drive 
St. John's, NL 
Canada A 1 B 3V6 
T: 709-177-7796 
F: 709-177-6770 
www.easternhealth.ca 
June 29, 2006 
I have reviewed Karen Dobbin-Williams' outline for the study she proposes , looking at 
hypothermia and hyperglycemia as risk factors for surgical site infection. I arn please to 
offer the support of the Perioperative Program for th is study. 
Sincerely, 
Maria Tracey 
Perioperative Program Director 
Eastern Health 
MT/jmy 




